{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:53:01Z","timestamp":1794631981879,"version":"4.9.1"},"reference-count":776,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:00:00Z","timestamp":1663977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Strategic Research Area MultiPark (Multidisciplinary Research in neurodegenerative diseases), Lund University"},{"name":"The Swedish Alzheimer Foundation"},{"name":"The Swedish Brain Foundation"},{"DOI":"10.13039\/501100003173","name":"Crafoordska Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Swedish Medical Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A.E. Berger Foundation"},{"name":"Thurings Foundation"},{"name":"Swedish mental health foundation"},{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["721802"],"award-info":[{"award-number":["721802"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-124096OB-I00"],"award-info":[{"award-number":["PID2021-124096OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P18-RT-1372"],"award-info":[{"award-number":["P18-RT-1372"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009042","name":"Universidad de Sevilla","doi-asserted-by":"crossref","award":["US-1264806"],"award-info":[{"award-number":["US-1264806"]}],"id":[{"id":"10.13039\/100009042","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    ApoE is the major lipid and cholesterol carrier in the CNS. There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of\n                    <jats:italic>APOE4<\/jats:italic>\n                    is one of the most influential risk factors for the development of late-onset Alzheimer's disease (AD). Neuroinflammation has become the third hallmark of AD, together with Amyloid-\u03b2 plaques and neurofibrillary tangles of hyperphosphorylated aggregated tau protein. This review aims to broadly and extensively describe the differential aspects concerning apoE. Starting from the evolution of apoE to how\n                    <jats:italic>APOE's<\/jats:italic>\n                    single-nucleotide polymorphisms affect its structure, function, and involvement during health and disease. This review reflects on how\n                    <jats:italic>APOE's<\/jats:italic>\n                    polymorphisms impact critical aspects of AD pathology, such as the neuroinflammatory response, particularly the effect of APOE on astrocytic and microglial function and microglial dynamics, synaptic function, amyloid-\u03b2 load, tau pathology, autophagy, and cell\u2013cell communication. We discuss influential factors affecting AD pathology combined with the\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype, such as sex, age, diet, physical exercise, current therapies and clinical trials in the AD field. The impact of the\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype in other neurodegenerative diseases characterized by overt inflammation, e.g., alpha- synucleinopathies and Parkinson's disease, traumatic brain injury, stroke, amyotrophic lateral sclerosis, and multiple sclerosis, is also addressed. Therefore, this review gathers the most relevant findings related to the\n                    <jats:italic>APOE<\/jats:italic>\n                    genotype up to date and its implications on AD and CNS pathologies to provide a deeper understanding of the knowledge in the\n                    <jats:italic>APOE<\/jats:italic>\n                    field.\n                  <\/jats:p>","DOI":"10.1186\/s13024-022-00566-4","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T14:03:38Z","timestamp":1664028218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":283,"title":["APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-0059","authenticated-orcid":false,"given":"Rosal\u00eda","family":"Fern\u00e1ndez-Calle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine C.","family":"Konings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fronti\u00f1\u00e1n-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Garc\u00eda-Revilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Camprub\u00ed-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isak","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Boza-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Lu\u00eds","family":"Venero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta M.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar K.","family":"Gouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Deierborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,24]]},"reference":[{"key":"566_CR1","volume-title":"World Alzheimer Report 2021: Journey through the diagnosis of dementia","author":"S Gauthier","year":"2021","unstructured":"Gauthier S, Rosa-Neto P, Morais JA, Webster C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London: Alzheimer\u2019s Disease International; 2021."},{"issue":"8 Suppl","key":"566_CR2","first-page":"S177","volume":"26","author":"W Wong","year":"2020","unstructured":"Wong W. Economic burden of Alzheimer disease and managed care considerations. Am J Manag Care. 2020;26(8 Suppl):S177\u201383.","journal-title":"Am J Manag Care"},{"issue":"5054","key":"566_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"5","key":"566_CR4","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, et al. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2(5):a006270.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"566_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0014-4886(95)90041-1","volume":"131","author":"ME Harris","year":"1995","unstructured":"Harris ME, et al. Direct evidence of oxidative injury produced by the Alzheimer\u2019s beta-amyloid peptide (1\u201340) in cultured hippocampal neurons. Exp Neurol. 1995;131(2):193\u2013202.","journal-title":"Exp Neurol"},{"issue":"6","key":"566_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1515\/revneuro-2017-0063","volume":"29","author":"AB Reiss","year":"2018","unstructured":"Reiss AB, et al. Amyloid toxicity in Alzheimer\u2019s disease. Rev Neurosci. 2018;29(6):613\u201327.","journal-title":"Rev Neurosci"},{"key":"566_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","volume":"167","author":"JA Soria Lopez","year":"2019","unstructured":"Soria Lopez JA, Gonzalez HM, Leger GC. Alzheimer\u2019s disease. Handb Clin Neurol. 2019;167:231\u201355.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"566_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1750-3639.1993.tb00724.x","volume":"3","author":"KS Kosik","year":"1993","unstructured":"Kosik KS. The molecular and cellular biology of tau. Brain Pathol. 1993;3(1):39\u201343.","journal-title":"Brain Pathol"},{"issue":"7","key":"566_CR9","doi-asserted-by":"publisher","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","volume":"2","author":"EM Mandelkow","year":"2012","unstructured":"Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med. 2012;2(7):a006247.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"566_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):5\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"566_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fncel.2018.00338","volume":"12","author":"AD Alonso","year":"2018","unstructured":"Alonso AD, et al. Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability. Front Cell Neurosci. 2018;12:338.","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"566_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41583-020-0325-z","volume":"21","author":"S Saez-Atienzar","year":"2020","unstructured":"Saez-Atienzar S, Masliah E. Cellular senescence and Alzheimer disease: the egg and the chicken scenario. Nat Rev Neurosci. 2020;21(8):433\u201344.","journal-title":"Nat Rev Neurosci"},{"key":"566_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fncel.2020.00129","volume":"14","author":"CC Walton","year":"2020","unstructured":"Walton CC, et al. Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis. Front Cell Neurosci. 2020;14:129.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"566_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/WCO.0000000000000672","volume":"32","author":"C Duyckaerts","year":"2019","unstructured":"Duyckaerts C, Clavaguera F, Potier MC. The prion-like propagation hypothesis in Alzheimer\u2019s and Parkinson\u2019s disease. Curr Opin Neurol. 2019;32(2):266\u201371.","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"566_CR15","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u201333.","journal-title":"Brain"},{"issue":"1","key":"566_CR16","first-page":"2","volume":"6","author":"H Hampel","year":"2019","unstructured":"Hampel H, et al. Revisiting the Cholinergic Hypothesis in Alzheimer\u2019s Disease: Emerging Evidence from Translational and Clinical Research. J Prev Alzheimers Dis. 2019;6(1):2\u201315.","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"566_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14740338.2020.1721456","volume":"19","author":"A Haake","year":"2020","unstructured":"Haake A, et al. An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Expert Opin Drug Saf. 2020;19(2):147\u201357.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"566_CR18","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s12035-018-1188-4","volume":"56","author":"M Sochocka","year":"2019","unstructured":"Sochocka M, et al. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer\u2019s Disease-a Critical Review. Mol Neurobiol. 2019;56(3):1841\u201351.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"566_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/alz.12192","volume":"17","author":"AFT Arnsten","year":"2021","unstructured":"Arnsten AFT, et al. Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer\u2019s disease. Alzheimers Dement. 2021;17(1):115\u201324.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"566_CR20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jalz.2017.11.005","volume":"14","author":"CD Paspalas","year":"2018","unstructured":"Paspalas CD, et al. The aged rhesus macaque manifests Braak stage III\/IV Alzheimer\u2019s-like pathology. Alzheimers Dement. 2018;14(5):680\u201391.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"566_CR21","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference? Neurol Genet. 2020;6(5):e512.","journal-title":"Neurol Genet"},{"issue":"5","key":"566_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/gim.2015.117","volume":"18","author":"C Van Cauwenberghe","year":"2016","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2016;18(5):421\u201330.","journal-title":"Genet Med"},{"issue":"6311","key":"566_CR23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"4","key":"566_CR24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3233\/JAD-130746","volume":"37","author":"AJ Larner","year":"2013","unstructured":"Larner AJ. Presenilin-1 mutations in Alzheimer\u2019s disease: an update on genotype-phenotype relationships. J Alzheimers Dis. 2013;37(4):653\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"6534","key":"566_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"5226","key":"566_CR26","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.7638621","volume":"269","author":"E Levy-Lahad","year":"1995","unstructured":"Levy-Lahad E, et al. A familial Alzheimer\u2019s disease locus on chromosome 1. Science. 1995;269(5226):970\u20133.","journal-title":"Science"},{"issue":"6543","key":"566_CR27","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, et al. Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature. 1995;376(6543):775\u20138.","journal-title":"Nature"},{"issue":"1","key":"566_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/archneurol.2011.221","volume":"69","author":"TS Wingo","year":"2012","unstructured":"Wingo TS, et al. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol. 2012;69(1):59\u201364.","journal-title":"Arch Neurol"},{"issue":"6","key":"566_CR29","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 2016;12(6):733\u201348.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"566_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, et al. Early-Onset Alzheimer\u2019s Disease: What Is Missing in Research? Curr Neurol Neurosci Rep. 2021;21(2):4.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"566_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/B978-0-444-64076-5.00026-0","volume":"148","author":"S Carmona","year":"2018","unstructured":"Carmona S, Hardy J, Guerreiro R. The genetic landscape of Alzheimer disease. Handb Clin Neurol. 2018;148:395\u2013408.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"566_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ana.410430519","volume":"43","author":"JC Troncoso","year":"1998","unstructured":"Troncoso JC, et al. Neuropathology of preclinical and clinical late-onset Alzheimer\u2019s disease. Ann Neurol. 1998;43(5):673\u20136.","journal-title":"Ann Neurol"},{"issue":"1","key":"566_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, et al. APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):63.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"566_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, et al. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"key":"566_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol. 2008;8:9.","journal-title":"BMC Neurol"},{"issue":"12","key":"566_CR36","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","volume":"18","author":"Y Shi","year":"2018","unstructured":"Shi Y, Holtzman DM. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat Rev Immunol. 2018;18(12):759\u201372.","journal-title":"Nat Rev Immunol"},{"key":"566_CR37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jocn.2018.10.034","volume":"59","author":"MH Ahmad","year":"2019","unstructured":"Ahmad MH, Fatima M, Mondal AC. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease: Rational insights for the therapeutic approaches. J Clin Neurosci. 2019;59:6\u201311.","journal-title":"J Clin Neurosci"},{"key":"566_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2019.00014","volume":"11","author":"CG Fernandez","year":"2019","unstructured":"Fernandez CG, et al. The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer\u2019s Disease. Front Aging Neurosci. 2019;11:14.","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"566_CR39","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/nan.12529","volume":"45","author":"M Tzioras","year":"2019","unstructured":"Tzioras M, et al. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2019;45(4):327\u201346.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"566_CR40","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture. Nat Commun. 2020;11(1):4799.","journal-title":"Nat Commun"},{"issue":"4","key":"566_CR41","doi-asserted-by":"publisher","first-page":"a023705","DOI":"10.1101\/cshperspect.a023705","volume":"9","author":"FI Hinz","year":"2017","unstructured":"Hinz FI, Geschwind DH. Molecular Genetics of Neurodegenerative Dementias. Cold Spring Harb Perspect Biol. 2017;9(4):a023705.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"566_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"7","key":"566_CR43","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141(7):2181\u201393.","journal-title":"Brain"},{"issue":"1","key":"566_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cbf.1396","volume":"26","author":"M Kasap","year":"2008","unstructured":"Kasap M, et al. Apolipoprotein E phylogeny and evolution. Cell Biochem Funct. 2008;26(1):43\u201350.","journal-title":"Cell Biochem Funct"},{"issue":"10","key":"566_CR45","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S0022-2275(20)34273-5","volume":"26","author":"HA Barakat","year":"1985","unstructured":"Barakat HA, St Clair RW. Characterization of plasma lipoproteins of grain- and cholesterol-fed White Carneau and Show Racer pigeons. J Lipid Res. 1985;26(10):1252\u201368.","journal-title":"J Lipid Res"},{"key":"566_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ygcen.2017.05.023","volume":"256","author":"CV Mello","year":"2018","unstructured":"Mello CV, Lovell PV. Avian genomics lends insights into endocrine function in birds. Gen Comp Endocrinol. 2018;256:123\u20139.","journal-title":"Gen Comp Endocrinol"},{"issue":"1","key":"566_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12862-019-1519-8","volume":"19","author":"J-Q Liu","year":"2019","unstructured":"Liu J-Q, et al. Gain and loss events in the evolution of the apolipoprotein family in vertebrata. BMC Evol Biol. 2019;19(1):209.","journal-title":"BMC Evol Biol"},{"key":"566_CR48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.arr.2017.06.002","volume":"37","author":"P Huebbe","year":"2017","unstructured":"Huebbe P, Rimbach G. Evolution of human apolipoprotein E (APOE) isoforms: Gene structure, protein function and interaction with dietary factors. Ageing Res Rev. 2017;37:146\u201361.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"566_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1515\/bc.2010.129","volume":"391","author":"M Dieckmann","year":"2010","unstructured":"Dieckmann M, Dietrich MF, Herz J. Lipoprotein receptors\u2013an evolutionarily ancient multifunctional receptor family. Biol Chem. 2010;391(11):1341\u201363.","journal-title":"Biol Chem"},{"issue":"10","key":"566_CR50","doi-asserted-by":"publisher","first-page":"e47760","DOI":"10.1371\/journal.pone.0047760","volume":"7","author":"AM McIntosh","year":"2012","unstructured":"McIntosh AM, et al. The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes). PLoS ONE. 2012;7(10):e47760.","journal-title":"PLoS ONE"},{"issue":"5","key":"566_CR51","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/rej.2011.1169","volume":"14","author":"D Seripa","year":"2011","unstructured":"Seripa D, et al. The genetics of the human APOE polymorphism. Rejuvenation Res. 2011;14(5):491\u2013500.","journal-title":"Rejuvenation Res"},{"issue":"1","key":"566_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1086\/381662","volume":"79","author":"CE Finch","year":"2004","unstructured":"Finch CE, Stanford CB. Meat-adaptive genes and the evolution of slower aging in humans. Q Rev Biol. 2004;79(1):3\u201350.","journal-title":"Q Rev Biol"},{"issue":"5","key":"566_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.tins.2014.03.001","volume":"37","author":"DA Raichlen","year":"2014","unstructured":"Raichlen DA, Alexander GE. Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci. 2014;37(5):247\u201355.","journal-title":"Trends Neurosci"},{"issue":"5","key":"566_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00109-012-0901-4","volume":"90","author":"W Enard","year":"2012","unstructured":"Enard W. Functional primate genomics\u2013leveraging the medical potential. J Mol Med (Berl). 2012;90(5):471\u201380.","journal-title":"J Mol Med (Berl)"},{"key":"566_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","volume":"45","author":"KH Weisgraber","year":"1994","unstructured":"Weisgraber KH. Apolipoprotein E: structure-function relationships. Adv Protein Chem. 1994;45:249\u2013302.","journal-title":"Adv Protein Chem"},{"issue":"20","key":"566_CR56","doi-asserted-by":"publisher","first-page":"11587","DOI":"10.1073\/pnas.201279298","volume":"98","author":"RL Raffai","year":"2001","unstructured":"Raffai RL, et al. Introduction of human apolipoprotein E4 \u201cdomain interaction\u201d into mouse apolipoprotein E. Proc Natl Acad Sci U S A. 2001;98(20):11587\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"566_CR57","doi-asserted-by":"publisher","first-page":"e0179497","DOI":"10.1371\/journal.pone.0179497","volume":"12","author":"E van Exel","year":"2017","unstructured":"van Exel E, et al. Effect of APOE epsilon4 allele on survival and fertility in an adverse environment. PLoS ONE. 2017;12(7):e0179497.","journal-title":"PLoS ONE"},{"issue":"4","key":"566_CR58","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1096\/fj.201601084R","volume":"31","author":"BC Trumble","year":"2017","unstructured":"Trumble BC, et al. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. FASEB J. 2017;31(4):1508\u201315.","journal-title":"FASEB J"},{"issue":"4","key":"566_CR59","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1086\/303070","volume":"67","author":"SM Fullerton","year":"2000","unstructured":"Fullerton SM, et al. Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67(4):881\u2013900.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"566_CR60","doi-asserted-by":"publisher","first-page":"e10022","DOI":"10.1371\/journal.pone.0010022","volume":"5","author":"F Drenos","year":"2010","unstructured":"Drenos F, Kirkwood TB. Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E. PLoS ONE. 2010;5(4):e10022.","journal-title":"PLoS ONE"},{"issue":"10","key":"566_CR61","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1016\/S0021-9258(18)88963-3","volume":"260","author":"HK Das","year":"1985","unstructured":"Das HK, et al. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem. 1985;260(10):6240\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"566_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis. Neuron. 2021;109(2):205\u201321.","journal-title":"Neuron"},{"issue":"12","key":"566_CR63","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/pro.2379","volume":"22","author":"C Frieden","year":"2013","unstructured":"Frieden C, Garai K. Concerning the structure of apoE. Protein Sci. 2013;22(12):1820\u20135.","journal-title":"Protein Sci"},{"issue":"5","key":"566_CR64","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","volume":"257","author":"KH Weisgraber","year":"1982","unstructured":"Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257(5):2518\u201321.","journal-title":"J Biol Chem"},{"issue":"3","key":"566_CR65","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2007.04831.x","volume":"103","author":"B Maloney","year":"2007","unstructured":"Maloney B, et al. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer\u2019s disease. J Neurochem. 2007;103(3):1237\u201357.","journal-title":"J Neurochem"},{"issue":"3","key":"566_CR66","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nbdi.2002.0483","volume":"9","author":"AM Fagan","year":"2002","unstructured":"Fagan AM, et al. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2002;9(3):305\u201318.","journal-title":"Neurobiol Dis"},{"key":"566_CR67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s40478-015-0250-y","volume":"3","author":"F Liao","year":"2015","unstructured":"Liao F, et al. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models. Acta Neuropathol Commun. 2015;3:70.","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"566_CR68","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1194\/jlr.R076315","volume":"58","author":"LM Tai","year":"2017","unstructured":"Tai LM, et al. EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer\u2019s disease. J Lipid Res. 2017;58(9):1733\u201355.","journal-title":"J Lipid Res"},{"issue":"1","key":"566_CR69","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajpa.21298","volume":"143","author":"DT Eisenberg","year":"2010","unstructured":"Eisenberg DT, Kuzawa CW, Hayes MG. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol. 2010;143(1):100\u201311.","journal-title":"Am J Phys Anthropol"},{"issue":"3","key":"566_CR70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3233\/JAD-2008-13303","volume":"13","author":"LM Bekris","year":"2008","unstructured":"Bekris LM, et al. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis. 2008;13(3):255\u201366.","journal-title":"J Alzheimers Dis"},{"key":"566_CR71","doi-asserted-by":"publisher","first-page":"630502","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain MA, Laurent B, Plourde M. APOE and Alzheimer\u2019s Disease: From Lipid Transport to Physiopathology and Therapeutics. Front Neurosci. 2021;15:630502.","journal-title":"Front Neurosci"},{"issue":"3","key":"566_CR72","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/genes10030222","volume":"10","author":"P Abondio","year":"2019","unstructured":"Abondio P, et al. The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity. Genes (Basel). 2019;10(3):222.","journal-title":"Genes (Basel)"},{"issue":"3","key":"566_CR73","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/aje\/kwu442","volume":"181","author":"S Kern","year":"2015","unstructured":"Kern S, et al. The distribution of apolipoprotein E genotype over the adult lifespan and in relation to country of birth. Am J Epidemiol. 2015;181(3):214\u20137.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"566_CR74","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680\u20133.","journal-title":"Nat Med"},{"issue":"2","key":"566_CR75","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1172\/JCI113096","volume":"80","author":"MR Wardell","year":"1987","unstructured":"Wardell MR, et al. Apolipoprotein E2-Christchurch (136 Arg\u2013\u2013Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia. J Clin Invest. 1987;80(2):483\u201390.","journal-title":"J Clin Invest"},{"issue":"8","key":"566_CR76","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/S0021-9258(18)68957-4","volume":"263","author":"A Lalazar","year":"1988","unstructured":"Lalazar A, et al. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J Biol Chem. 1988;263(8):3542\u20135.","journal-title":"J Biol Chem"},{"key":"566_CR77","doi-asserted-by":"publisher","unstructured":"Hernandez I, Gelpi E, Molina-Porcel L, Bernal S, Rodr\u00edguez-Santiago B, Dols-Icardo O, Ruiz A, Alcolea D, Boada M, Lle\u00f3 A, Clarim\u00f3n J. Heterozygous APOE Christchurch in familial Alzheimer's disease without mutations in other Mendelian genes. Neuropathol Appl Neurobiol. 2021;47(4):579-82. https:\/\/doi.org\/10.1111\/nan.12670.","DOI":"10.1111\/nan.12670"},{"issue":"613","key":"566_CR78","doi-asserted-by":"publisher","first-page":"eabc9375","DOI":"10.1126\/scitranslmed.abc9375","volume":"13","author":"CC Liu","year":"2021","unstructured":"Liu CC, et al. APOE3-Jacksonville (V236E) variant reduces self-aggregation and risk of dementia. Sci Transl Med. 2021;13(613):eabc9375.","journal-title":"Sci Transl Med"},{"issue":"5","key":"566_CR79","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","volume":"96","author":"M Kockx","year":"2018","unstructured":"Kockx M, Traini M, Kritharides L. Cell-specific production, secretion, and function of apolipoprotein E. J Mol Med (Berl). 2018;96(5):361\u201371.","journal-title":"J Mol Med (Berl)"},{"issue":"26","key":"566_CR80","doi-asserted-by":"publisher","first-page":"13340","DOI":"10.1016\/S0021-9258(18)37710-X","volume":"263","author":"YK Paik","year":"1988","unstructured":"Paik YK, et al. Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem. 1988;263(26):13340\u20139.","journal-title":"J Biol Chem"},{"issue":"4","key":"566_CR81","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI112130","volume":"76","author":"JK Boyles","year":"1985","unstructured":"Boyles JK, et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76(4):1501\u201313.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"566_CR82","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2004.11.005","volume":"19","author":"M Morikawa","year":"2005","unstructured":"Morikawa M, et al. Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-beta. Neurobiol Dis. 2005;19(1\u20132):66\u201376.","journal-title":"Neurobiol Dis"},{"key":"566_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainres.2009.12.039","volume":"1315","author":"IB Bruinsma","year":"2010","unstructured":"Bruinsma IB, et al. Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1\u201340)-mediated cell death. Brain Res. 2010;1315:169\u201380.","journal-title":"Brain Res"},{"issue":"19","key":"566_CR84","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci. 2006;26(19):4985\u201394.","journal-title":"J Neurosci"},{"issue":"2","key":"566_CR85","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2353\/ajpath.2010.090973","volume":"177","author":"M Buttini","year":"2010","unstructured":"Buttini M, et al. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol. 2010;177(2):563\u20139.","journal-title":"Am J Pathol"},{"issue":"6","key":"566_CR86","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1161\/CIRCRESAHA.107.157198","volume":"101","author":"M Kockx","year":"2007","unstructured":"Kockx M, et al. Secretion of apolipoprotein E from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network. Circ Res. 2007;101(6):607\u201316.","journal-title":"Circ Res"},{"issue":"9","key":"566_CR87","doi-asserted-by":"publisher","first-page":"e1601576","DOI":"10.1126\/sciadv.1601576","volume":"3","author":"M Frenkel-Pinter","year":"2017","unstructured":"Frenkel-Pinter M, et al. Interplay between protein glycosylation pathways in Alzheimer\u2019s disease. Sci Adv. 2017;3(9):e1601576.","journal-title":"Sci Adv"},{"issue":"1","key":"566_CR88","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13195-020-00664-9","volume":"12","author":"CP Boix","year":"2020","unstructured":"Boix CP, et al. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):96.","journal-title":"Alzheimers Res Ther"},{"key":"566_CR89","doi-asserted-by":"publisher","first-page":"625348","DOI":"10.3389\/fnins.2020.625348","volume":"14","author":"H Haukedal","year":"2020","unstructured":"Haukedal H, Freude KK. Implications of Glycosylation in Alzheimer\u2019s Disease. Front Neurosci. 2020;14:625348.","journal-title":"Front Neurosci"},{"issue":"2","key":"566_CR90","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/glycob\/cwz084","volume":"30","author":"SA Flowers","year":"2020","unstructured":"Flowers SA, et al. O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain. Glycobiology. 2020;30(2):74\u201385.","journal-title":"Glycobiology"},{"issue":"19","key":"566_CR91","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/1873-3468.12702","volume":"591","author":"IG Schulman","year":"2017","unstructured":"Schulman IG. Liver X receptors link lipid metabolism and inflammation. FEBS Lett. 2017;591(19):2978\u201391.","journal-title":"FEBS Lett"},{"key":"566_CR92","doi-asserted-by":"publisher","unstructured":"Carb\u00f3 JM, Le\u00f3n TE, Font-D\u00edaz J, De la Rosa JV, Castrillo A, Picard FR, Staudenraus D, Huber M, Ced\u00f3 L, Escol\u00e0-Gil JC, Campos L, Bakiri L, Wagner EF, Caelles C, Stratmann T, Van Ginderachter JA, Valledor AF. Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment. Cancer Res. 2021;81(4):968-85. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3360.","DOI":"10.1158\/0008-5472.CAN-19-3360"},{"key":"566_CR93","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3389\/fimmu.2019.01811","volume":"10","author":"E Wouters","year":"2019","unstructured":"Wouters E, et al. Liver X Receptor Alpha Is Important in Maintaining Blood-Brain Barrier Function. Front Immunol. 2019;10:1811.","journal-title":"Front Immunol"},{"issue":"9","key":"566_CR94","doi-asserted-by":"publisher","first-page":"6925","DOI":"10.1002\/jcp.26480","volume":"233","author":"MS Spagnuolo","year":"2018","unstructured":"Spagnuolo MS, et al. Brain-derived neurotrophic factor modulates cholesterol homeostasis and Apolipoprotein E synthesis in human cell models of astrocytes and neurons. J Cell Physiol. 2018;233(9):6925\u201343.","journal-title":"J Cell Physiol"},{"issue":"1","key":"566_CR95","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13041-020-00609-1","volume":"13","author":"W Zhao","year":"2020","unstructured":"Zhao W, et al. Axl receptor tyrosine kinase is a regulator of apolipoprotein E. Mol Brain. 2020;13(1):66.","journal-title":"Mol Brain"},{"issue":"6","key":"566_CR96","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrd4280","volume":"13","author":"C Hong","year":"2014","unstructured":"Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov. 2014;13(6):433\u201344.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"566_CR97","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41582-020-0315-9","volume":"16","author":"H Wood","year":"2020","unstructured":"Wood H. Retinoid X receptor mediates brain clean-up after stroke. Nat Rev Neurol. 2020;16(3):128\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"566_CR98","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/13543776.2019.1643322","volume":"29","author":"S Schierle","year":"2019","unstructured":"Schierle S, Merk D. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents. Expert Opin Ther Pat. 2019;29(8):605\u201321.","journal-title":"Expert Opin Ther Pat"},{"issue":"18","key":"566_CR99","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1111\/bph.14668","volume":"176","author":"NF Fitz","year":"2019","unstructured":"Fitz NF, et al. Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer\u2019s disease. Br J Pharmacol. 2019;176(18):3599\u2013610.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"566_CR100","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/156720507780362227","volume":"4","author":"R Koldamova","year":"2007","unstructured":"Koldamova R, Lefterov I. Role of LXR and ABCA1 in the pathogenesis of Alzheimer\u2019s disease - implications for a new therapeutic approach. Curr Alzheimer Res. 2007;4(2):171\u20138.","journal-title":"Curr Alzheimer Res"},{"issue":"4","key":"566_CR101","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.3390\/ijms22041593","volume":"22","author":"L Jacobo-Albavera","year":"2021","unstructured":"Jacobo-Albavera L, et al. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease. Int J Mol Sci. 2021;22(4):1593.","journal-title":"Int J Mol Sci"},{"issue":"38","key":"566_CR102","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1523\/JNEUROSCI.1937-12.2012","volume":"32","author":"NF Fitz","year":"2012","unstructured":"Fitz NF, et al. Abca1 deficiency affects Alzheimer\u2019s disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. J Neurosci. 2012;32(38):13125\u201336.","journal-title":"J Neurosci"},{"issue":"48","key":"566_CR103","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1523\/JNEUROSCI.1400-19.2019","volume":"39","author":"V Rawat","year":"2019","unstructured":"Rawat V, et al. ApoE4 Alters ABCA1 Membrane Trafficking in Astrocytes. J Neurosci. 2019;39(48):9611\u201322.","journal-title":"J Neurosci"},{"issue":"7","key":"566_CR104","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","volume":"36","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism. Arterioscler Thromb Vasc Biol. 2016;36(7):1305\u201315.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"566_CR105","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","volume":"109","author":"K Nieweg","year":"2009","unstructured":"Nieweg K, Schaller H, Pfrieger FW. Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem. 2009;109(1):125\u201334.","journal-title":"J Neurochem"},{"issue":"11","key":"566_CR106","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/molcells.2014.0248","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim J, et al. Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Mol Cells. 2014;37(11):767\u201376.","journal-title":"Mol Cells"},{"issue":"39","key":"566_CR107","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.1054-16.2016","volume":"36","author":"C Lane-Donovan","year":"2016","unstructured":"Lane-Donovan C, et al. Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice. J Neurosci. 2016;36(39):10141\u201350.","journal-title":"J Neurosci"},{"issue":"3","key":"566_CR108","doi-asserted-by":"publisher","first-page":"e0229240","DOI":"10.1371\/journal.pone.0229240","volume":"15","author":"Y Tensaouti","year":"2020","unstructured":"Tensaouti Y, Yu TS, Kernie SG. Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury. PLoS ONE. 2020;15(3):e0229240.","journal-title":"PLoS ONE"},{"issue":"8","key":"566_CR109","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbalip.2010.02.007","volume":"1801","author":"JE Vance","year":"2010","unstructured":"Vance JE, Hayashi H. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta. 2010;1801(8):806\u201318.","journal-title":"Biochim Biophys Acta"},{"key":"566_CR110","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.nbd.2013.01.018","volume":"54","author":"JM Karasinska","year":"2013","unstructured":"Karasinska JM, et al. ABCA1 influences neuroinflammation and neuronal death. Neurobiol Dis. 2013;54:445\u201355.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"566_CR111","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1194\/jlr.M700364-JLR200","volume":"49","author":"PT Tarr","year":"2008","unstructured":"Tarr PT, Edwards PA. ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2. J Lipid Res. 2008;49(1):169\u201382.","journal-title":"J Lipid Res"},{"issue":"11","key":"566_CR112","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/1873-3468.13428","volume":"593","author":"E Hubin","year":"2019","unstructured":"Hubin E, et al. Apolipoprotein E associated with reconstituted high-density lipoprotein-like particles is protected from aggregation. FEBS Lett. 2019;593(11):1144\u201353.","journal-title":"FEBS Lett"},{"issue":"38","key":"566_CR113","doi-asserted-by":"publisher","first-page":"11657","DOI":"10.1021\/bi000099m","volume":"39","author":"JA Morrow","year":"2000","unstructured":"Morrow JA, et al. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. Biochemistry. 2000;39(38):11657\u201366.","journal-title":"Biochemistry"},{"issue":"17","key":"566_CR114","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/ijms21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW. ApoE Lipidation as a Therapeutic Target in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21(17):6336.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"566_CR115","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"566_CR116","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/07853890701214881","volume":"39","author":"P May","year":"2007","unstructured":"May P, et al. The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med. 2007;39(3):219\u201328.","journal-title":"Ann Med"},{"issue":"4","key":"566_CR117","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","volume":"83","author":"N Zhao","year":"2018","unstructured":"Zhao N, et al. Apolipoprotein E, Receptors, and Modulation of Alzheimer\u2019s Disease. Biol Psychiatry. 2018;83(4):347\u201357.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"566_CR118","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","volume":"46","author":"J Ruiz","year":"2005","unstructured":"Ruiz J, et al. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. J Lipid Res. 2005;46(8):1721\u201331.","journal-title":"J Lipid Res"},{"issue":"5","key":"566_CR119","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrn2620","volume":"10","author":"G Bu","year":"2009","unstructured":"Bu G. Apolipoprotein E and its receptors in Alzheimer\u2019s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci. 2009;10(5):333\u201344.","journal-title":"Nat Rev Neurosci"},{"issue":"10","key":"566_CR120","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3390\/ijms19103090","volume":"19","author":"P Dlugosz","year":"2018","unstructured":"Dlugosz P, Nimpf J. The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor. Int J Mol Sci. 2018;19(10):3090.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"566_CR121","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/biom10060964","volume":"10","author":"Y Jossin","year":"2020","unstructured":"Jossin Y. Reelin Functions, Mechanisms of Action and Signaling Pathways During Brain Development and Maturation. Biomolecules. 2020;10(6):964.","journal-title":"Biomolecules"},{"issue":"2","key":"566_CR122","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0896-6273(00)80860-0","volume":"24","author":"G D'Arcangelo","year":"1999","unstructured":"D\u2019Arcangelo G, et al. Reelin is a ligand for lipoprotein receptors. Neuron. 1999;24(2):471\u20139.","journal-title":"Neuron"},{"key":"566_CR123","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1326-6-30","volume":"6","author":"SS Reddy","year":"2011","unstructured":"Reddy SS, et al. Similarities and differences in structure, expression, and functions of VLDLR and ApoER2. Mol Neurodegener. 2011;6:30.","journal-title":"Mol Neurodegener"},{"key":"566_CR124","doi-asserted-by":"publisher","first-page":"30","DOI":"10.20517\/2347-8659.2018.26","volume":"5","author":"M Leon","year":"2018","unstructured":"Leon M, et al. Therapeutic approach targeting apolipoprotein E binding region and low-density lipoprotein receptor for Alzheimer\u2019s disease. Neuroimmunol Neuroinflammation. 2018;5:30.","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"566_CR125","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.dadm.2018.10.005","volume":"11","author":"TJ Nelson","year":"2019","unstructured":"Nelson TJ, Sen A. Apolipoprotein E particle size is increased in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2019;11:10\u20138.","journal-title":"Alzheimers Dement (Amst)"},{"key":"566_CR126","doi-asserted-by":"publisher","first-page":"e68231","DOI":"10.7554\/eLife.68231","volume":"10","author":"AR Garcia","year":"2021","unstructured":"Garcia AR, et al. APOE4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical Amerindian subsistence population. Elife. 2021;10:e68231.","journal-title":"Elife"},{"issue":"20","key":"566_CR127","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1021\/acs.jpcb.1c03011","volume":"125","author":"DD Prakashchand","year":"2021","unstructured":"Prakashchand DD, Mondal J. Conformational Reorganization of Apolipoprotein E Triggered by Phospholipid Assembly. J Phys Chem B. 2021;125(20):5285\u201395.","journal-title":"J Phys Chem B"},{"issue":"13","key":"566_CR128","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1021\/bi1020106","volume":"50","author":"K Garai","year":"2011","unstructured":"Garai K, Baban B, Frieden C. Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles. Biochemistry. 2011;50(13):2550\u20138.","journal-title":"Biochemistry"},{"key":"566_CR129","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1423-0127-18-4","volume":"18","author":"YH Hsieh","year":"2011","unstructured":"Hsieh YH, Chou CY. Structural and functional characterization of human apolipoprotein E 72\u2013166 peptides in both aqueous and lipid environments. J Biomed Sci. 2011;18:4.","journal-title":"J Biomed Sci"},{"issue":"53","key":"566_CR130","doi-asserted-by":"publisher","first-page":"55483","DOI":"10.1074\/jbc.M409324200","volume":"279","author":"J Heeren","year":"2004","unstructured":"Heeren J, et al. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J Biol Chem. 2004;279(53):55483\u201392.","journal-title":"J Biol Chem"},{"issue":"6","key":"566_CR131","doi-asserted-by":"publisher","first-page":"e1006165","DOI":"10.1371\/journal.pcbi.1006165","volume":"14","author":"N Henry","year":"2018","unstructured":"Henry N, et al. Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach. PLoS Comput Biol. 2018;14(6):e1006165.","journal-title":"PLoS Comput Biol"},{"key":"566_CR132","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.jbc.2021.100715","volume":"296","author":"JM Cooper","year":"2021","unstructured":"Cooper JM, et al. Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism. J Biol Chem. 2021;296:100715.","journal-title":"J Biol Chem"},{"key":"566_CR133","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2021.05.007","volume":"328","author":"YA Khalil","year":"2021","unstructured":"Khalil YA, et al. APOE gene variants in primary dyslipidemia. Atherosclerosis. 2021;328:11\u201322.","journal-title":"Atherosclerosis"},{"issue":"1","key":"566_CR134","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12863-021-00968-1","volume":"22","author":"XN Zhao","year":"2021","unstructured":"Zhao XN, et al. Association between apolipoprotein gene polymorphisms and hyperlipidemia: a meta-analysis. BMC Genom Data. 2021;22(1):14.","journal-title":"BMC Genom Data"},{"issue":"1","key":"566_CR135","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41398-022-01881-6","volume":"12","author":"AM Miranda","year":"2022","unstructured":"Miranda AM, et al. Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice. Transl Psychiatry. 2022;12(1):129.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"566_CR136","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov I, et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res Ther. 2019;11(1):113.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"566_CR137","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1038\/s41467-021-23762-0","volume":"12","author":"NF Fitz","year":"2021","unstructured":"Fitz NF, et al. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease. Nat Commun. 2021;12(1):3416.","journal-title":"Nat Commun"},{"issue":"32","key":"566_CR138","doi-asserted-by":"publisher","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","volume":"271","author":"LM Dong","year":"1996","unstructured":"Dong LM, Weisgraber KH. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 1996;271(32):19053\u20137.","journal-title":"J Biol Chem"},{"issue":"51","key":"566_CR139","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1021\/bi1017655","volume":"49","author":"D Nguyen","year":"2010","unstructured":"Nguyen D, et al. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry. 2010;49(51):10881\u20139.","journal-title":"Biochemistry"},{"issue":"4","key":"566_CR140","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/ATVBAHA.112.301193","volume":"33","author":"H Li","year":"2013","unstructured":"Li H, et al. Molecular mechanisms responsible for the differential effects of apoE3 and apoE4 on plasma lipoprotein-cholesterol levels. Arterioscler Thromb Vasc Biol. 2013;33(4):687\u201393.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"566_CR141","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.1705080114","volume":"114","author":"C Frieden","year":"2017","unstructured":"Frieden C, Wang H, Ho CMW. A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions. Proc Natl Acad Sci U S A. 2017;114(24):6292\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"566_CR142","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0014-5793(99)01285-5","volume":"459","author":"VV Shuvaev","year":"1999","unstructured":"Shuvaev VV, Laffont I, Siest G. Kinetics of apolipoprotein E isoforms-binding to the major glycosaminoglycans of the extracellular matrix. FEBS Lett. 1999;459(3):353\u20137.","journal-title":"FEBS Lett"},{"issue":"25","key":"566_CR143","doi-asserted-by":"publisher","first-page":"6702","DOI":"10.1021\/bi8003999","volume":"47","author":"Y Yamauchi","year":"2008","unstructured":"Yamauchi Y, et al. Role of the N- and C-terminal domains in binding of apolipoprotein E isoforms to heparan sulfate and dermatan sulfate: a surface plasmon resonance study. Biochemistry. 2008;47(25):6702\u201310.","journal-title":"Biochemistry"},{"issue":"7","key":"566_CR144","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1074\/jbc.M411719200","volume":"280","author":"M Futamura","year":"2005","unstructured":"Futamura M, et al. Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces. J Biol Chem. 2005;280(7):5414\u201322.","journal-title":"J Biol Chem"},{"issue":"14","key":"566_CR145","doi-asserted-by":"publisher","first-page":"10160","DOI":"10.1016\/S0021-9258(18)82186-X","volume":"268","author":"ZS Ji","year":"1993","unstructured":"Ji ZS, et al. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J Biol Chem. 1993;268(14):10160\u20137.","journal-title":"J Biol Chem"},{"issue":"17","key":"566_CR146","doi-asserted-by":"publisher","first-page":"14782","DOI":"10.1074\/jbc.M213207200","volume":"278","author":"H Saito","year":"2003","unstructured":"Saito H, et al. Characterization of the heparin binding sites in human apolipoprotein E. J Biol Chem. 2003;278(17):14782\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"566_CR147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40(1):1\u201316.","journal-title":"J Lipid Res"},{"key":"566_CR148","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fcell.2018.00163","volume":"6","author":"SM Alavi Naini","year":"2018","unstructured":"Alavi Naini SM, Soussi-Yanicostas N. Heparan Sulfate as a Therapeutic Target in Tauopathies: Insights From Zebrafish. Front Cell Dev Biol. 2018;6:163.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"566_CR149","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1093\/glycob\/cwp205","volume":"20","author":"E Sandwall","year":"2010","unstructured":"Sandwall E, et al. Heparan sulfate mediates amyloid-beta internalization and cytotoxicity. Glycobiology. 2010;20(5):533\u201341.","journal-title":"Glycobiology"},{"key":"566_CR150","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.matbio.2013.12.009","volume":"35","author":"X Zhang","year":"2014","unstructured":"Zhang X, Wang B, Li JP. Implications of heparan sulfate and heparanase in neuroinflammation. Matrix Biol. 2014;35:174\u201381.","journal-title":"Matrix Biol"},{"issue":"6","key":"566_CR151","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1111\/j.1471-4159.1993.tb07453.x","volume":"61","author":"KR Brunden","year":"1993","unstructured":"Brunden KR, et al. pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J Neurochem. 1993;61(6):2147\u201354.","journal-title":"J Neurochem"},{"issue":"5","key":"566_CR152","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1523\/JNEUROSCI.5491-10.2011","volume":"31","author":"T Kanekiyo","year":"2011","unstructured":"Kanekiyo T, et al. Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci. 2011;31(5):1644\u201351.","journal-title":"J Neurosci"},{"issue":"332","key":"566_CR153","doi-asserted-by":"publisher","first-page":"332ra44","DOI":"10.1126\/scitranslmed.aad3650","volume":"8","author":"CC Liu","year":"2016","unstructured":"Liu CC, et al. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-beta clearance and aggregation in Alzheimer\u2019s disease. Sci Transl Med. 2016;8(332):332ra44.","journal-title":"Sci Transl Med"},{"issue":"36","key":"566_CR154","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34(36):11929\u201347.","journal-title":"J Neurosci"},{"issue":"2","key":"566_CR155","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0006-8993(99)01542-5","volume":"833","author":"Y Motoi","year":"1999","unstructured":"Motoi Y, et al. Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain. Brain Res. 1999;833(2):209\u201315.","journal-title":"Brain Res"},{"issue":"1","key":"566_CR156","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbrc.2014.11.111","volume":"456","author":"R Yajima","year":"2015","unstructured":"Yajima R, et al. ApoE-isoform-dependent cellular uptake of amyloid-beta is mediated by lipoprotein receptor LR11\/SorLA. Biochem Biophys Res Commun. 2015;456(1):482\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"566_CR157","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/dvdy.21283","volume":"236","author":"S Zhao","year":"2007","unstructured":"Zhao S, et al. Selective expression of LDLR and VLDLR in myelinating oligodendrocytes. Dev Dyn. 2007;236(9):2708\u201312.","journal-title":"Dev Dyn"},{"issue":"5","key":"566_CR158","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","volume":"88","author":"A Rapp","year":"2006","unstructured":"Rapp A, Gmeiner B, Huttinger M. Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes. Biochimie. 2006;88(5):473\u201383.","journal-title":"Biochimie"},{"issue":"20","key":"566_CR159","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1128\/MCB.24.20.8872-8883.2004","volume":"24","author":"P May","year":"2004","unstructured":"May P, et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol. 2004;24(20):8872\u201383.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"566_CR160","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck GW, et al. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron. 1993;11(4):575\u201380.","journal-title":"Neuron"},{"issue":"5","key":"566_CR161","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jnr.20774","volume":"83","author":"G Wicher","year":"2006","unstructured":"Wicher G, et al. Low density lipoprotein receptor-related protein-2\/megalin is expressed in oligodendrocytes in the mouse spinal cord white matter. J Neurosci Res. 2006;83(5):864\u201373.","journal-title":"J Neurosci Res"},{"issue":"3","key":"566_CR162","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1471-4159.2008.05462.x","volume":"106","author":"A Bento-Abreu","year":"2008","unstructured":"Bento-Abreu A, et al. Megalin is a receptor for albumin in astrocytes and is required for the synthesis of the neurotrophic factor oleic acid. J Neurochem. 2008;106(3):1149\u201359.","journal-title":"J Neurochem"},{"issue":"3","key":"566_CR163","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2010.07.005","volume":"45","author":"X Alvira-Botero","year":"2010","unstructured":"Alvira-Botero X, et al. Megalin interacts with APP and the intracellular adapter protein FE65 in neurons. Mol Cell Neurosci. 2010;45(3):306\u201315.","journal-title":"Mol Cell Neurosci"},{"issue":"28","key":"566_CR164","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1523\/JNEUROSCI.0250-20.2020","volume":"40","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Abeta Clearance. J Neurosci. 2020;40(28):5347\u201361.","journal-title":"J Neurosci"},{"key":"566_CR165","doi-asserted-by":"publisher","first-page":"e27347","DOI":"10.7554\/eLife.27347","volume":"6","author":"TJ Mosca","year":"2017","unstructured":"Mosca TJ, et al. Presynaptic LRP4 promotes synapse number and function of excitatory CNS neurons. Elife. 2017;6:e27347.","journal-title":"Elife"},{"issue":"1","key":"566_CR166","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/glia.21081","volume":"59","author":"C Halleskog","year":"2011","unstructured":"Halleskog C, et al. WNT signaling in activated microglia is proinflammatory. Glia. 2011;59(1):119\u201331.","journal-title":"Glia"},{"key":"566_CR167","doi-asserted-by":"publisher","first-page":"101937","DOI":"10.1016\/j.pneurobio.2020.101937","volume":"199","author":"S Guerit","year":"2021","unstructured":"Guerit S, et al. Astrocyte-derived Wnt growth factors are required for endothelial blood-brain barrier maintenance. Prog Neurobiol. 2021;199:101937.","journal-title":"Prog Neurobiol"},{"key":"566_CR168","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13041-015-0183-1","volume":"9","author":"Y Huang","year":"2016","unstructured":"Huang Y, et al. Lrp5\/6 are required for cerebellar development and for suppressing TH expression in Purkinje cells via beta-catenin. Mol Brain. 2016;9:7.","journal-title":"Mol Brain"},{"issue":"16","key":"566_CR169","doi-asserted-by":"publisher","first-page":"e2004993","DOI":"10.1002\/advs.202004993","volume":"8","author":"HM Chow","year":"2021","unstructured":"Chow HM, et al. Low-Density Lipoprotein Receptor-Related Protein 6 Cell Surface Availability Regulates Fuel Metabolism in Astrocytes. Adv Sci (Weinh). 2021;8(16):e2004993.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"566_CR170","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","volume":"84","author":"CC Liu","year":"2014","unstructured":"Liu CC, et al. Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease. Neuron. 2014;84(1):63\u201377.","journal-title":"Neuron"},{"issue":"4","key":"566_CR171","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, et al. TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell. 2017;170(4):649-663 e13.","journal-title":"Cell"},{"issue":"1","key":"566_CR172","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/eji.201141679","volume":"42","author":"H Ito","year":"2012","unstructured":"Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 2012;42(1):176\u201385.","journal-title":"Eur J Immunol"},{"issue":"5","key":"566_CR173","first-page":"3875","volume":"55","author":"G Rosciszewski","year":"2018","unstructured":"Rosciszewski G, et al. Toll-Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Activation Balance Astrocyte Polarization into a Proinflammatory Phenotype. Mol Neurobiol. 2018;55(5):3875\u201388.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"566_CR174","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.4049\/jimmunol.173.6.3916","volume":"173","author":"JK Olson","year":"2004","unstructured":"Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173(6):3916\u201324.","journal-title":"J Immunol"},{"issue":"34","key":"566_CR175","doi-asserted-by":"publisher","first-page":"13798","DOI":"10.1073\/pnas.0702553104","volume":"104","author":"SC Tang","year":"2007","unstructured":"Tang SC, et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc Natl Acad Sci U S A. 2007;104(34):13798\u2013803.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"566_CR176","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/clinchem\/45.9.1431","volume":"45","author":"K Yamauchi","year":"1999","unstructured":"Yamauchi K, et al. Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E. Clin Chem. 1999;45(9):1431\u20138.","journal-title":"Clin Chem"},{"issue":"11","key":"566_CR177","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Huang Y, Rall SC Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. J Lipid Res. 1999;40(11):1933\u201349.","journal-title":"J Lipid Res"},{"issue":"6","key":"566_CR178","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, et al. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer\u2019s Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron. 2018;98(6):1141-1154 e7.","journal-title":"Neuron"},{"issue":"23","key":"566_CR179","doi-asserted-by":"publisher","first-page":"e2404","DOI":"10.1212\/WNL.0000000000009582","volume":"94","author":"J Yin","year":"2020","unstructured":"Yin J, et al. Effect of ApoE isoforms on mitochondria in Alzheimer disease. Neurology. 2020;94(23):e2404\u201311.","journal-title":"Neurology"},{"issue":"1","key":"566_CR180","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1038\/s41598-020-61142-8","volume":"10","author":"E Area-Gomez","year":"2020","unstructured":"Area-Gomez E, et al. APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice. Sci Rep. 2020;10(1):4277.","journal-title":"Sci Rep"},{"issue":"5","key":"566_CR181","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.molcel.2016.07.016","volume":"63","author":"CM Cremers","year":"2016","unstructured":"Cremers CM, et al. Polyphosphate: A Conserved Modifier of Amyloidogenic Processes. Mol Cell. 2016;63(5):768\u201380.","journal-title":"Mol Cell"},{"key":"566_CR182","doi-asserted-by":"publisher","first-page":"105211","DOI":"10.1016\/j.phrs.2020.105211","volume":"163","author":"EA Borden","year":"2021","unstructured":"Borden EA, et al. Is there a link between inorganic polyphosphate (polyP), mitochondria, and neurodegeneration? Pharmacol Res. 2021;163:105211.","journal-title":"Pharmacol Res"},{"issue":"21","key":"566_CR183","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.V118.21.986.986","volume":"118","author":"SA Smith","year":"2011","unstructured":"Smith SA, et al. Novel Polyphosphate-Binding Proteins in Human Plasma and Platelet Releasates. Blood. 2011;118(21):986\u2013986.","journal-title":"Blood"},{"issue":"37","key":"566_CR184","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1523\/JNEUROSCI.2994-18.2019","volume":"39","author":"YA Huang","year":"2019","unstructured":"Huang YA, et al. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer\u2019s Disease Risk. J Neurosci. 2019;39(37):7408\u201327.","journal-title":"J Neurosci"},{"issue":"1","key":"566_CR185","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat Commun. 2020;11(1):5540.","journal-title":"Nat Commun"},{"issue":"3","key":"566_CR186","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L. HDL and cholesterol handling in the brain. Cardiovasc Res. 2014;103(3):405\u201313.","journal-title":"Cardiovasc Res"},{"key":"566_CR187","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nbd.2014.07.015","volume":"72 Pt A","author":"DA Hottman","year":"2014","unstructured":"Hottman DA, et al. HDL and cognition in neurodegenerative disorders. Neurobiol Dis. 2014;72 Pt A:22\u201336.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"566_CR188","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","volume":"94","author":"RW Mahley","year":"2016","unstructured":"Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med (Berl). 2016;94(7):739\u201346.","journal-title":"J Mol Med (Berl)"},{"issue":"45","key":"566_CR189","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR, et al. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci. 2008;28(45):11445\u201353.","journal-title":"J Neurosci"},{"issue":"5","key":"566_CR190","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2009.05.011","volume":"32","author":"PM Sullivan","year":"2011","unstructured":"Sullivan PM, et al. Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiol Aging. 2011;32(5):791\u2013801.","journal-title":"Neurobiol Aging"},{"issue":"46","key":"566_CR191","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1523\/JNEUROSCI.1922-05.2005","volume":"25","author":"G Ramaswamy","year":"2005","unstructured":"Ramaswamy G, et al. Effect of domain interaction on apolipoprotein E levels in mouse brain. J Neurosci. 2005;25(46):10658\u201363.","journal-title":"J Neurosci"},{"issue":"4","key":"566_CR192","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","volume":"124","author":"PM Sullivan","year":"2004","unstructured":"Sullivan PM, et al. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience. 2004;124(4):725\u201333.","journal-title":"Neuroscience"},{"key":"566_CR193","doi-asserted-by":"publisher","unstructured":"Giannisis A, Patra K, Edlund AK, Nieto LA, Benedicto-Gras J, Moussaud S, de la Rosa A, Twohig D, Bengtsson T, Fu Y, Bu G, Bial G, Foquet L, Hammarstedt C, Strom S, Kannisto K, Raber J, Ellis E, Nielsen HM. Brain integrity is altered by hepatic APOE \u03b54 in humanized-liver mice. Mol Psychiatry. 2022. https:\/\/doi.org\/10.1038\/s41380-022-01548-0.","DOI":"10.1038\/s41380-022-01548-0"},{"key":"566_CR194","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-8-13","volume":"8","author":"JD Ulrich","year":"2013","unstructured":"Ulrich JD, et al. In vivo measurement of apolipoprotein E from the brain interstitial fluid using microdialysis. Mol Neurodegener. 2013;8:13.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"566_CR195","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1172\/JCI115288","volume":"88","author":"MF Linton","year":"1991","unstructured":"Linton MF, et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest. 1991;88(1):270\u201381.","journal-title":"J Clin Invest"},{"issue":"Suppl","key":"566_CR196","doi-asserted-by":"publisher","first-page":"S156","DOI":"10.1194\/jlr.R800058-JLR200","volume":"50","author":"GS Getz","year":"2009","unstructured":"Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009;50(Suppl):S156\u201361.","journal-title":"J Lipid Res"},{"issue":"1","key":"566_CR197","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-019-0337-1","volume":"14","author":"TV Huynh","year":"2019","unstructured":"Huynh TV, et al. Lack of hepatic apoE does not influence early Abeta deposition: observations from a new APOE knock-in model. Mol Neurodegener. 2019;14(1):37.","journal-title":"Mol Neurodegener"},{"key":"566_CR198","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-1326-2-7","volume":"2","author":"SE Wahrle","year":"2007","unstructured":"Wahrle SE, et al. Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol Neurodegener. 2007;2:7.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"566_CR199","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00401-014-1266-2","volume":"127","author":"E Martinez-Morillo","year":"2014","unstructured":"Martinez-Morillo E, et al. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer\u2019s disease patients and controls. Acta Neuropathol. 2014;127(5):633\u201343.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"566_CR200","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-020-00585-7","volume":"12","author":"K Minta","year":"2020","unstructured":"Minta K, et al. Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases. Alzheimers Res Ther. 2020;12(1):19.","journal-title":"Alzheimers Res Ther"},{"issue":"53","key":"566_CR201","doi-asserted-by":"publisher","first-page":"27204","DOI":"10.1074\/jbc.M116.721779","volume":"291","author":"AT Baker-Nigh","year":"2016","unstructured":"Baker-Nigh AT, et al. Human Central Nervous System (CNS) ApoE Isoforms Are Increased by Age, Differentially Altered by Amyloidosis, and Relative Amounts Reversed in the CNS Compared with Plasma. J Biol Chem. 2016;291(53):27204\u201318.","journal-title":"J Biol Chem"},{"issue":"11","key":"566_CR202","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1074\/mcp.M112.018861","volume":"11","author":"R Simon","year":"2012","unstructured":"Simon R, et al. Total ApoE and ApoE4 isoform assays in an Alzheimer\u2019s disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides. Mol Cell Proteomics. 2012;11(11):1389\u2013403.","journal-title":"Mol Cell Proteomics"},{"key":"566_CR203","doi-asserted-by":"publisher","first-page":"111004","DOI":"10.1016\/j.exger.2020.111004","volume":"138","author":"A Fernandes","year":"2020","unstructured":"Fernandes A, et al. C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer\u2019s disease dementia. Exp Gerontol. 2020;138:111004.","journal-title":"Exp Gerontol"},{"issue":"4","key":"566_CR204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/jgs.15770","volume":"67","author":"M Berger","year":"2019","unstructured":"Berger M, et al. The INTUIT Study: Investigating Neuroinflammation Underlying Postoperative Cognitive Dysfunction. J Am Geriatr Soc. 2019;67(4):794\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"20","key":"566_CR205","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1093\/hmg\/dds296","volume":"21","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, et al. Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer\u2019s disease. Hum Mol Genet. 2012;21(20):4558\u201371.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"566_CR206","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","volume":"9","author":"HM Nielsen","year":"2017","unstructured":"Nielsen HM, et al. Peripheral apoE isoform levels in cognitively normal APOE epsilon3\/epsilon4 individuals are associated with regional gray matter volume and cerebral glucose metabolism. Alzheimers Res Ther. 2017;9(1):5.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"566_CR207","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3233\/JAD-210065","volume":"81","author":"AK Edlund","year":"2021","unstructured":"Edlund AK, et al. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3\/varepsilon4 Carriers. J Alzheimers Dis. 2021;81(1):339\u201354.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"566_CR208","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL, et al. Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals. Alzheimers Dement. 2018;14(1):71\u201380.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"566_CR209","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/alz.12165","volume":"16","author":"KL Rasmussen","year":"2020","unstructured":"Rasmussen KL, et al. APOE and dementia - resequencing and genotyping in 105,597 individuals. Alzheimers Dement. 2020;16(12):1624\u201337.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"566_CR210","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3233\/JAD-190175","volume":"71","author":"K Patra","year":"2019","unstructured":"Patra K, et al. Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer\u2019s Disease. J Alzheimers Dis. 2019;71(4):1217\u201331.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"566_CR211","doi-asserted-by":"publisher","first-page":"e38013","DOI":"10.1371\/journal.pone.0038013","volume":"7","author":"KR Wildsmith","year":"2012","unstructured":"Wildsmith KR, et al. In vivo human apolipoprotein E isoform fractional turnover rates in the CNS. PLoS ONE. 2012;7(6):e38013.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"566_CR212","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.13607","volume":"139","author":"DJ DiSabato","year":"2016","unstructured":"DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. 2016;139(Suppl 2):136\u201353.","journal-title":"J Neurochem"},{"issue":"6","key":"566_CR213","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41423-019-0223-3","volume":"16","author":"HYF Yong","year":"2019","unstructured":"Yong HYF, et al. The benefits of neuroinflammation for the repair of the injured central nervous system. Cell Mol Immunol. 2019;16(6):540\u20136.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"566_CR214","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/bc.bc_18_17","volume":"3","author":"SJ Schimmel","year":"2017","unstructured":"Schimmel SJ, Acosta S, Lozano D. Neuroinflammation in traumatic brain injury: A chronic response to an acute injury. Brain Circ. 2017;3(3):135\u201342.","journal-title":"Brain Circ"},{"issue":"1","key":"566_CR215","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12974-019-1516-2","volume":"16","author":"RL Jayaraj","year":"2019","unstructured":"Jayaraj RL, et al. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142.","journal-title":"J Neuroinflammation"},{"issue":"7","key":"566_CR216","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40263-020-00721-9","volume":"34","author":"JD Jones","year":"2020","unstructured":"Jones JD. Potential of Glial Cell Modulators in the Management of Substance Use Disorders. CNS Drugs. 2020;34(7):697\u2013722.","journal-title":"CNS Drugs"},{"key":"566_CR217","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.bbi.2020.11.013","volume":"91","author":"AE Perkins","year":"2021","unstructured":"Perkins AE, et al. Assessment of neuroinflammation in the aging hippocampus using large-molecule microdialysis: Sex differences and role of purinergic receptors. Brain Behav Immun. 2021;91:546\u201355.","journal-title":"Brain Behav Immun"},{"key":"566_CR218","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, et al. Neuroinflammation as a Common Feature of Neurodegenerative Disorders. Front Pharmacol. 2019;10:1008.","journal-title":"Front Pharmacol"},{"issue":"7","key":"566_CR219","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T, et al. Neuroinflammation pathways: a general review. Int J Neurosci. 2017;127(7):624\u201333.","journal-title":"Int J Neurosci"},{"issue":"10","key":"566_CR220","first-page":"136","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, et al. Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med. 2015;3(10):136.","journal-title":"Ann Transl Med"},{"issue":"1","key":"566_CR221","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"5726","key":"566_CR222","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"issue":"12","key":"566_CR223","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman SE, et al. The microglial sensome revealed by direct RNA sequencing. Nat Neurosci. 2013;16(12):1896\u2013905.","journal-title":"Nat Neurosci"},{"issue":"7","key":"566_CR224","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1523\/JNEUROSCI.0993-19.2019","volume":"40","author":"I Diaz-Aparicio","year":"2020","unstructured":"Diaz-Aparicio I, et al. Microglia Actively Remodel Adult Hippocampal Neurogenesis through the Phagocytosis Secretome. J Neurosci. 2020;40(7):1453\u201382.","journal-title":"J Neurosci"},{"issue":"6048","key":"566_CR225","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli RC, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456\u20138.","journal-title":"Science"},{"issue":"11","key":"566_CR226","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/glia.23637","volume":"67","author":"E Bar","year":"2019","unstructured":"Bar E, Barak B. Microglia roles in synaptic plasticity and myelination in homeostatic conditions and neurodevelopmental disorders. Glia. 2019;67(11):2125\u201341.","journal-title":"Glia"},{"issue":"2","key":"566_CR227","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1073858414530512","volume":"21","author":"D Gomez-Nicola","year":"2015","unstructured":"Gomez-Nicola D, Perry VH. Microglial dynamics and role in the healthy and diseased brain: a paradigm of functional plasticity. Neuroscientist. 2015;21(2):169\u201384.","journal-title":"Neuroscientist"},{"issue":"1","key":"566_CR228","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40635-015-0039-0","volume":"3","author":"ER Zanier","year":"2015","unstructured":"Zanier ER, et al. Shape descriptors of the \u201cnever resting\u201d microglia in three different acute brain injury models in mice. Intensive Care Med Exp. 2015;3(1):39.","journal-title":"Intensive Care Med Exp"},{"issue":"2","key":"566_CR229","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41380-019-0609-8","volume":"25","author":"YL Tan","year":"2020","unstructured":"Tan YL, Yuan Y, Tian L. Microglial regional heterogeneity and its role in the brain. Mol Psychiatry. 2020;25(2):351\u201367.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"566_CR230","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/jcm8101719","volume":"8","author":"J Garcia-Revilla","year":"2019","unstructured":"Garcia-Revilla J, et al. Reformulating Pro-Oxidant Microglia in Neurodegeneration. J Clin Med. 2019;8(10):1719.","journal-title":"J Clin Med"},{"issue":"1_suppl","key":"566_CR231","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1177\/0271678X20951995","volume":"40","author":"PT Ronaldson","year":"2020","unstructured":"Ronaldson PT, Davis TP. Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity. J Cereb Blood Flow Metab. 2020;40(1_suppl):S6\u201324.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"566_CR232","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10\u201320.","journal-title":"Brain Res Bull"},{"issue":"6","key":"566_CR233","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1096\/fj.10-176891","volume":"25","author":"E Cudaback","year":"2011","unstructured":"Cudaback E, et al. Apolipoprotein E isoform-dependent microglia migration. FASEB J. 2011;25(6):2082\u201391.","journal-title":"FASEB J"},{"issue":"48","key":"566_CR234","doi-asserted-by":"publisher","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","volume":"29","author":"SB Dumanis","year":"2009","unstructured":"Dumanis SB, et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J Neurosci. 2009;29(48):15317\u201322.","journal-title":"J Neurosci"},{"issue":"4","key":"566_CR235","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia"},{"issue":"4","key":"566_CR236","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich JD, et al. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215(4):1047\u201358.","journal-title":"J Exp Med"},{"issue":"6","key":"566_CR237","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/glia.23974","volume":"69","author":"MF Lanfranco","year":"2021","unstructured":"Lanfranco MF, et al. Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation. Glia. 2021;69(6):1478\u201393.","journal-title":"Glia"},{"issue":"9","key":"566_CR238","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nri3265","volume":"12","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12(9):623\u201335.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"566_CR239","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0022-2275(20)32409-3","volume":"41","author":"DT Laskowitz","year":"2000","unstructured":"Laskowitz DT, et al. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res. 2000;41(4):613\u201320.","journal-title":"J Lipid Res"},{"issue":"3","key":"566_CR240","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2567.2003.01665.x","volume":"109","author":"C Tenger","year":"2003","unstructured":"Tenger C, Zhou X. Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. Immunology. 2003;109(3):392\u20137.","journal-title":"Immunology"},{"issue":"1","key":"566_CR241","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1172\/JCI114971","volume":"87","author":"RA Terkeltaub","year":"1991","unstructured":"Terkeltaub RA, et al. Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo. J Clin Invest. 1991;87(1):20\u20136.","journal-title":"J Clin Invest"},{"issue":"7060","key":"566_CR242","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nature04001","volume":"437","author":"P van den Elzen","year":"2005","unstructured":"van den Elzen P, et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature. 2005;437(7060):906\u201310.","journal-title":"Nature"},{"issue":"44","key":"566_CR243","doi-asserted-by":"publisher","first-page":"eabh0050","DOI":"10.1126\/sciadv.abh0050","volume":"7","author":"B Winkler","year":"2021","unstructured":"Winkler B, et al. Brain inflammation triggers macrophage invasion across the blood-brain barrier in Drosophila during pupal stages. Sci Adv. 2021;7(44):eabh0050.","journal-title":"Sci Adv"},{"key":"566_CR244","doi-asserted-by":"publisher","first-page":"661838","DOI":"10.3389\/fncel.2021.661838","volume":"15","author":"F Takata","year":"2021","unstructured":"Takata F, et al. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Front Cell Neurosci. 2021;15:661838.","journal-title":"Front Cell Neurosci"},{"issue":"30","key":"566_CR245","doi-asserted-by":"publisher","first-page":"21776","DOI":"10.1074\/jbc.M611422200","volume":"282","author":"AV Gafencu","year":"2007","unstructured":"Gafencu AV, et al. Inflammatory signaling pathways regulating ApoE gene expression in macrophages. J Biol Chem. 2007;282(30):21776\u201385.","journal-title":"J Biol Chem"},{"issue":"7790","key":"566_CR246","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature. 2020;577(7790):399\u2013404.","journal-title":"Nature"},{"issue":"10","key":"566_CR247","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19(10):622\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"566_CR248","doi-asserted-by":"publisher","first-page":"281","DOI":"10.14348\/molcells.2021.0060","volume":"44","author":"E Lee","year":"2021","unstructured":"Lee E, et al. Distinct Features of Brain-Resident Macrophages: Microglia and Non-Parenchymal Brain Macrophages. Mol Cells. 2021;44(5):281\u201391.","journal-title":"Mol Cells"},{"issue":"4","key":"566_CR249","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225\u201342.","journal-title":"Nat Rev Immunol"},{"key":"566_CR250","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3389\/fimmu.2017.01905","volume":"8","author":"STT Schetters","year":"2017","unstructured":"Schetters STT, et al. Neuroinflammation: Microglia and T Cells Get Ready to Tango. Front Immunol. 2017;8:1905.","journal-title":"Front Immunol"},{"issue":"2","key":"566_CR251","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, et al. Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry. 2018;23(2):177\u201398.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"566_CR252","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","volume":"21","author":"H Mathys","year":"2017","unstructured":"Mathys H, et al. Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep. 2017;21(2):366\u201380.","journal-title":"Cell Rep"},{"key":"566_CR253","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.ebiom.2018.08.026","volume":"35","author":"LM James","year":"2018","unstructured":"James LM, et al. The effects of human leukocyte antigen DRB1*13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women. EBioMedicine. 2018;35:288\u201394.","journal-title":"EBioMedicine"},{"key":"566_CR254","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.expneurol.2014.01.001","volume":"258","author":"KA Kigerl","year":"2014","unstructured":"Kigerl KA, et al. Pattern recognition receptors and central nervous system repair. Exp Neurol. 2014;258:5\u201316.","journal-title":"Exp Neurol"},{"issue":"11","key":"566_CR255","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","volume":"14","author":"TK Ulland","year":"2018","unstructured":"Ulland TK, Colonna M. TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol. 2018;14(11):667\u201375.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"566_CR256","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, et al. Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration. Cell. 2018;173(5):1073\u201381.","journal-title":"Cell"},{"issue":"6","key":"566_CR257","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41593-018-0145-x","volume":"21","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Amit I, Schwartz M. Microglial immune checkpoint mechanisms. Nat Neurosci. 2018;21(6):779\u201386.","journal-title":"Nat Neurosci"},{"issue":"17","key":"566_CR258","doi-asserted-by":"publisher","first-page":"e101997","DOI":"10.15252\/embj.2019101997","volume":"38","author":"V Stratoulias","year":"2019","unstructured":"Stratoulias V, et al. Microglial subtypes: diversity within the microglial community. EMBO J. 2019;38(17):e101997.","journal-title":"EMBO J"},{"issue":"8","key":"566_CR259","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987\u201391.","journal-title":"Nat Neurosci"},{"issue":"1","key":"566_CR260","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","volume":"13","author":"M Gratuze","year":"2018","unstructured":"Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer\u2019s disease. Mol Neurodegener. 2018;13(1):66.","journal-title":"Mol Neurodegener"},{"key":"566_CR261","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13148-016-0202-9","volume":"8","author":"N Celarain","year":"2016","unstructured":"Celarain N, et al. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer\u2019s disease hippocampus. Clin Epigenetics. 2016;8:37.","journal-title":"Clin Epigenetics"},{"issue":"6344","key":"566_CR262","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin D, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356(6344):eaal3222.","journal-title":"Science"},{"issue":"2","key":"566_CR263","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"566_CR264","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"2","key":"566_CR265","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","volume":"138","author":"A Boza-Serrano","year":"2019","unstructured":"Boza-Serrano A, et al. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer\u2019s disease. Acta Neuropathol. 2019;138(2):251\u201373.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"566_CR266","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay TR, von Saucken VE, Landreth GE. TREM2 in Neurodegenerative Diseases. Mol Neurodegener. 2017;12(1):56.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"566_CR267","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer\u2019s Disease. Cell. 2017;169(7):1276-1290 e17.","journal-title":"Cell"},{"key":"566_CR268","doi-asserted-by":"publisher","unstructured":"Audrain M, Haure-Mirande JV, Mleczko J, Wang M, Griffin JK, St George-Hyslop PH, Fraser P, Zhang B, Gandy S, Ehrlich ME. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice. Alzheimers Dement. 2021;17(2):149-63. https:\/\/doi.org\/10.1002\/alz.12256.","DOI":"10.1002\/alz.12256"},{"issue":"3","key":"566_CR269","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566-581 e9.","journal-title":"Immunity"},{"issue":"3","key":"566_CR270","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","volume":"214","author":"L Zhong","year":"2017","unstructured":"Zhong L, et al. Soluble TREM2 induces inflammatory responses and enhances microglial survival. J Exp Med. 2017;214(3):597\u2013607.","journal-title":"J Exp Med"},{"issue":"4","key":"566_CR271","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, et al. TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron. 2016;90(4):724\u201339.","journal-title":"Neuron"},{"issue":"1","key":"566_CR272","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, et al. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy. Mol Neurodegener. 2017;12(1):74.","journal-title":"Mol Neurodegener"},{"issue":"43","key":"566_CR273","doi-asserted-by":"publisher","first-page":"11524","DOI":"10.1073\/pnas.1710311114","volume":"114","author":"CEG Leyns","year":"2017","unstructured":"Leyns CEG, et al. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc Natl Acad Sci U S A. 2017;114(43):11524\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"566_CR274","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22(2):191\u2013204.","journal-title":"Nat Neurosci"},{"issue":"8","key":"566_CR275","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, et al. TREM2 function impedes tau seeding in neuritic plaques. Nat Neurosci. 2019;22(8):1217\u201322.","journal-title":"Nat Neurosci"},{"issue":"8","key":"566_CR276","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41593-020-0650-6","volume":"23","author":"BJ Andreone","year":"2020","unstructured":"Andreone BJ, et al. Alzheimer\u2019s-associated PLCgamma2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia. Nat Neurosci. 2020;23(8):927\u201338.","journal-title":"Nat Neurosci"},{"issue":"5","key":"566_CR277","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, et al. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge. Neuron. 2020;105(5):837-854 e9.","journal-title":"Neuron"},{"issue":"1","key":"566_CR278","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade A, et al. Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun. 2020;11(1):5370.","journal-title":"Nat Commun"},{"issue":"1","key":"566_CR279","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno L, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019;11(1):16.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"566_CR280","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1042\/BJ20100016","volume":"428","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Kodvawala A, Hui DY. Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms. Biochem J. 2010;428(1):47\u201354.","journal-title":"Biochem J"},{"key":"566_CR281","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461.","journal-title":"Front Immunol"},{"key":"566_CR282","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pneurobio.2018.09.007","volume":"171","author":"X Shen","year":"2018","unstructured":"Shen X, et al. Caspases orchestrate microglia instrumental functions. Prog Neurobiol. 2018;171:50\u201371.","journal-title":"Prog Neurobiol"},{"key":"566_CR283","doi-asserted-by":"publisher","first-page":"602508","DOI":"10.3389\/fnins.2020.602508","volume":"14","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, et al. TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment. Front Neurosci. 2020;14:602508.","journal-title":"Front Neurosci"},{"issue":"2","key":"566_CR284","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jaci.2019.02.027","volume":"144","author":"EM Gordon","year":"2019","unstructured":"Gordon EM, et al. Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1beta secretion by bronchoalveolar fluid macrophages from asthmatic subjects. J Allergy Clin Immunol. 2019;144(2):426-441 e3.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"566_CR285","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-020-01869-3","volume":"17","author":"MY Wong","year":"2020","unstructured":"Wong MY, et al. 25-Hydroxycholesterol amplifies microglial IL-1beta production in an apoE isoform-dependent manner. J Neuroinflammation. 2020;17(1):192.","journal-title":"J Neuroinflammation"},{"issue":"5528","key":"566_CR286","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1126\/science.1061663","volume":"293","author":"Q Lu","year":"2001","unstructured":"Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001;293(5528):306\u201311.","journal-title":"Science"},{"issue":"7598","key":"566_CR287","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nature17630","volume":"532","author":"L Fourgeaud","year":"2016","unstructured":"Fourgeaud L, et al. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532(7598):240\u20134.","journal-title":"Nature"},{"issue":"10","key":"566_CR288","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ni.2986","volume":"15","author":"A Zagorska","year":"2014","unstructured":"Zagorska A, et al. Diversification of TAM receptor tyrosine kinase function. Nat Immunol. 2014;15(10):920\u20138.","journal-title":"Nat Immunol"},{"issue":"5","key":"566_CR289","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang Y, et al. Microglia use TAM receptors to detect and engulf amyloid beta plaques. Nat Immunol. 2021;22(5):586\u201394.","journal-title":"Nat Immunol"},{"issue":"5","key":"566_CR290","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, et al. Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of beta-amyloidosis. Neuron. 2017;96(5):1013-1023 e4.","journal-title":"Neuron"},{"issue":"6501","key":"566_CR291","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma J, et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 1994;372(6501):92\u20134.","journal-title":"Nature"},{"issue":"6","key":"566_CR292","doi-asserted-by":"publisher","first-page":"e0155878","DOI":"10.1371\/journal.pone.0155878","volume":"11","author":"L Auderset","year":"2016","unstructured":"Auderset L, Cullen CL, Young KM. Low Density Lipoprotein-Receptor Related Protein 1 Is Differentially Expressed by Neuronal and Glial Populations in the Developing and Mature Mouse Central Nervous System. PLoS ONE. 2016;11(6):e0155878.","journal-title":"PLoS ONE"},{"issue":"1","key":"566_CR293","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12974-016-0772-7","volume":"13","author":"L Yang","year":"2016","unstructured":"Yang L, et al. LRP1 modulates the microglial immune response via regulation of JNK and NF-kappaB signaling pathways. J Neuroinflammation. 2016;13(1):304.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"566_CR294","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-016-0343-2","volume":"4","author":"TY Chuang","year":"2016","unstructured":"Chuang TY, et al. LRP1 expression in microglia is protective during CNS autoimmunity. Acta Neuropathol Commun. 2016;4(1):68.","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"566_CR295","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/glia.23599","volume":"67","author":"C Brifault","year":"2019","unstructured":"Brifault C, et al. LRP1 deficiency in microglia blocks neuro-inflammation in the spinal dorsal horn and neuropathic pain processing. Glia. 2019;67(6):1210\u201324.","journal-title":"Glia"},{"issue":"1\u20132","key":"566_CR296","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneuroim.2009.06.010","volume":"214","author":"A Pocivavsek","year":"2009","unstructured":"Pocivavsek A, et al. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation. J Neuroimmunol. 2009;214(1\u20132):25\u201332.","journal-title":"J Neuroimmunol"},{"issue":"9","key":"566_CR297","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1007\/s12035-020-01982-7","volume":"57","author":"Y He","year":"2020","unstructured":"He Y, et al. Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4\/NF-kappaB\/MAPKs Signaling Pathways in APP\/PS1 Transgenic Mice. Mol Neurobiol. 2020;57(9):3727\u201343.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"566_CR298","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74(4):691\u2013705.","journal-title":"Neuron"},{"key":"566_CR299","first-page":"983640","volume":"2012","author":"H Crehan","year":"2012","unstructured":"Crehan H, Hardy J, Pocock J. Microglia, Alzheimer\u2019s disease, and complement. Int J Alzheimers Dis. 2012;2012:983640.","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"566_CR300","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin C, et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25(3):496\u2013506.","journal-title":"Nat Med"},{"issue":"5","key":"566_CR301","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.celrep.2020.01.010","volume":"30","author":"T Masuda","year":"2020","unstructured":"Masuda T, et al. Microglia Heterogeneity in the Single-Cell Era. Cell Rep. 2020;30(5):1271\u201381.","journal-title":"Cell Rep"},{"key":"566_CR302","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fncel.2018.00488","volume":"12","author":"S Bachiller","year":"2018","unstructured":"Bachiller S, et al. Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front Cell Neurosci. 2018;12:488.","journal-title":"Front Cell Neurosci"},{"key":"566_CR303","doi-asserted-by":"publisher","unstructured":"De Schepper S, Crowley G, Hong S. Understanding microglial diversity and implications for neuronal function in health and disease. Dev Neurobiol. 2021;81(5):507-23. https:\/\/doi.org\/10.1002\/dneu.22777.","DOI":"10.1002\/dneu.22777"},{"issue":"7744","key":"566_CR304","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"T Masuda","year":"2019","unstructured":"Masuda T, et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. 2019;566(7744):388\u201392.","journal-title":"Nature"},{"key":"566_CR305","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2018.01014","volume":"9","author":"DA Menassa","year":"2018","unstructured":"Menassa DA, Gomez-Nicola D. Microglial Dynamics During Human Brain Development. Front Immunol. 2018;9:1014.","journal-title":"Front Immunol"},{"issue":"1","key":"566_CR306","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41598-017-01747-8","volume":"7","author":"BM Davis","year":"2017","unstructured":"Davis BM, et al. Characterizing microglia activation: a spatial statistics approach to maximize information extraction. Sci Rep. 2017;7(1):1576.","journal-title":"Sci Rep"},{"key":"566_CR307","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3389\/fimmu.2018.01753","volume":"9","author":"ML Dubbelaar","year":"2018","unstructured":"Dubbelaar ML, et al. The Kaleidoscope of Microglial Phenotypes. Front Immunol. 2018;9:1753.","journal-title":"Front Immunol"},{"issue":"4","key":"566_CR308","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, et al. The Major Risk Factors for Alzheimer\u2019s Disease: Age, Sex, and Genes Modulate the Microglia Response to Abeta Plaques. Cell Rep. 2019;27(4):1293-1306 e6.","journal-title":"Cell Rep"},{"issue":"3","key":"566_CR309","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/brain\/awx355","volume":"141","author":"R Mito","year":"2018","unstructured":"Mito R, et al. Fibre-specific white matter reductions in Alzheimer\u2019s disease and mild cognitive impairment. Brain. 2018;141(3):888\u2013902.","journal-title":"Brain"},{"issue":"1","key":"566_CR310","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1038\/s41598-019-41363-2","volume":"9","author":"F Ji","year":"2019","unstructured":"Ji F, et al. White matter microstructural abnormalities and default network degeneration are associated with early memory deficit in Alzheimer\u2019s disease continuum. Sci Rep. 2019;9(1):4749.","journal-title":"Sci Rep"},{"issue":"7","key":"566_CR311","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.neuron.2021.01.027","volume":"109","author":"S Safaiyan","year":"2021","unstructured":"Safaiyan S, et al. White matter aging drives microglial diversity. Neuron. 2021;109(7):1100-1117.e10.","journal-title":"Neuron"},{"issue":"9","key":"566_CR312","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/mp.2010.90","volume":"16","author":"V Heise","year":"2011","unstructured":"Heise V, et al. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol Psychiatry. 2011;16(9):908\u201316.","journal-title":"Mol Psychiatry"},{"issue":"19","key":"566_CR313","doi-asserted-by":"publisher","first-page":"e1807","DOI":"10.1212\/WNL.0000000000008377","volume":"93","author":"SS Mirza","year":"2019","unstructured":"Mirza SS, et al. APOE epsilon4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia. Neurology. 2019;93(19):e1807\u201319.","journal-title":"Neurology"},{"key":"566_CR314","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2017.01.014","volume":"53","author":"CH Sudre","year":"2017","unstructured":"Sudre CH, et al. APOE epsilon4 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis. Neurobiol Aging. 2017;53:67\u201375.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"566_CR315","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.15252\/embj.201490791","volume":"34","author":"T Goldmann","year":"2015","unstructured":"Goldmann T, et al. USP18 lack in microglia causes destructive interferonopathy of the mouse brain. EMBO J. 2015;34(12):1612\u201329.","journal-title":"EMBO J"},{"key":"566_CR316","doi-asserted-by":"publisher","first-page":"564351","DOI":"10.3389\/fcell.2020.564351","volume":"8","author":"L Auderset","year":"2020","unstructured":"Auderset L, et al. Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Is a Negative Regulator of Oligodendrocyte Progenitor Cell Differentiation in the Adult Mouse Brain. Front Cell Dev Biol. 2020;8:564351.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"566_CR317","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/jnc.14271","volume":"144","author":"Y Hase","year":"2018","unstructured":"Hase Y, et al. White matter degeneration in vascular and other ageing-related dementias. J Neurochem. 2018;144(5):617\u201333.","journal-title":"J Neurochem"},{"key":"566_CR318","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101121","volume":"21","author":"J Peng","year":"2019","unstructured":"Peng J, et al. LRP1 activation attenuates white matter injury by modulating microglial polarization through Shc1\/PI3K\/Akt pathway after subarachnoid hemorrhage in rats. Redox Biol. 2019;21: 101121.","journal-title":"Redox Biol"},{"issue":"1","key":"566_CR319","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, et al. Single-Cell RNA Sequencing of Microglia throughout the Mouse Lifespan and in the Injured Brain Reveals Complex Cell-State Changes. Immunity. 2019;50(1):253-271 e6.","journal-title":"Immunity"},{"issue":"2","key":"566_CR320","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"29","key":"566_CR321","doi-asserted-by":"publisher","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","volume":"262","author":"RE Pitas","year":"1987","unstructured":"Pitas RE, et al. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J Biol Chem. 1987;262(29):14352\u201360.","journal-title":"J Biol Chem"},{"issue":"4","key":"566_CR322","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","volume":"6","author":"J Zhang","year":"2015","unstructured":"Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6(4):254\u201364.","journal-title":"Protein Cell"},{"issue":"33","key":"566_CR323","doi-asserted-by":"publisher","first-page":"29919","DOI":"10.1074\/jbc.M203934200","volume":"277","author":"JS Gong","year":"2002","unstructured":"Gong JS, et al. Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem. 2002;277(33):29919\u201326.","journal-title":"J Biol Chem"},{"issue":"14","key":"566_CR324","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","volume":"26","author":"J Zhao","year":"2017","unstructured":"Zhao J, et al. APOE epsilon4\/epsilon4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet. 2017;26(14):2690\u2013700.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"566_CR325","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw J, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185(13):2213-2233 e25.","journal-title":"Cell"},{"issue":"583","key":"566_CR326","doi-asserted-by":"publisher","first-page":"eaaz4564","DOI":"10.1126\/scitranslmed.aaz4564","volume":"13","author":"G Sienski","year":"2021","unstructured":"Sienski G, et al. APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia. Sci Transl Med. 2021;13(583):eaaz4564.","journal-title":"Sci Transl Med"},{"issue":"6","key":"566_CR327","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, et al. Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell. 2019;177(6):1522-1535 e14.","journal-title":"Cell"},{"issue":"1","key":"566_CR328","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, et al. ApoE4 Impairs Neuron-Astrocyte Coupling of Fatty Acid Metabolism. Cell Rep. 2021;34(1):108572.","journal-title":"Cell Rep"},{"issue":"5","key":"566_CR329","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2017.08.024","volume":"26","author":"L Liu","year":"2017","unstructured":"Liu L, et al. The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE\/D. Cell Metab. 2017;26(5):719-737 e6.","journal-title":"Cell Metab"},{"issue":"10","key":"566_CR330","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","volume":"33","author":"P Schonfeld","year":"2013","unstructured":"Schonfeld P, Reiser G. Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain. J Cereb Blood Flow Metab. 2013;33(10):1493\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"key":"566_CR331","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuint.2017.03.018","volume":"109","author":"P Schonfeld","year":"2017","unstructured":"Schonfeld P, Reiser G. Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration. Neurochem Int. 2017;109:68\u201377.","journal-title":"Neurochem Int"},{"issue":"1","key":"566_CR332","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2017.06.003","volume":"42","author":"TB Nguyen","year":"2017","unstructured":"Nguyen TB, et al. DGAT1-Dependent Lipid Droplet Biogenesis Protects Mitochondrial Function during Starvation-Induced Autophagy. Dev Cell. 2017;42(1):9-21 e5.","journal-title":"Dev Cell"},{"key":"566_CR333","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","volume":"62","author":"R Sultana","year":"2013","unstructured":"Sultana R, Perluigi M, Butterfield DA. Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med. 2013;62:157\u201369.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"566_CR334","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2015.09.020","volume":"163","author":"AP Bailey","year":"2015","unstructured":"Bailey AP, et al. Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila. Cell. 2015;163(2):340\u201353.","journal-title":"Cell"},{"issue":"7","key":"566_CR335","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41419-020-02776-4","volume":"11","author":"E Schmukler","year":"2020","unstructured":"Schmukler E, et al. Altered mitochondrial dynamics and function in APOE4-expressing astrocytes. Cell Death Dis. 2020;11(7):578.","journal-title":"Cell Death Dis"},{"key":"566_CR336","doi-asserted-by":"publisher","first-page":"104742","DOI":"10.1016\/j.nbd.2020.104742","volume":"136","author":"HC Williams","year":"2020","unstructured":"Williams HC, et al. APOE alters glucose flux through central carbon pathways in astrocytes. Neurobiol Dis. 2020;136:104742.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"566_CR337","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","volume":"16","author":"BC Farmer","year":"2021","unstructured":"Farmer BC, et al. APOEpsilon4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis. Mol Neurodegener. 2021;16(1):62.","journal-title":"Mol Neurodegener"},{"issue":"5123","key":"566_CR338","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"issue":"11","key":"566_CR339","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1212\/01.WNL.0000128091.92139.0F","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, et al. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 2004;62(11):1977\u201383.","journal-title":"Neurology"},{"issue":"20","key":"566_CR340","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(20):9649\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"566_CR341","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman DM, et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2000;97(6):2892\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"566_CR342","doi-asserted-by":"publisher","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","volume":"96","author":"KR Bales","year":"1999","unstructured":"Bales KR, et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 1999;96(26):15233\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"566_CR343","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales KR, et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997;17(3):263\u20134.","journal-title":"Nat Genet"},{"issue":"11","key":"566_CR344","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, et al. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci. 2005;25(11):2803\u201310.","journal-title":"J Neurosci"},{"issue":"11","key":"566_CR345","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"566_CR346","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.21843","volume":"67","author":"JC Morris","year":"2010","unstructured":"Morris JC, et al. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010;67(1):122\u201331.","journal-title":"Ann Neurol"},{"issue":"16","key":"566_CR347","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, et al. Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106(16):6820\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"566_CR348","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","volume":"56","author":"T Sunderland","year":"2004","unstructured":"Sunderland T, et al. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer\u2019s disease: the effect of APOE epsilon4 allele. Biol Psychiatry. 2004;56(9):670\u20136.","journal-title":"Biol Psychiatry"},{"issue":"5","key":"566_CR349","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, et al. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron. 2017;96(5):1024-1032 e3.","journal-title":"Neuron"},{"issue":"38","key":"566_CR350","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1021\/bi961074j","volume":"35","author":"SJ Wood","year":"1996","unstructured":"Wood SJ, Chan W, Wetzel R. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. Biochemistry. 1996;35(38):12623\u20138.","journal-title":"Biochemistry"},{"issue":"5","key":"566_CR351","first-page":"1030","volume":"145","author":"T Wisniewski","year":"1994","unstructured":"Wisniewski T, et al. Acceleration of Alzheimer\u2019s fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994;145(5):1030\u20135.","journal-title":"Am J Pathol"},{"issue":"Pt 2","key":"566_CR352","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/bj3060599","volume":"306","author":"EM Castano","year":"1995","unstructured":"Castano EM, et al. Fibrillogenesis in Alzheimer\u2019s disease of amyloid beta peptides and apolipoprotein E. Biochem J. 1995;306(Pt 2):599\u2013604.","journal-title":"Biochem J"},{"issue":"52","key":"566_CR353","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280(52):43224\u201335.","journal-title":"J Biol Chem"},{"issue":"52","key":"566_CR354","doi-asserted-by":"publisher","first-page":"43236","DOI":"10.1074\/jbc.M508780200","volume":"280","author":"SE Wahrle","year":"2005","unstructured":"Wahrle SE, et al. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J Biol Chem. 2005;280(52):43236\u201342.","journal-title":"J Biol Chem"},{"issue":"1","key":"566_CR355","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","volume":"541","author":"Y Namba","year":"1991","unstructured":"Namba Y, et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541(1):163\u20136.","journal-title":"Brain Res"},{"issue":"1","key":"566_CR356","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9440(10)64700-1","volume":"156","author":"GK Gouras","year":"2000","unstructured":"Gouras GK, et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol. 2000;156(1):15\u201320.","journal-title":"Am J Pathol"},{"issue":"5","key":"566_CR357","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/hmg\/ddt525","volume":"23","author":"W Zhao","year":"2014","unstructured":"Zhao W, et al. Human APOE genotype affects intraneuronal Abeta1-42 accumulation in a lentiviral gene transfer model. Hum Mol Genet. 2014;23(5):1365\u201375.","journal-title":"Hum Mol Genet"},{"issue":"15","key":"566_CR358","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1523\/JNEUROSCI.3993-06.2007","volume":"27","author":"X He","year":"2007","unstructured":"He X, et al. Apolipoprotein receptor 2 and X11 alpha\/beta mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and beta-secretase, leading to amyloid-beta production. J Neurosci. 2007;27(15):4052\u201360.","journal-title":"J Neurosci"},{"issue":"3","key":"566_CR359","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, et al. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Abeta Secretion. Cell. 2017;168(3):427-441 e21.","journal-title":"Cell"},{"issue":"8","key":"566_CR360","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway JM, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11(8):457\u201370.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"566_CR361","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo T, Xu H, Bu G. ApoE and Abeta in Alzheimer\u2019s disease: accidental encounters or partners? Neuron. 2014;81(4):740\u201354.","journal-title":"Neuron"},{"issue":"2","key":"566_CR362","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/72237","volume":"6","author":"N Iwata","year":"2000","unstructured":"Iwata N, et al. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med. 2000;6(2):143\u201350.","journal-title":"Nat Med"},{"issue":"49","key":"566_CR363","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem. 1998;273(49):32730\u20138.","journal-title":"J Biol Chem"},{"issue":"5","key":"566_CR364","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron. 2008;58(5):681\u201393.","journal-title":"Neuron"},{"issue":"10","key":"566_CR365","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, et al. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2006;65(10):1012\u201321.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"566_CR366","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","volume":"162","author":"DG Cook","year":"2003","unstructured":"Cook DG, et al. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer\u2019s disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol. 2003;162(1):313\u20139.","journal-title":"Am J Pathol"},{"issue":"53","key":"566_CR367","doi-asserted-by":"publisher","first-page":"44593","DOI":"10.1074\/jbc.M112.420224","volume":"287","author":"J Li","year":"2012","unstructured":"Li J, et al. Differential regulation of amyloid-beta endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms. J Biol Chem. 2012;287(53):44593\u2013601.","journal-title":"J Biol Chem"},{"issue":"7","key":"566_CR368","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nm1058","volume":"10","author":"M Koistinaho","year":"2004","unstructured":"Koistinaho M, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med. 2004;10(7):719\u201326.","journal-title":"Nat Med"},{"issue":"3","key":"566_CR369","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","volume":"287","author":"CY Lee","year":"2012","unstructured":"Lee CY, et al. Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. J Biol Chem. 2012;287(3):2032\u201344.","journal-title":"J Biol Chem"},{"issue":"17","key":"566_CR370","doi-asserted-by":"publisher","first-page":"13959","DOI":"10.1074\/jbc.M111.288746","volume":"287","author":"JM Basak","year":"2012","unstructured":"Basak JM, et al. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Abeta uptake and degradation by astrocytes. J Biol Chem. 2012;287(17):13959\u201371.","journal-title":"J Biol Chem"},{"issue":"19","key":"566_CR371","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","volume":"110","author":"PB Verghese","year":"2013","unstructured":"Verghese PB, et al. ApoE influences amyloid-beta (Abeta) clearance despite minimal apoE\/Abeta association in physiological conditions. Proc Natl Acad Sci U S A. 2013;110(19):E1807\u201316.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"566_CR372","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, et al. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest. 2008;118(12):4002\u201313.","journal-title":"J Clin Invest"},{"key":"566_CR373","doi-asserted-by":"publisher","first-page":"e29595","DOI":"10.7554\/eLife.29595","volume":"6","author":"J Robert","year":"2017","unstructured":"Robert J, et al. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. Elife. 2017;6:e29595.","journal-title":"Elife"},{"issue":"1","key":"566_CR374","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13(1):57.","journal-title":"Mol Neurodegener"},{"issue":"7806","key":"566_CR375","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020;581(7806):71\u20136.","journal-title":"Nature"},{"issue":"7399","key":"566_CR376","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512\u20136.","journal-title":"Nature"},{"issue":"20","key":"566_CR377","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.1074\/jbc.M111.225532","volume":"286","author":"K Nishitsuji","year":"2011","unstructured":"Nishitsuji K, et al. Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model. J Biol Chem. 2011;286(20):17536\u201342.","journal-title":"J Biol Chem"},{"issue":"89","key":"566_CR378","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med. 2011;3(89):89ra57.","journal-title":"Sci Transl Med"},{"issue":"11","key":"566_CR379","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, et al. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"566_CR380","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl M, et al. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron"},{"issue":"12","key":"566_CR381","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286\u2013300.","journal-title":"Brain"},{"issue":"15","key":"566_CR382","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, et al. Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci U S A. 2001;98(15):8838\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"566_CR383","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","volume":"24","author":"WJ Brecht","year":"2004","unstructured":"Brecht WJ, et al. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 2004;24(10):2527\u201334.","journal-title":"J Neurosci"},{"key":"566_CR384","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2012.08.003","volume":"1475","author":"TT Rohn","year":"2012","unstructured":"Rohn TT, et al. Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer\u2019s disease brain. Brain Res. 2012;1475:106\u201315.","journal-title":"Brain Res"},{"key":"566_CR385","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-4-13","volume":"4","author":"TF Gendron","year":"2009","unstructured":"Gendron TF, Petrucelli L. The role of tau in neurodegeneration. Mol Neurodegener. 2009;4:13.","journal-title":"Mol Neurodegener"},{"key":"566_CR386","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fnagi.2017.00311","volume":"9","author":"W Hu","year":"2017","unstructured":"Hu W, et al. Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis. Front Aging Neurosci. 2017;9:311.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"566_CR387","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, et al. Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med. 2021;27(5):871\u201381.","journal-title":"Nat Med"},{"issue":"577","key":"566_CR388","doi-asserted-by":"publisher","first-page":"eabc0655","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"JS Sanchez","year":"2021","unstructured":"Sanchez JS, et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci Transl Med. 2021;13(577):eabc0655.","journal-title":"Sci Transl Med"},{"issue":"4","key":"566_CR389","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006;112(4):389\u2013404.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"566_CR390","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13195-020-00710-6","volume":"12","author":"MS Baek","year":"2020","unstructured":"Baek MS, et al. Effect of APOE epsilon4 genotype on amyloid-beta and tau accumulation in Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):140.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"566_CR391","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.neurobiolaging.2013.10.074","volume":"35","author":"L Yu","year":"2014","unstructured":"Yu L, et al. Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. 2014;35(4):819\u201326.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"566_CR392","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cmet.2018.05.011","volume":"27","author":"MP Mattson","year":"2018","unstructured":"Mattson MP, Arumugam TV. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 2018;27(6):1176\u201399.","journal-title":"Cell Metab"},{"issue":"2","key":"566_CR393","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ana.25142","volume":"83","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL, et al. [(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer\u2019s disease. Ann Neurol. 2018;83(2):248\u201357.","journal-title":"Ann Neurol"},{"issue":"1","key":"566_CR394","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","volume":"11","author":"JW Vogel","year":"2020","unstructured":"Vogel JW, et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease. Nat Commun. 2020;11(1):2612.","journal-title":"Nat Commun"},{"issue":"11","key":"566_CR395","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216(11):2546\u201361.","journal-title":"J Exp Med"},{"issue":"1","key":"566_CR396","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LSB, Ossenkoppele R. Amyloid-beta-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci. 2020;21(1):21\u201335.","journal-title":"Nat Rev Neurosci"},{"issue":"7673","key":"566_CR397","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549(7673):523\u20137.","journal-title":"Nature"},{"issue":"10","key":"566_CR398","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109(10):1657-1674.e7.","journal-title":"Neuron"},{"issue":"1","key":"566_CR399","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1038\/s41598-021-82901-1","volume":"11","author":"AM Jablonski","year":"2021","unstructured":"Jablonski AM, et al. Astrocytic expression of the Alzheimer\u2019s disease risk allele, ApoEepsilon4, potentiates neuronal tau pathology in multiple preclinical models. Sci Rep. 2021;11(1):3438.","journal-title":"Sci Rep"},{"issue":"1","key":"566_CR400","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00401-021-02315-1","volume":"142","author":"SS Kang","year":"2021","unstructured":"Kang SS, et al. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer\u2019s disease. Acta Neuropathol. 2021;142(1):139\u201358.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"566_CR401","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","volume":"89","author":"A Litvinchuk","year":"2021","unstructured":"Litvinchuk A, et al. Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model. Ann Neurol. 2021;89(5):952\u201366.","journal-title":"Ann Neurol"},{"issue":"5","key":"566_CR402","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24(5):647\u201357.","journal-title":"Nat Med"},{"issue":"5","key":"566_CR403","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/ana.25455","volume":"85","author":"AR Wadhwani","year":"2019","unstructured":"Wadhwani AR, et al. Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease. Ann Neurol. 2019;85(5):726\u201339.","journal-title":"Ann Neurol"},{"issue":"10","key":"566_CR404","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang C, et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109(10):1657-1674 e7.","journal-title":"Neuron"},{"issue":"4","key":"566_CR405","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s12035-019-01859-4","volume":"57","author":"EJ Koller","year":"2020","unstructured":"Koller EJ, et al. Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy. Mol Neurobiol. 2020;57(4):1986\u20132001.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"566_CR406","doi-asserted-by":"publisher","first-page":"e80180","DOI":"10.1371\/journal.pone.0080180","volume":"8","author":"TT Rohn","year":"2013","unstructured":"Rohn TT, et al. Immunolocalization of an amino-terminal fragment of apolipoprotein E in the Pick\u2019s disease brain. PLoS ONE. 2013;8(12):e80180.","journal-title":"PLoS ONE"},{"issue":"1","key":"566_CR407","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/alz.12173","volume":"17","author":"AJ Weigand","year":"2021","unstructured":"Weigand AJ, et al. APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia. Alzheimers Dement. 2021;17(1):61\u20139.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"566_CR408","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016;79(1):110\u20139.","journal-title":"Ann Neurol"},{"issue":"7","key":"566_CR409","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s00259-021-05192-8","volume":"48","author":"G Salvado","year":"2021","unstructured":"Salvado G, et al. Differential associations of APOE-epsilon2 and APOE-epsilon4 alleles with PET-measured amyloid-beta and tau deposition in older individuals without dementia. Eur J Nucl Med Mol Imaging. 2021;48(7):2212\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"566_CR410","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","volume":"77","author":"J Therriault","year":"2020","unstructured":"Therriault J, et al. Association of Apolipoprotein E epsilon4 With Medial Temporal Tau Independent of Amyloid-beta. JAMA Neurol. 2020;77(4):470\u20139.","journal-title":"JAMA Neurol"},{"key":"566_CR411","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-981-32-9358-8_15","volume":"1184","author":"E Rodriguez-Vieitez","year":"2019","unstructured":"Rodriguez-Vieitez E, Nielsen HM. Associations Between APOE Variants, Tau and alpha-Synuclein. Adv Exp Med Biol. 2019;1184:177\u201386.","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"566_CR412","doi-asserted-by":"publisher","first-page":"e1913909","DOI":"10.1001\/jamanetworkopen.2019.13909","volume":"2","author":"VK Ramanan","year":"2019","unstructured":"Ramanan VK, et al. Association of Apolipoprotein E varepsilon4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults. JAMA Netw Open. 2019;2(10):e1913909.","journal-title":"JAMA Netw Open"},{"issue":"23","key":"566_CR413","doi-asserted-by":"publisher","first-page":"10563","DOI":"10.7150\/thno.48522","volume":"10","author":"S Yan","year":"2020","unstructured":"Yan S, et al. Association of sex and APOE epsilon4 with brain tau deposition and atrophy in older adults with Alzheimer\u2019s disease. Theranostics. 2020;10(23):10563\u201372.","journal-title":"Theranostics"},{"key":"566_CR414","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnagi.2013.00011","volume":"5","author":"SL Risacher","year":"2013","unstructured":"Risacher SL, et al. The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI). Front Aging Neurosci. 2013;5:11.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"566_CR415","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00401-017-1685-y","volume":"133","author":"Y Deming","year":"2017","unstructured":"Deming Y, et al. Genome-wide association study identifies four novel loci associated with Alzheimer\u2019s endophenotypes and disease modifiers. Acta Neuropathol. 2017;133(5):839\u201356.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"566_CR416","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12883-019-1591-0","volume":"20","author":"C Wattmo","year":"2020","unstructured":"Wattmo C, Blennow K, Hansson O. Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer\u2019s disease. BMC Neurol. 2020;20(1):10.","journal-title":"BMC Neurol"},{"key":"566_CR417","doi-asserted-by":"publisher","first-page":"633576","DOI":"10.3389\/fnins.2021.633576","volume":"15","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer\u2019s Disease: Exploring Interactions With Sex. Front Neurosci. 2021;15:633576.","journal-title":"Front Neurosci"},{"issue":"1","key":"566_CR418","doi-asserted-by":"publisher","first-page":"13728","DOI":"10.1038\/s41598-017-14204-3","volume":"7","author":"G Koch","year":"2017","unstructured":"Koch G, et al. CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer\u2019s disease. Sci Rep. 2017;7(1):13728.","journal-title":"Sci Rep"},{"issue":"5","key":"566_CR419","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1007\/s00259-018-4242-6","volume":"46","author":"A Leuzy","year":"2019","unstructured":"Leuzy A, et al. Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2019;46(5):1152\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"566_CR420","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1007\/s00259-020-04758-2","volume":"47","author":"EE Wolters","year":"2020","unstructured":"Wolters EE, et al. Regional [(18)F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2020;47(12):2866\u201378.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"22","key":"566_CR421","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1212\/WNL.0b013e3181ffe4d1","volume":"75","author":"GC Chiang","year":"2010","unstructured":"Chiang GC, et al. Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects. Neurology. 2010;75(22):1976\u201381.","journal-title":"Neurology"},{"issue":"6","key":"566_CR422","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/WNL.0000000000003585","volume":"88","author":"MJ Grothe","year":"2017","unstructured":"Grothe MJ, et al. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology. 2017;88(6):569\u201376.","journal-title":"Neurology"},{"issue":"1","key":"566_CR423","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s40478-020-01095-1","volume":"8","author":"AC Robinson","year":"2020","unstructured":"Robinson AC, et al. Influence of APOE genotype in primary age-related tauopathy. Acta Neuropathol Commun. 2020;8(1):215.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"566_CR424","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","volume":"9","author":"N Zhao","year":"2018","unstructured":"Zhao N, et al. APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat Commun. 2018;9(1):4388.","journal-title":"Nat Commun"},{"issue":"37","key":"566_CR425","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/JNEUROSCI.2569-11.2011","volume":"31","author":"K Yamada","year":"2011","unstructured":"Yamada K, et al. In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci. 2011;31(37):13110\u20137.","journal-title":"J Neurosci"},{"issue":"7803","key":"566_CR426","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","volume":"580","author":"JN Rauch","year":"2020","unstructured":"Rauch JN, et al. LRP1 is a master regulator of tau uptake and spread. Nature. 2020;580(7803):381\u20135.","journal-title":"Nature"},{"issue":"15","key":"566_CR427","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi Y, et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron. 2021;109(15):2413-2426.e7.","journal-title":"Neuron"},{"issue":"5","key":"566_CR428","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann Neurol. 1990;27(5):457\u201364.","journal-title":"Ann Neurol"},{"issue":"4","key":"566_CR429","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"10","key":"566_CR430","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, et al. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging. 2006;27(10):1372\u201384.","journal-title":"Neurobiol Aging"},{"issue":"5594","key":"566_CR431","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298(5594):789\u201391.","journal-title":"Science"},{"issue":"1","key":"566_CR432","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1041610298005110","volume":"10","author":"P Davidsson","year":"1998","unstructured":"Davidsson P, Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer\u2019s disease. Int Psychogeriatr. 1998;10(1):11\u201323.","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"566_CR433","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-2005-7203","volume":"7","author":"PH Reddy","year":"2005","unstructured":"Reddy PH, et al. Differential loss of synaptic proteins in Alzheimer\u2019s disease: implications for synaptic dysfunction. J Alzheimers Dis. 2005;7(2):103\u201317 (discussion 173-80).","journal-title":"J Alzheimers Dis"},{"issue":"34","key":"566_CR434","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25(34):7709\u201317.","journal-title":"J Neurosci"},{"issue":"10","key":"566_CR435","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1073\/pnas.0811698106","volume":"106","author":"RM Koffie","year":"2009","unstructured":"Koffie RM, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci U S A. 2009;106(10):4012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"566_CR436","doi-asserted-by":"publisher","first-page":"a005777","DOI":"10.1101\/cshperspect.a005777","volume":"4","author":"M Sheng","year":"2012","unstructured":"Sheng M, Sabatini BL, Sudhof TC. Synapses and Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol. 2012;4(5):a005777.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"566_CR437","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert MP, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11):6448\u201353.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"566_CR438","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, et al. Oligomeric Abeta-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:48.","journal-title":"Mol Neurodegener"},{"key":"566_CR439","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1038\/ncomms14726","volume":"8","author":"O Klementieva","year":"2017","unstructured":"Klementieva O, et al. Pre-plaque conformational changes in Alzheimer\u2019s disease-linked Abeta and APP. Nat Commun. 2017;8:14726.","journal-title":"Nat Commun"},{"issue":"5","key":"566_CR440","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0002-9440(10)64463-X","volume":"161","author":"RH Takahashi","year":"2002","unstructured":"Takahashi RH, et al. Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol. 2002;161(5):1869\u201379.","journal-title":"Am J Pathol"},{"key":"566_CR441","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fncel.2020.00072","volume":"14","author":"C Perdigao","year":"2020","unstructured":"Perdigao C, et al. Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer\u2019s Disease. Front Cell Neurosci. 2020;14:72.","journal-title":"Front Cell Neurosci"},{"issue":"5545","key":"566_CR442","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","volume":"294","author":"DH Mauch","year":"2001","unstructured":"Mauch DH, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294(5545):1354\u20137.","journal-title":"Science"},{"issue":"6","key":"566_CR443","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00018-003-3018-7","volume":"60","author":"FW Pfrieger","year":"2003","unstructured":"Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci. 2003;60(6):1158\u201371.","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"566_CR444","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, et al. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"566_CR445","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley RW, Huang Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron. 2012;76(5):871\u201385.","journal-title":"Neuron"},{"issue":"6","key":"566_CR446","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","volume":"109","author":"X Li","year":"2021","unstructured":"Li X, et al. Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. Neuron. 2021;109(6):957-970 e8.","journal-title":"Neuron"},{"issue":"5160","key":"566_CR447","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.8171342","volume":"264","author":"BP Nathan","year":"1994","unstructured":"Nathan BP, et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264(5160):850\u20132.","journal-title":"Science"},{"issue":"1\u20132","key":"566_CR448","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0006-8993(01)03367-4","volume":"928","author":"BP Nathan","year":"2002","unstructured":"Nathan BP, et al. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 2002;928(1\u20132):96\u2013105.","journal-title":"Brain Res"},{"issue":"6","key":"566_CR449","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1046\/j.1471-4159.1999.0732613.x","volume":"73","author":"B Teter","year":"1999","unstructured":"Teter B, et al. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem. 1999;73(6):2613\u20136.","journal-title":"J Neurochem"},{"issue":"2","key":"566_CR450","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.nbd.2004.10.013","volume":"18","author":"C Wang","year":"2005","unstructured":"Wang C, et al. Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology. Neurobiol Dis. 2005;18(2):390\u20138.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"566_CR451","first-page":"e00134","volume":"6","author":"E Nwabuisi-Heath","year":"2014","unstructured":"Nwabuisi-Heath E, et al. ApoE4 delays dendritic spine formation during neuron development and accelerates loss of mature spines in vitro. ASN Neuro. 2014;6(1):e00134.","journal-title":"ASN Neuro"},{"issue":"26","key":"566_CR452","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","volume":"107","author":"Y Chen","year":"2010","unstructured":"Chen Y, et al. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A. 2010;107(26):12011\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"566_CR453","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1097\/00001756-200412030-00020","volume":"15","author":"BL Trommer","year":"2004","unstructured":"Trommer BL, et al. ApoE isoform affects LTP in human targeted replacement mice. NeuroReport. 2004;15(17):2655\u20138.","journal-title":"NeuroReport"},{"key":"566_CR454","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1750-1326-4-21","volume":"4","author":"KM Korwek","year":"2009","unstructured":"Korwek KM, et al. ApoE isoform-dependent changes in hippocampal synaptic function. Mol Neurodegener. 2009;4:21.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"566_CR455","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neulet.2004.07.084","volume":"369","author":"HW Kitamura","year":"2004","unstructured":"Kitamura HW, et al. Age-dependent enhancement of hippocampal long-term potentiation in knock-in mice expressing human apolipoprotein E4 instead of mouse apolipoprotein E. Neurosci Lett. 2004;369(3):173\u20138.","journal-title":"Neurosci Lett"},{"issue":"5","key":"566_CR456","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1101\/lm.030031.112","volume":"20","author":"GA Rodriguez","year":"2013","unstructured":"Rodriguez GA, et al. Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex. Learn Mem. 2013;20(5):256\u201366.","journal-title":"Learn Mem"},{"issue":"41","key":"566_CR457","doi-asserted-by":"publisher","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling Y, et al. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci. 2010;30(41):13707\u201317.","journal-title":"J Neurosci"},{"issue":"2","key":"566_CR458","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbr.2008.05.008","volume":"193","author":"A Bour","year":"2008","unstructured":"Bour A, et al. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav Brain Res. 2008;193(2):174\u201382.","journal-title":"Behav Brain Res"},{"issue":"Pt 7","key":"566_CR459","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/brain\/aws127","volume":"135","author":"RM Koffie","year":"2012","unstructured":"Koffie RM, et al. Apolipoprotein E4 effects in Alzheimer\u2019s disease are mediated by synaptotoxic oligomeric amyloid-beta. Brain. 2012;135(Pt 7):2155\u201368.","journal-title":"Brain"},{"key":"566_CR460","doi-asserted-by":"publisher","first-page":"734001","DOI":"10.3389\/fnins.2021.734001","volume":"15","author":"SC Konings","year":"2021","unstructured":"Konings SC, et al. Astrocytic and Neuronal Apolipoprotein E Isoforms Differentially Affect Neuronal Excitability. Front Neurosci. 2021;15:734001.","journal-title":"Front Neurosci"},{"issue":"8","key":"566_CR461","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.ajpath.2019.04.010","volume":"189","author":"T Bilousova","year":"2019","unstructured":"Bilousova T, et al. Apolipoprotein E\/Amyloid-beta Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4. Am J Pathol. 2019;189(8):1621\u201336.","journal-title":"Am J Pathol"},{"key":"566_CR462","doi-asserted-by":"publisher","first-page":"120700","DOI":"10.1016\/j.biomaterials.2021.120700","volume":"271","author":"C Chun","year":"2021","unstructured":"Chun C, et al. Astrocyte-derived extracellular vesicles enhance the survival and electrophysiological function of human cortical neurons in vitro. Biomaterials. 2021;271:120700.","journal-title":"Biomaterials"},{"issue":"51","key":"566_CR463","doi-asserted-by":"publisher","first-page":"eabk0473","DOI":"10.1126\/sciadv.abk0473","volume":"7","author":"T Phongpreecha","year":"2021","unstructured":"Phongpreecha T, et al. Single-synapse analyses of Alzheimer\u2019s disease implicate pathologic tau, DJ1, CD47, and ApoE. Sci Adv. 2021;7(51):eabk0473.","journal-title":"Sci Adv"},{"key":"566_CR464","doi-asserted-by":"publisher","first-page":"e40048","DOI":"10.7554\/eLife.40048","volume":"7","author":"X Xian","year":"2018","unstructured":"Xian X, et al. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. Elife. 2018;7:e40048.","journal-title":"Elife"},{"issue":"42","key":"566_CR465","doi-asserted-by":"publisher","first-page":"39944","DOI":"10.1074\/jbc.M205147200","volume":"277","author":"EJ Weeber","year":"2002","unstructured":"Weeber EJ, et al. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem. 2002;277(42):39944\u201352.","journal-title":"J Biol Chem"},{"issue":"9","key":"566_CR466","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/brain\/awy197","volume":"141","author":"S Gao","year":"2018","unstructured":"Gao S, et al. Genetic variation within endolysosomal system is associated with late-onset Alzheimer\u2019s disease. Brain. 2018;141(9):2711\u201320.","journal-title":"Brain"},{"issue":"3","key":"566_CR467","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.immuni.2013.08.026","volume":"39","author":"DL Bonilla","year":"2013","unstructured":"Bonilla DL, et al. Autophagy Regulates Phagocytosis by Modulating the Expression of Scavenger Receptors. Immunity. 2013;39(3):537\u201347.","journal-title":"Immunity"},{"issue":"3","key":"566_CR468","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s12035-013-8620-6","volume":"49","author":"R Fu","year":"2014","unstructured":"Fu R, et al. Phagocytosis of Microglia in the Central Nervous System Diseases. Mol Neurobiol. 2014;49(3):1422\u201334.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"566_CR469","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.biopsych.2019.05.008","volume":"87","author":"A Di Meco","year":"2020","unstructured":"Di Meco A, et al. Autophagy Dysfunction in Alzheimer\u2019s Disease: Mechanistic Insights and New Therapeutic Opportunities. Biol Psychiat. 2020;87(9):797\u2013807.","journal-title":"Biol Psychiat"},{"issue":"3","key":"566_CR470","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch S, et al. Impaired Autophagy in APOE4 Astrocytes. J Alzheimers Dis. 2016;51(3):915\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"566_CR471","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-019-0323-7","volume":"14","author":"ZP Van Acker","year":"2019","unstructured":"Van Acker ZP, Bretou M, Annaert W. Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: impact of genetic risk factors. Molecular Neurodegener. 2019;14(1):20.","journal-title":"Molecular Neurodegener"},{"issue":"2","key":"566_CR472","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","volume":"288","author":"L Avrahami","year":"2013","unstructured":"Avrahami L, et al. Inhibition of Glycogen Synthase Kinase-3 Ameliorates \u03b2-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model. J Biol Chem. 2013;288(2):1295\u2013306.","journal-title":"J Biol Chem"},{"issue":"35","key":"566_CR473","doi-asserted-by":"publisher","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","volume":"35","author":"Q Xiao","year":"2015","unstructured":"Xiao Q, et al. Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing A Generation and Amyloid Plaque Pathogenesis. J Neurosci. 2015;35(35):12137\u201351.","journal-title":"J Neurosci"},{"issue":"10","key":"566_CR474","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4161\/auto.29647","volume":"10","author":"M-H Cho","year":"2014","unstructured":"Cho M-H, et al. Autophagy in microglia degrades extracellular \u03b2-amyloid fibrils and regulates the NLRP3 inflammasome. Autophagy. 2014;10(10):1761\u201375.","journal-title":"Autophagy"},{"issue":"7","key":"566_CR475","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1096\/fj.201700359","volume":"31","author":"RA Nixon","year":"2017","unstructured":"Nixon RA. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease. FASEB J. 2017;31(7):2729\u201343.","journal-title":"FASEB J"},{"key":"566_CR476","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-10-151","volume":"10","author":"A Francois","year":"2013","unstructured":"Francois A, et al. Involvement of interleukin-1beta in the autophagic process of microglia: relevance to Alzheimer\u2019s disease. J Neuroinflammation. 2013;10:151.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"566_CR477","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-017-0154-5","volume":"6","author":"M Qian","year":"2017","unstructured":"Qian M, Fang X, Wang X. Autophagy and inflammation. Clin Transl Med. 2017;6(1):1.","journal-title":"Clin Transl Med"},{"key":"566_CR478","doi-asserted-by":"publisher","first-page":"101202","DOI":"10.1016\/j.arr.2020.101202","volume":"65","author":"A-G Wu","year":"2021","unstructured":"Wu A-G, et al. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Res Rev. 2021;65:101202.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"566_CR479","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/emboj.2008.31","volume":"27","author":"MA Delgado","year":"2008","unstructured":"Delgado MA, et al. Toll-like receptors control autophagy. EMBO J. 2008;27(7):1110\u201321.","journal-title":"EMBO J"},{"issue":"14","key":"566_CR480","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1111\/bph.15192","volume":"178","author":"BC King","year":"2020","unstructured":"King BC, et al. Outside in: Roles of complement in autophagy. Br J Pharmacol. 2020;178(14):2786\u2013801.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"566_CR481","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, et al. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157(1):277\u201386.","journal-title":"Am J Pathol"},{"issue":"12","key":"566_CR482","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"23","key":"566_CR483","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1242\/jcs.019265","volume":"120","author":"RA Nixon","year":"2007","unstructured":"Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci. 2007;120(23):4081\u201391.","journal-title":"J Cell Sci"},{"issue":"5","key":"566_CR484","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.ajpath.2013.01.034","volume":"182","author":"MA Kuszczyk","year":"2013","unstructured":"Kuszczyk MA, et al. Blocking the Interaction between Apolipoprotein E and A\u03b2 Reduces Intraneuronal Accumulation of A\u03b2 and Inhibits Synaptic Degeneration. Am J Pathol. 2013;182(5):1750\u201368.","journal-title":"Am J Pathol"},{"issue":"8","key":"566_CR485","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1007\/s12035-018-0892-4","volume":"55","author":"E Schmukler","year":"2018","unstructured":"Schmukler E, Michaelson DM, Pinkas-Kramarski R. The Interplay Between Apolipoprotein E4 and the Autophagic\u2013Endocytic\u2013Lysosomal Axis. Mol Neurobiol. 2018;55(8):6863\u201380.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"566_CR486","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3233\/JAD-190074","volume":"70","author":"S Simonovitch","year":"2019","unstructured":"Simonovitch S, et al. The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo. J Alzheimers Dis. 2019;70(3):861\u201375.","journal-title":"J Alzheimers Dis"},{"key":"566_CR487","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fnins.2017.00702","volume":"11","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, et al. The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo. Front Neurosci. 2017;11:702.","journal-title":"Front Neurosci"},{"issue":"2","key":"566_CR488","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s11357-020-00161-9","volume":"42","author":"C Pomilio","year":"2020","unstructured":"Pomilio C, et al. Microglial autophagy is impaired by prolonged exposure to beta-amyloid peptides: evidence from experimental models and Alzheimer\u2019s disease patients. Geroscience. 2020;42(2):613\u201332.","journal-title":"Geroscience"},{"issue":"2","key":"566_CR489","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jalz.2017.07.754","volume":"14","author":"PA Parcon","year":"2018","unstructured":"Parcon PA, et al. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs. Alzheimers Dement. 2018;14(2):230\u201342.","journal-title":"Alzheimers Dement"},{"issue":"44","key":"566_CR490","doi-asserted-by":"publisher","first-page":"15271","DOI":"10.1523\/JNEUROSCI.2034-12.2012","volume":"32","author":"LBJ McIntire","year":"2012","unstructured":"McIntire LBJ, et al. Reduction of Synaptojanin 1 Ameliorates Synaptic and Behavioral Impairments in a Mouse Model of Alzheimer\u2019s Disease. J Neurosci. 2012;32(44):15271\u20136.","journal-title":"J Neurosci"},{"issue":"38","key":"566_CR491","doi-asserted-by":"publisher","first-page":"11965","DOI":"10.1073\/pnas.1510011112","volume":"112","author":"L Zhu","year":"2015","unstructured":"Zhu L, et al. Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer\u2019s disease pathogenesis. Proc Natl Acad Sci. 2015;112(38):11965\u201370.","journal-title":"Proc Natl Acad Sci"},{"key":"566_CR492","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2018.05.012","volume":"122","author":"CJ Cortes","year":"2019","unstructured":"Cortes CJ, La Spada AR. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities. Neurobiol Dis. 2019;122:83\u201393.","journal-title":"Neurobiol Dis"},{"key":"566_CR493","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.bioelechem.2019.107447","volume":"133","author":"D Lima","year":"2020","unstructured":"Lima D, et al. Electrochemical detection of specific interactions between apolipoprotein E isoforms and DNA sequences related to Alzheimer\u2019s disease. Bioelectrochemistry. 2020;133:107447.","journal-title":"Bioelectrochemistry"},{"issue":"2","key":"566_CR494","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neurobiolaging.2013.08.003","volume":"35","author":"R Tiribuzi","year":"2014","unstructured":"Tiribuzi R, et al. miR128 up-regulation correlates with impaired amyloid \u03b2(1\u201342) degradation in monocytes from patients with sporadic Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(2):345\u201356.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"566_CR495","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1016\/j.celrep.2016.02.006","volume":"14","author":"K Reddy","year":"2016","unstructured":"Reddy K, et al. Dysregulation of Nutrient Sensing and CLEARance in Presenilin Deficiency. Cell Rep. 2016;14(9):2166\u201379.","journal-title":"Cell Rep"},{"issue":"45","key":"566_CR496","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini DM. Twenty-five years of mTOR: Uncovering the link from nutrients to growth. Proc Natl Acad Sci. 2017;114(45):11818\u201325.","journal-title":"Proc Natl Acad Sci"},{"issue":"17","key":"566_CR497","doi-asserted-by":"publisher","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo A, et al. Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-\u03b2, and Tau. J Biol Chem. 2010;285(17):13107\u201320.","journal-title":"J Biol Chem"},{"key":"566_CR498","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fnagi.2017.00173","volume":"9","author":"MA Shafei","year":"2017","unstructured":"Shafei MA, Harris M, Conway ME. Divergent Metabolic Regulation of Autophagy and mTORC1\u2014Early Events in Alzheimer\u2019s Disease? Front Aging Neurosci. 2017;9:173.","journal-title":"Front Aging Neurosci"},{"issue":"11","key":"566_CR499","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrn2009","volume":"7","author":"J Herz","year":"2006","unstructured":"Herz J, Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci. 2006;7(11):850\u20139.","journal-title":"Nat Rev Neurosci"},{"key":"566_CR500","doi-asserted-by":"crossref","unstructured":"Rebeck GW, et al. Mol Neurodegener.\u00a02006;1(1).","DOI":"10.1186\/1750-1326-1-15"},{"issue":"1","key":"566_CR501","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2051-5960-1-3","volume":"1","author":"SC Yates","year":"2013","unstructured":"Yates SC, et al. Dysfunction of the mTOR pathway is a risk factor for Alzheimer\u2019s disease. Acta Neuropathol Commun. 2013;1(1):3.","journal-title":"Acta Neuropathol Commun"},{"key":"566_CR502","doi-asserted-by":"publisher","first-page":"108537","DOI":"10.1016\/j.envres.2019.108537","volume":"176","author":"W Li","year":"2019","unstructured":"Li W, et al. Proteomes analysis reveals the involvement of autophagy in AD-like neuropathology induced by noise exposure and ApoE4. Environmental Research. 2019;176:108537.","journal-title":"Environmental Research"},{"issue":"29","key":"566_CR503","doi-asserted-by":"publisher","first-page":"44873","DOI":"10.18632\/oncotarget.10349","volume":"7","author":"A-L Lin","year":"2016","unstructured":"Lin A-L, Butterfield DA, Richardson A. mTOR: Alzheimer\u2019s disease prevention for APOE4 carriers. Oncotarget. 2016;7(29):44873\u20134.","journal-title":"Oncotarget"},{"issue":"1","key":"566_CR504","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/0271678X15621575","volume":"37","author":"A-L Lin","year":"2016","unstructured":"Lin A-L, et al. Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2016;37(1):217\u201326.","journal-title":"J Cereb Blood Flow Metab"},{"key":"566_CR505","doi-asserted-by":"publisher","first-page":"104834","DOI":"10.1016\/j.nbd.2020.104834","volume":"139","author":"A-L Lin","year":"2020","unstructured":"Lin A-L, et al. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer\u2019s disease. Neurobiol Dis. 2020;139:104834.","journal-title":"Neurobiol Dis"},{"issue":"476","key":"566_CR506","doi-asserted-by":"publisher","first-page":"eaar4289","DOI":"10.1126\/scitranslmed.aar4289","volume":"11","author":"M Kaeberlein","year":"2019","unstructured":"Kaeberlein M, Galvan V. Rapamycin and Alzheimer\u2019s disease: Time for a clinical trial? Sci Transl Med. 2019;11(476):eaar4289.","journal-title":"Sci Transl Med"},{"issue":"1","key":"566_CR507","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1016\/j.cub.2012.10.041","volume":"23","author":"C Dallrmi","year":"2013","unstructured":"Dallrmi C, Devereaux KA, De Paolo G. The Role of Lipids in the Control of Autophagy. Curr Biol. 2013;23(1):R33\u201345.","journal-title":"Curr Biol"},{"issue":"1","key":"566_CR508","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-020-00954-1","volume":"8","author":"K Ando","year":"2020","unstructured":"Ando K, et al. The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2020;8(1):79.","journal-title":"Acta Neuropathol Commun"},{"issue":"44","key":"566_CR509","doi-asserted-by":"publisher","first-page":"32050","DOI":"10.1074\/jbc.M113.504365","volume":"288","author":"L Zhu","year":"2013","unstructured":"Zhu L, et al. Reduction of Synaptojanin 1 Accelerates A\u03b2 Clearance and Attenuates Cognitive Deterioration in an Alzheimer Mouse Model. J Biol Chem. 2013;288(44):32050\u201363.","journal-title":"J Biol Chem"},{"key":"566_CR510","doi-asserted-by":"publisher","unstructured":"Cao J, Huang M, Guo L, Zhu L, Hou J, Zhang L, Pero A, Ng S, El Gaamouch F, Elder G, Sano M, Goate A, Tcw J, Haroutunian V, Zhang B, Cai D. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis. Mol Psychiatry. 2021;26(9):4687-701. https:\/\/doi.org\/10.1038\/s41380-020-0824-3.","DOI":"10.1038\/s41380-020-0824-3"},{"issue":"21","key":"566_CR511","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1523\/JNEUROSCI.0887-09.2009","volume":"29","author":"KR Bales","year":"2009","unstructured":"Bales KR, et al. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J Neurosci. 2009;29(21):6771\u20139.","journal-title":"J Neurosci"},{"issue":"50","key":"566_CR512","doi-asserted-by":"publisher","first-page":"41774","DOI":"10.1074\/jbc.M112.407957","volume":"287","author":"KL Youmans","year":"2012","unstructured":"Youmans KL, et al. APOE4-specific changes in Abeta accumulation in a new transgenic mouse model of Alzheimer disease. J Biol Chem. 2012;287(50):41774\u201386.","journal-title":"J Biol Chem"},{"issue":"2","key":"566_CR513","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg SM, et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38(2):254\u20139.","journal-title":"Ann Neurol"},{"issue":"7","key":"566_CR514","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","volume":"72","author":"PT Nelson","year":"2013","unstructured":"Nelson PT, et al. APOE-epsilon2 and APOE-epsilon4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol. 2013;72(7):708\u201315.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"566_CR515","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","volume":"156","author":"I Tesseur","year":"2000","unstructured":"Tesseur I, et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am J Pathol. 2000;156(3):951\u201364.","journal-title":"Am J Pathol"},{"issue":"9","key":"566_CR516","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2174\/1567205013666160415154550","volume":"13","author":"M Zhou","year":"2016","unstructured":"Zhou M, et al. APOE4 Induces Site-Specific Tau Phosphorylation Through Calpain-CDK5 Signaling Pathway in EFAD-Tg Mice. Curr Alzheimer Res. 2016;13(9):1048\u201355.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"566_CR517","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1097\/00001756-200205070-00026","volume":"13","author":"MC Ljungberg","year":"2002","unstructured":"Ljungberg MC, et al. Truncated apoE forms tangle-like structures in a neuronal cell line. NeuroReport. 2002;13(6):867\u201370.","journal-title":"NeuroReport"},{"key":"566_CR518","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3389\/fnins.2017.00702","volume":"11","author":"T Nuriel","year":"2017","unstructured":"Nuriel T, et al. The Endosomal-Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo. Front Neurosci. 2017;11:702.","journal-title":"Front Neurosci"},{"issue":"10","key":"566_CR519","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"566_CR520","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10522-021-09910-5","volume":"22","author":"Z Li","year":"2021","unstructured":"Li Z, et al. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021;22(2):165\u201387.","journal-title":"Biogerontology"},{"issue":"4","key":"566_CR521","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.cger.2013.07.002","volume":"29","author":"CN Harada","year":"2013","unstructured":"Harada CN, Natelson Love MC, Triebel KL. Normal cognitive aging. Clin Geriatr Med. 2013;29(4):737\u201352.","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"566_CR522","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1515\/REVNEURO.2010.21.3.187","volume":"21","author":"AM Fjell","year":"2010","unstructured":"Fjell AM, Walhovd KB. Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci. 2010;21(3):187\u2013221.","journal-title":"Rev Neurosci"},{"issue":"8","key":"566_CR523","doi-asserted-by":"publisher","first-page":"e1003289","DOI":"10.1371\/journal.pmed.1003289","volume":"17","author":"H Saddiki","year":"2020","unstructured":"Saddiki H, et al. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study. PLoS Med. 2020;17(8):e1003289.","journal-title":"PLoS Med"},{"key":"566_CR524","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neubiorev.2017.01.044","volume":"75","author":"S Di Benedetto","year":"2017","unstructured":"Di Benedetto S, et al. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. 2017;75:114\u201328.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"566_CR525","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s41232-020-00137-4","volume":"40","author":"K Otani","year":"2020","unstructured":"Otani K, Shichita T. Cerebral sterile inflammation in neurodegenerative diseases. Inflamm Regen. 2020;40(1):28.","journal-title":"Inflamm Regen"},{"key":"566_CR526","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.neuroimage.2017.12.027","volume":"172","author":"F Corlier","year":"2018","unstructured":"Corlier F, et al. Systemic inflammation as a predictor of brain aging: Contributions of physical activity, metabolic risk, and genetic risk. Neuroimage. 2018;172:118\u201329.","journal-title":"Neuroimage"},{"issue":"1","key":"566_CR527","doi-asserted-by":"publisher","first-page":"3","DOI":"10.18632\/aging.101704","volume":"11","author":"KA Walker","year":"2018","unstructured":"Walker KA. Inflammation and neurodegeneration: chronicity matters. Aging (Albany NY). 2018;11(1):3\u20134.","journal-title":"Aging (Albany NY)"},{"issue":"7448","key":"566_CR528","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature12143","volume":"497","author":"G Zhang","year":"2013","unstructured":"Zhang G, et al. Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappaB and GnRH. Nature. 2013;497(7448):211\u20136.","journal-title":"Nature"},{"issue":"1","key":"566_CR529","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1038\/s41598-021-81705-7","volume":"11","author":"NC Cullen","year":"2021","unstructured":"Cullen NC, et al. Accelerated inflammatory aging in Alzheimer\u2019s disease and its relation to amyloid, tau, and cognition. Sci Rep. 2021;11(1):1965.","journal-title":"Sci Rep"},{"key":"566_CR530","doi-asserted-by":"publisher","first-page":"e62199","DOI":"10.7554\/eLife.62199","volume":"9","author":"M Shinohara","year":"2020","unstructured":"Shinohara M, et al. APOE2 is associated with longevity independent of Alzheimer\u2019s disease. Elife. 2020;9:e62199.","journal-title":"Elife"},{"issue":"5","key":"566_CR531","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao N, et al. Alzheimer\u2019s Risk Factors Age, APOE Genotype, and Sex Drive Distinct Molecular Pathways. Neuron. 2020;106(5):727-742 e6.","journal-title":"Neuron"},{"issue":"52","key":"566_CR532","doi-asserted-by":"publisher","first-page":"43168","DOI":"10.1074\/jbc.M505598200","volume":"280","author":"AJ Horvath","year":"2005","unstructured":"Horvath AJ, et al. The murine orthologue of human antichymotrypsin: a structural paradigm for clade A3 serpins. J Biol Chem. 2005;280(52):43168\u201378.","journal-title":"J Biol Chem"},{"issue":"Pt 11","key":"566_CR533","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1093\/brain\/awl255","volume":"129","author":"J Padmanabhan","year":"2006","unstructured":"Padmanabhan J, et al. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer\u2019s disease brain, induces tau phosphorylation in neurons. Brain. 2006;129(Pt 11):3020\u201334.","journal-title":"Brain"},{"issue":"2","key":"566_CR534","doi-asserted-by":"publisher","first-page":"e941","DOI":"10.1212\/NXI.0000000000000941","volume":"8","author":"N Fissolo","year":"2021","unstructured":"Fissolo N, et al. CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e941.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"566_CR535","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41420-020-00325-8","volume":"6","author":"ZM Wang","year":"2020","unstructured":"Wang ZM, et al. SerpinA3N deficiency deteriorates impairments of learning and memory in mice following hippocampal stab injury. Cell Death Discov. 2020;6:88.","journal-title":"Cell Death Discov"},{"issue":"6","key":"566_CR536","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/jnc.14860","volume":"151","author":"DM Angelova","year":"2019","unstructured":"Angelova DM, Brown DR. Microglia and the aging brain: are senescent microglia the key to neurodegeneration? J Neurochem. 2019;151(6):676\u201388.","journal-title":"J Neurochem"},{"issue":"4","key":"566_CR537","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3390\/ijms18040769","volume":"18","author":"EC Koellhoffer","year":"2017","unstructured":"Koellhoffer EC, McCullough LD, Ritzel RM. Old Maids: Aging and Its Impact on Microglia Function. Int J Mol Sci. 2017;18(4):769.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"566_CR538","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/npp.2016.185","volume":"42","author":"A Niraula","year":"2017","unstructured":"Niraula A, Sheridan JF, Godbout JP. Microglia Priming with Aging and Stress. Neuropsychopharmacology. 2017;42(1):318\u201333.","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"566_CR539","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/glia.23135","volume":"65","author":"RA Rice","year":"2017","unstructured":"Rice RA, et al. Microglial repopulation resolves inflammation and promotes brain recovery after injury. Glia. 2017;65(6):931\u201344.","journal-title":"Glia"},{"issue":"1","key":"566_CR540","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-019-1678-y","volume":"17","author":"LG Coleman Jr","year":"2020","unstructured":"Coleman LG Jr, Zou J, Crews FT. Microglial depletion and repopulation in brain slice culture normalizes sensitized proinflammatory signaling. J Neuroinflammation. 2020;17(1):27.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"566_CR541","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1002\/glia.23477","volume":"66","author":"AR Najafi","year":"2018","unstructured":"Najafi AR, et al. A limited capacity for microglial repopulation in the adult brain. Glia. 2018;66(11):2385\u201396.","journal-title":"Glia"},{"issue":"12","key":"566_CR542","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1002\/alz.12362","volume":"17","author":"KB Rajan","year":"2021","unstructured":"Rajan KB, et al. Population estimate of people with clinical Alzheimer\u2019s disease and mild cognitive impairment in the United States (2020\u20132060). Alzheimers Dement. 2021;17(12):1966\u201375.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"566_CR543","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3233\/JAD-180141","volume":"64","author":"CR Beam","year":"2018","unstructured":"Beam CR, et al. Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer\u2019s Disease. J Alzheimers Dis. 2018;64(4):1077\u201383.","journal-title":"J Alzheimers Dis"},{"key":"566_CR544","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37\u201348.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"566_CR545","doi-asserted-by":"publisher","first-page":"10867","DOI":"10.1038\/s41598-021-90084-y","volume":"11","author":"L Mosconi","year":"2021","unstructured":"Mosconi L, et al. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Sci Rep. 2021;11(1):10867.","journal-title":"Sci Rep"},{"issue":"8","key":"566_CR546","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamaneurol.2018.0821","volume":"75","author":"TJ Hohman","year":"2018","unstructured":"Hohman TJ, et al. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018;75(8):989\u201398.","journal-title":"JAMA Neurol"},{"issue":"1","key":"566_CR547","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13195-017-0271-9","volume":"9","author":"G Li","year":"2017","unstructured":"Li G, et al. Cerebrospinal fluid biomarkers for Alzheimer\u2019s and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimers Res Ther. 2017;9(1):48.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"566_CR548","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12974-021-02235-7","volume":"18","author":"CK Posillico","year":"2021","unstructured":"Posillico CK, Garcia-Hernandez RE, Tronson NC. Sex differences and similarities in the neuroimmune response to central administration of poly I:C. J Neuroinflammation. 2021;18(1):193.","journal-title":"J Neuroinflammation"},{"key":"566_CR549","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neurobiolaging.2018.04.004","volume":"70","author":"DW Fisher","year":"2018","unstructured":"Fisher DW, Bennett DA, Dong H. Sexual dimorphism in predisposition to Alzheimer\u2019s disease. Neurobiol Aging. 2018;70:308\u201324.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"566_CR550","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12974-021-02120-3","volume":"18","author":"S Qi","year":"2021","unstructured":"Qi S, et al. X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals. J Neuroinflammation. 2021;18(1):70.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"566_CR551","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12974-021-02124-z","volume":"18","author":"J Han","year":"2021","unstructured":"Han J, et al. Uncovering sex differences of rodent microglia. J Neuroinflammation. 2021;18(1):74.","journal-title":"J Neuroinflammation"},{"key":"566_CR552","doi-asserted-by":"publisher","first-page":"753946","DOI":"10.3389\/fnmol.2021.753946","volume":"14","author":"OJ Kalimon","year":"2021","unstructured":"Kalimon OJ, Sullivan PG. Sex Differences in Mitochondrial Function Following a Controlled Cortical Impact Traumatic Brain Injury in Rodents. Front Mol Neurosci. 2021;14:753946.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"566_CR553","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.cell.2017.11.042","volume":"172","author":"MS Thion","year":"2018","unstructured":"Thion MS, et al. Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner. Cell. 2018;172(3):500-516 e16.","journal-title":"Cell"},{"issue":"9","key":"566_CR554","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.3390\/ijms19092793","volume":"19","author":"DV Chistyakov","year":"2018","unstructured":"Chistyakov DV, et al. Sex-Mediated Differences in LPS Induced Alterations of TNFalpha, IL-10 Expression, and Prostaglandin Synthesis in Primary Astrocytes. Int J Mol Sci. 2018;19(9):2793.","journal-title":"Int J Mol Sci"},{"key":"566_CR555","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2042-6410-2-7","volume":"2","author":"M Santos-Galindo","year":"2011","unstructured":"Santos-Galindo M, et al. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ. 2011;2:7.","journal-title":"Biol Sex Differ"},{"issue":"1","key":"566_CR556","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-020-00382-8","volume":"15","author":"R Larramona-Arcas","year":"2020","unstructured":"Larramona-Arcas R, et al. Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice. Mol Neurodegener. 2020;15(1):35.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"566_CR557","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3390\/ijms21093219","volume":"21","author":"A Crespo-Castrillo","year":"2020","unstructured":"Crespo-Castrillo A, Arevalo MA. Microglial and Astrocytic Function in Physiological and Pathological Conditions: Estrogenic Modulation. Int J Mol Sci. 2020;21(9):3219.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"566_CR558","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.3390\/nu11122862","volume":"11","author":"ER Leeming","year":"2019","unstructured":"Leeming ER, et al. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients. 2019;11(12):2862.","journal-title":"Nutrients"},{"issue":"2","key":"566_CR559","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.chom.2020.06.008","volume":"28","author":"P Fang","year":"2020","unstructured":"Fang P, et al. The Microbiome as a Modifier of Neurodegenerative Disease Risk. Cell Host Microbe. 2020;28(2):201\u201322.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"566_CR560","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF, et al. The gut microbiome in neurological disorders. Lancet Neurol. 2020;19(2):179\u201394.","journal-title":"Lancet Neurol"},{"issue":"2","key":"566_CR561","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13668-019-0271-4","volume":"8","author":"AM McGrattan","year":"2019","unstructured":"McGrattan AM, et al. Diet and Inflammation in Cognitive Ageing and Alzheimer\u2019s Disease. Curr Nutr Rep. 2019;8(2):53\u201365.","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"566_CR562","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/nu13010037","volume":"13","author":"A Megur","year":"2020","unstructured":"Megur A, et al. The Microbiota-Gut-Brain Axis and Alzheimer\u2019s Disease: Neuroinflammation Is to Blame? Nutrients. 2020;13(1):37.","journal-title":"Nutrients"},{"issue":"1","key":"566_CR563","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-019-1434-3","volume":"16","author":"Q Ma","year":"2019","unstructured":"Ma Q, et al. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019;16(1):53.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"566_CR564","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-2010-100012","volume":"20","author":"CM Carlsson","year":"2010","unstructured":"Carlsson CM. Type 2 diabetes mellitus, dyslipidemia, and Alzheimer\u2019s disease. J Alzheimers Dis. 2010;20(3):711\u201322.","journal-title":"J Alzheimers Dis"},{"key":"566_CR565","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fnins.2018.00383","volume":"12","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, Mudher A. Alzheimer\u2019s Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Front Neurosci. 2018;12:383.","journal-title":"Front Neurosci"},{"issue":"2","key":"566_CR566","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1039\/C1CS15112F","volume":"41","author":"AS DeToma","year":"2012","unstructured":"DeToma AS, et al. Misfolded proteins in Alzheimer\u2019s disease and type II diabetes. Chem Soc Rev. 2012;41(2):608\u201321.","journal-title":"Chem Soc Rev"},{"key":"566_CR567","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnagi.2016.00159","volume":"8","author":"J Chung","year":"2016","unstructured":"Chung J, et al. Glucose Metabolic Brain Networks in Early-Onset vs. Late-Onset Alzheimer\u2019s Disease. Front Aging Neurosci. 2016;8:159.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"566_CR568","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018;14(3):168\u201381.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"566_CR569","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020;19(9):758\u201366.","journal-title":"Lancet Neurol"},{"key":"566_CR570","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","volume":"15","author":"D El-Lebedy","year":"2016","unstructured":"El-Lebedy D, Raslan HM, Mohammed AM. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc Diabetol. 2016;15:12.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"566_CR571","doi-asserted-by":"publisher","first-page":"346","DOI":"10.14336\/AD.2017.0715","volume":"9","author":"J Zhen","year":"2018","unstructured":"Zhen J, et al. Association of ApoE Genetic Polymorphism and Type 2 Diabetes with Cognition in Non-Demented Aging Chinese Adults: A Community Based Cross-Sectional Study. Aging Dis. 2018;9(3):346\u201357.","journal-title":"Aging Dis"},{"key":"566_CR572","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fphys.2017.01031","volume":"8","author":"JQ Luo","year":"2017","unstructured":"Luo JQ, et al. The Associations between Apolipoprotein E Gene Epsilon2\/Epsilon3\/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus. Front Physiol. 2017;8:1031.","journal-title":"Front Physiol"},{"key":"566_CR573","doi-asserted-by":"publisher","first-page":"104755","DOI":"10.1016\/j.nbd.2020.104755","volume":"137","author":"EM Rhea","year":"2020","unstructured":"Rhea EM, Raber J, Banks WA. ApoE and cerebral insulin: Trafficking, receptors, and resistance. Neurobiol Dis. 2020;137:104755.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"566_CR574","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.1038\/s41598-017-05802-2","volume":"7","author":"R Fallaize","year":"2017","unstructured":"Fallaize R, et al. APOE genotype influences insulin resistance, apolipoprotein CII and CIII according to plasma fatty acid profile in the Metabolic Syndrome. Sci Rep. 2017;7(1):6274.","journal-title":"Sci Rep"},{"issue":"30","key":"566_CR575","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","volume":"38","author":"L Wu","year":"2018","unstructured":"Wu L, Zhang X, Zhao L. Human ApoE Isoforms Differentially Modulate Brain Glucose and Ketone Body Metabolism: Implications for Alzheimer\u2019s Disease Risk Reduction and Early Intervention. J Neurosci. 2018;38(30):6665\u201381.","journal-title":"J Neurosci"},{"key":"566_CR576","doi-asserted-by":"publisher","first-page":"13842","DOI":"10.1038\/srep13842","volume":"5","author":"ES Chan","year":"2015","unstructured":"Chan ES, et al. Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice. Sci Rep. 2015;5:13842.","journal-title":"Sci Rep"},{"key":"566_CR577","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psyneuen.2016.11.028","volume":"77","author":"MT Traversy","year":"2017","unstructured":"Traversy MT, et al. Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene. Psychoneuroendocrinology. 2017;77:203\u201310.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"566_CR578","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","volume":"96","author":"N Zhao","year":"2017","unstructured":"Zhao N, et al. Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes. Neuron. 2017;96(1):115-129 e5.","journal-title":"Neuron"},{"issue":"1","key":"566_CR579","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12974-021-02256-2","volume":"18","author":"NS Jones","year":"2021","unstructured":"Jones NS, Watson KQ, Rebeck GW. High-fat diet increases gliosis and immediate early gene expression in APOE3 mice, but not APOE4 mice. J Neuroinflammation. 2021;18(1):214.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"566_CR580","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/nu13041362","volume":"13","author":"NG Norwitz","year":"2021","unstructured":"Norwitz NG, et al. Precision Nutrition for Alzheimer\u2019s Prevention in ApoE4 Carriers. Nutrients. 2021;13(4):1362.","journal-title":"Nutrients"},{"issue":"1","key":"566_CR581","first-page":"e12006","volume":"12","author":"M Shinohara","year":"2020","unstructured":"Shinohara M, et al. Interaction between APOE genotype and diabetes in cognitive decline. Alzheimers Dement (Amst). 2020;12(1):e12006.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"14","key":"566_CR582","doi-asserted-by":"publisher","first-page":"7643","DOI":"10.3390\/ijerph18147643","volume":"18","author":"X Li","year":"2021","unstructured":"Li X, et al. Effects of Exercise Training on Cardiopulmonary Function and Quality of Life in Elderly Patients with Pulmonary Fibrosis: A Meta-Analysis. Int J Environ Res Public Health. 2021;18(14):7643.","journal-title":"Int J Environ Res Public Health"},{"key":"566_CR583","doi-asserted-by":"publisher","first-page":"4840531","DOI":"10.1155\/2018\/4840531","volume":"2018","author":"MG Benedetti","year":"2018","unstructured":"Benedetti MG, et al. The Effectiveness of Physical Exercise on Bone Density in Osteoporotic Patients. Biomed Res Int. 2018;2018:4840531.","journal-title":"Biomed Res Int"},{"issue":"7850","key":"566_CR584","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/d41586-021-00419-y","volume":"591","author":"M Sacma","year":"2021","unstructured":"Sacma M, Geiger H. Exercise generates immune cells in bone. Nature. 2021;591(7850):371\u20132.","journal-title":"Nature"},{"key":"566_CR585","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/1471-2458-14-510","volume":"14","author":"SJ Blondell","year":"2014","unstructured":"Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies. BMC Public Health. 2014;14:510.","journal-title":"BMC Public Health"},{"issue":"6","key":"566_CR586","first-page":"789","volume":"72","author":"ZS Tan","year":"2017","unstructured":"Tan ZS, et al. Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study. J Gerontol A Biol Sci Med Sci. 2017;72(6):789\u201395.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"4","key":"566_CR587","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jalz.2014.01.008","volume":"11","author":"AM Tolppanen","year":"2015","unstructured":"Tolppanen AM, et al. Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia. Alzheimers Dement. 2015;11(4):434-443 e6.","journal-title":"Alzheimers Dement"},{"issue":"Pt 5","key":"566_CR588","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/brain\/awu041","volume":"137","author":"J Nyberg","year":"2014","unstructured":"Nyberg J, et al. Cardiovascular and cognitive fitness at age 18 and risk of early-onset dementia. Brain. 2014;137(Pt 5):1514\u201323.","journal-title":"Brain"},{"issue":"9 Pt B","key":"566_CR589","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.neubiorev.2013.04.005","volume":"37","author":"K Hotting","year":"2013","unstructured":"Hotting K, Roder B. Beneficial effects of physical exercise on neuroplasticity and cognition. Neurosci Biobehav Rev. 2013;37(9 Pt B):2243\u201357.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"566_CR590","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13195-019-0538-4","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson O, et al. Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):87.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"566_CR591","doi-asserted-by":"publisher","first-page":"e1322","DOI":"10.1212\/WNL.0000000000007021","volume":"92","author":"J Najar","year":"2019","unstructured":"Najar J, et al. Cognitive and physical activity and dementia: A 44-year longitudinal population study of women. Neurology. 2019;92(12):e1322\u201330.","journal-title":"Neurology"},{"issue":"19 Pt 2","key":"566_CR592","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1212\/01.wnl.0000296276.50595.86","volume":"70","author":"G Ravaglia","year":"2008","unstructured":"Ravaglia G, et al. Physical activity and dementia risk in the elderly: findings from a prospective Italian study. Neurology. 2008;70(19 Pt 2):1786\u201394.","journal-title":"Neurology"},{"issue":"11","key":"566_CR593","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1474-4422(05)70198-8","volume":"4","author":"S Rovio","year":"2005","unstructured":"Rovio S, et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer\u2019s disease. Lancet Neurol. 2005;4(11):705\u201311.","journal-title":"Lancet Neurol"},{"issue":"3","key":"566_CR594","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jgs.15241","volume":"66","author":"GA Panza","year":"2018","unstructured":"Panza GA, et al. Can Exercise Improve Cognitive Symptoms of Alzheimer\u2019s Disease? J Am Geriatr Soc. 2018;66(3):487\u201395.","journal-title":"J Am Geriatr Soc"},{"key":"566_CR595","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/CIA.S169565","volume":"13","author":"Z Du","year":"2018","unstructured":"Du Z, et al. Physical activity can improve cognition in patients with Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Clin Interv Aging. 2018;13:1593\u2013603.","journal-title":"Clin Interv Aging"},{"issue":"1","key":"566_CR596","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JAD-170567","volume":"61","author":"KS Frederiksen","year":"2018","unstructured":"Frederiksen KS, et al. Effects of Physical Exercise on Alzheimer\u2019s Disease Biomarkers: A Systematic Review of Intervention Studies. J Alzheimers Dis. 2018;61(1):359\u201372.","journal-title":"J Alzheimers Dis"},{"key":"566_CR597","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuroimage.2017.11.007","volume":"166","author":"J Firth","year":"2018","unstructured":"Firth J, et al. Effect of aerobic exercise on hippocampal volume in humans: A systematic review and meta-analysis. Neuroimage. 2018;166:230\u20138.","journal-title":"Neuroimage"},{"issue":"5","key":"566_CR598","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","volume":"9","author":"A De la Rosa","year":"2020","unstructured":"De la Rosa A, et al. Physical exercise in the prevention and treatment of Alzheimer\u2019s disease. J Sport Health Sci. 2020;9(5):394\u2013404.","journal-title":"J Sport Health Sci"},{"issue":"1","key":"566_CR599","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/156720512799015019","volume":"9","author":"AM Stranahan","year":"2012","unstructured":"Stranahan AM, Martin B, Maudsley S. Anti-inflammatory effects of physical activity in relationship to improved cognitive status in humans and mouse models of Alzheimer\u2019s disease. Curr Alzheimer Res. 2012;9(1):86\u201392.","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"566_CR600","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/cells8070691","volume":"8","author":"O Mee-Inta","year":"2019","unstructured":"Mee-Inta O, Zhao ZW, Kuo YM. Physical Exercise Inhibits Inflammation and Microglial Activation. Cells. 2019;8(7):691.","journal-title":"Cells"},{"issue":"1","key":"566_CR601","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-190654","volume":"73","author":"S Emrani","year":"2020","unstructured":"Emrani S, et al. Alzheimer\u2019s\/Vascular Spectrum Dementia: Classification in Addition to Diagnosis. J Alzheimers Dis. 2020;73(1):63\u201371.","journal-title":"J Alzheimers Dis"},{"key":"566_CR602","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-510X(02)00256-3","volume":"203\u2013204","author":"R Kalaria","year":"2002","unstructured":"Kalaria R. Similarities between Alzheimer\u2019s disease and vascular dementia. J Neurol Sci. 2002;203\u2013204:29\u201334.","journal-title":"J Neurol Sci"},{"key":"566_CR603","doi-asserted-by":"publisher","first-page":"653334","DOI":"10.3389\/fnagi.2021.653334","volume":"13","author":"S Bandyopadhyay","year":"2021","unstructured":"Bandyopadhyay S. Role of Neuron and Glia in Alzheimer\u2019s Disease and Associated Vascular Dysfunction. Front Aging Neurosci. 2021;13:653334.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"566_CR604","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-020-01771-y","volume":"17","author":"M Leardini-Tristao","year":"2020","unstructured":"Leardini-Tristao M, et al. Physical exercise promotes astrocyte coverage of microvessels in a model of chronic cerebral hypoperfusion. J Neuroinflammation. 2020;17(1):117.","journal-title":"J Neuroinflammation"},{"key":"566_CR605","doi-asserted-by":"publisher","first-page":"101173","DOI":"10.1016\/j.arr.2020.101173","volume":"64","author":"J de Frutos-Lucas","year":"2020","unstructured":"de Frutos-Lucas J, et al. Does APOE genotype moderate the relationship between physical activity, brain health and dementia risk? A systematic review. Ageing Res Rev. 2020;64:101173.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"566_CR606","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40119-020-00209-z","volume":"10","author":"S Tokgoz","year":"2021","unstructured":"Tokgoz S, Claassen J. Exercise as Potential Therapeutic Target to Modulate Alzheimer\u2019s Disease Pathology in APOE epsilon4 Carriers: A Systematic Review. Cardiol Ther. 2021;10(1):67\u201388.","journal-title":"Cardiol Ther"},{"issue":"7","key":"566_CR607","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/aje\/kwi092","volume":"161","author":"LJ Podewils","year":"2005","unstructured":"Podewils LJ, et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol. 2005;161(7):639\u201351.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"566_CR608","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-160424","volume":"56","author":"B Fenesi","year":"2017","unstructured":"Fenesi B, et al. Physical Exercise Moderates the Relationship of Apolipoprotein E (APOE) Genotype and Dementia Risk: A Population-Based Study. J Alzheimers Dis. 2017;56(1):297\u2013303.","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"566_CR609","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1212\/WNL.0b013e3182535d35","volume":"78","author":"AS Buchman","year":"2012","unstructured":"Buchman AS, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology. 2012;78(17):1323\u20139.","journal-title":"Neurology"},{"key":"566_CR610","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trci.2019.02.007","volume":"5","author":"CS Jensen","year":"2019","unstructured":"Jensen CS, et al. Patients with Alzheimer\u2019s disease who carry the APOE epsilon4 allele benefit more from physical exercise. Alzheimers Dement (N Y). 2019;5:99\u2013106.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"566_CR611","doi-asserted-by":"publisher","first-page":"e10098","DOI":"10.1590\/1414-431x202010098","volume":"54","author":"MES Colovati","year":"2020","unstructured":"Colovati MES, et al. Interaction between physical exercise and APOE gene polymorphism on cognitive function in older people. Braz J Med Biol Res. 2020;54(2):e10098.","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"566_CR612","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopsycho.2008.02.007","volume":"78","author":"SP Deeny","year":"2008","unstructured":"Deeny SP, et al. Exercise, APOE, and working memory: MEG and behavioral evidence for benefit of exercise in epsilon4 carriers. Biol Psychol. 2008;78(2):179\u201387.","journal-title":"Biol Psychol"},{"issue":"9","key":"566_CR613","doi-asserted-by":"publisher","first-page":"e905","DOI":"10.1212\/WNL.0000000000007003","volume":"92","author":"Y Stern","year":"2019","unstructured":"Stern Y, et al. Effect of aerobic exercise on cognition in younger adults: A randomized clinical trial. Neurology. 2019;92(9):e905\u201316.","journal-title":"Neurology"},{"issue":"3","key":"566_CR614","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3233\/JAD-201090","volume":"79","author":"M Fernandez-Matarrubia","year":"2021","unstructured":"Fernandez-Matarrubia M, et al. An Active Lifestyle Is Associated with Better Cognitive Function Over Time in APOE varepsilon4 Non-Carriers. J Alzheimers Dis. 2021;79(3):1257\u201368.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"566_CR615","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1037\/hea0000515","volume":"37","author":"FS Rodriguez","year":"2018","unstructured":"Rodriguez FS, et al. APOE e4-genotype and lifestyle interaction on cognitive performance: Results of the LIFE-Adult-study. Health Psychol. 2018;37(2):194\u2013205.","journal-title":"Health Psychol"},{"issue":"23","key":"566_CR616","doi-asserted-by":"publisher","first-page":"e2691","DOI":"10.1212\/WNL.0000000000007551","volume":"92","author":"DM Lyall","year":"2019","unstructured":"Lyall DM, et al. Assessing for interaction between APOE epsilon4, sex, and lifestyle on cognitive abilities. Neurology. 2019;92(23):e2691\u20138.","journal-title":"Neurology"},{"issue":"10","key":"566_CR617","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/gerona\/glaa054","volume":"75","author":"N Stringa","year":"2020","unstructured":"Stringa N, et al. Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results from Three Longitudinal Cohort Studies. J Gerontol A Biol Sci Med Sci. 2020;75(10):1880\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"566_CR618","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuroimage.2016.12.023","volume":"148","author":"R Kerestes","year":"2017","unstructured":"Kerestes R, et al. Multimodal evaluation of the amygdala\u2019s functional connectivity. Neuroimage. 2017;148:219\u201329.","journal-title":"Neuroimage"},{"key":"566_CR619","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnagi.2014.00061","volume":"6","author":"JC Smith","year":"2014","unstructured":"Smith JC, et al. Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:61.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"566_CR620","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1177\/0271678X21990342","volume":"41","author":"CS Kaufman","year":"2021","unstructured":"Kaufman CS, et al. Aerobic exercise improves hippocampal blood flow for hypertensive Apolipoprotein E4 carriers. J Cereb Blood Flow Metab. 2021;41(8):2026\u201337.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"5","key":"566_CR621","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/archneurol.2011.845","volume":"69","author":"D Head","year":"2012","unstructured":"Head D, et al. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. Arch Neurol. 2012;69(5):636\u201343.","journal-title":"Arch Neurol"},{"issue":"3\u20134","key":"566_CR622","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000449408","volume":"42","author":"C Steen Jensen","year":"2016","unstructured":"Steen Jensen C, et al. Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease. Dement Geriatr Cogn Disord. 2016;42(3\u20134):146\u201358.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"566_CR623","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/WAD.0000000000000385","volume":"34","author":"M Stojanovic","year":"2020","unstructured":"Stojanovic M, et al. Physical Exercise and Longitudinal Trajectories in Alzheimer Disease Biomarkers and Cognitive Functioning. Alzheimer Dis Assoc Disord. 2020;34(3):212\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"566_CR624","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.exger.2019.04.003","volume":"121","author":"CS Jensen","year":"2019","unstructured":"Jensen CS, et al. Exercise as a potential modulator of inflammation in patients with Alzheimer\u2019s disease measured in cerebrospinal fluid and plasma. Exp Gerontol. 2019;121:91\u20138.","journal-title":"Exp Gerontol"},{"key":"566_CR625","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1742-2094-10-114","volume":"10","author":"RA Kohman","year":"2013","unstructured":"Kohman RA, et al. Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice. J Neuroinflammation. 2013;10:114.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"566_CR626","doi-asserted-by":"publisher","first-page":"e1002279","DOI":"10.1371\/journal.pbio.1002279","volume":"13","author":"I Soto","year":"2015","unstructured":"Soto I, et al. APOE Stabilization by Exercise Prevents Aging Neurovascular Dysfunction and Complement Induction. PLoS Biol. 2015;13(10):e1002279.","journal-title":"PLoS Biol"},{"issue":"6","key":"566_CR627","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41366-018-0120-3","volume":"42","author":"YC Klimentidis","year":"2018","unstructured":"Klimentidis YC, et al. Genome-wide association study of habitual physical activity in over 377,000 UK Biobank participants identifies multiple variants including CADM2 and APOE. Int J Obes (Lond). 2018;42(6):1161\u201376.","journal-title":"Int J Obes (Lond)"},{"key":"566_CR628","doi-asserted-by":"publisher","unstructured":"Wojciechowicz B, Laguette MN, Sawczuk M, Humi\u0144ska-Lisowska K, Maciejewska-Skrendo A, Ficek K, Micha\u0142owska-Sawczyn M, Leo\u0144ska-Duniec A, Kaczmarczyk M, Chycki J, Trybek G, September AV, Ci\u0119szczyk P. Are KIF6 and APOE polymorphisms associated with power and endurance athletes? Eur J Sport Sci. 2021;21(9):1283-9. https:\/\/doi.org\/10.1080\/17461391.2020.1817983.","DOI":"10.1080\/17461391.2020.1817983"},{"issue":"4","key":"566_CR629","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10433-019-00513-1","volume":"16","author":"J Krell-Roesch","year":"2019","unstructured":"Krell-Roesch J, et al. Association of non-exercise physical activity in mid- and late-life with cognitive trajectories and the impact of APOE epsilon4 genotype status: the Mayo Clinic Study of Aging. Eur J Ageing. 2019;16(4):491\u2013502.","journal-title":"Eur J Ageing"},{"key":"566_CR630","doi-asserted-by":"publisher","first-page":"j2709","DOI":"10.1136\/bmj.j2709","volume":"357","author":"S Sabia","year":"2017","unstructured":"Sabia S, et al. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ. 2017;357:j2709.","journal-title":"BMJ"},{"issue":"3","key":"566_CR631","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10654-013-9773-3","volume":"28","author":"RF de Bruijn","year":"2013","unstructured":"de Bruijn RF, et al. The association between physical activity and dementia in an elderly population: the Rotterdam Study. Eur J Epidemiol. 2013;28(3):277\u201383.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"566_CR632","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68\u201380.","journal-title":"Lancet Neurol"},{"issue":"6075","key":"566_CR633","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, et al. ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models. Science. 2012;335(6075):1503\u20136.","journal-title":"Science"},{"issue":"2","key":"566_CR634","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.trci.2016.06.001","volume":"2","author":"K Ghosal","year":"2016","unstructured":"Ghosal K, et al. A randomized controlled study to evaluate the effect of bexarotene on amyloid-\u03b2 and apolipoprotein E metabolism in healthy subjects. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions. 2016;2(2):110\u201320.","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"issue":"1","key":"566_CR635","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","volume":"8","author":"JL Cummings","year":"2016","unstructured":"Cummings JL, et al. Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer\u2019s disease. Alzheimer\u2019s Research & Therapy. 2016;8(1):4.","journal-title":"Alzheimer's Research & Therapy"},{"key":"566_CR636","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","volume":"10","author":"J Hu","year":"2015","unstructured":"Hu J, et al. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Abeta metabolism in apoE4-targeted replacement mice. Mol Neurodegener. 2015;10:6.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"566_CR637","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"JB Rosenberg","year":"2018","unstructured":"Rosenberg JB, et al. AAVrh. 10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer\u2019s Disease. Human Gene Therapy Clin Dev. 2018;29(1):24\u201347.","journal-title":"Human Gene Therapy Clin Dev"},{"issue":"3","key":"566_CR638","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(12)70015-7","volume":"11","author":"R Sperling","year":"2012","unstructured":"Sperling R, et al. Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol. 2012;11(3):241\u20139.","journal-title":"Lancet Neurol"},{"issue":"1","key":"566_CR639","first-page":"e12101","volume":"12","author":"L VandeVrede","year":"2020","unstructured":"VandeVrede L, et al. Symptomatic amyloid-related imaging abnormalities in an APOE \u03b54\/\u03b54 patient treated with aducanumab. Alzheimers Dement. 2020;12(1):e12101.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"566_CR640","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Investig. 2018;128(5):2144\u201355.","journal-title":"J Clin Investig"},{"issue":"12","key":"566_CR641","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1084\/jem.20121274","volume":"209","author":"J Kim","year":"2012","unstructured":"Kim J, et al. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of A\u03b2 amyloidosis. J Exp Med. 2012;209(12):2149\u201356.","journal-title":"J Exp Med"},{"issue":"21","key":"566_CR642","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0646-14.2014","volume":"34","author":"F Liao","year":"2014","unstructured":"Liao F, et al. Anti-ApoE Antibody Given after Plaque Onset Decreases A Accumulation and Improves Brain Function in a Mouse Model of A Amyloidosis. J Neurosci. 2014;34(21):7281\u201392.","journal-title":"J Neurosci"},{"issue":"581","key":"566_CR643","doi-asserted-by":"publisher","first-page":"eabd7522","DOI":"10.1126\/scitranslmed.abd7522","volume":"13","author":"M Xiong","year":"2021","unstructured":"Xiong M, et al. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13(581):eabd7522.","journal-title":"Sci Transl Med"},{"issue":"1","key":"566_CR644","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI200317522","volume":"111","author":"S Przedborski","year":"2003","unstructured":"Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest. 2003;111(1):3\u201310.","journal-title":"J Clin Invest"},{"key":"566_CR645","doi-asserted-by":"publisher","first-page":"101336","DOI":"10.1016\/j.arr.2021.101336","volume":"68","author":"R Gupta","year":"2021","unstructured":"Gupta R, et al. Post-translational modifications: Regulators of neurodegenerative proteinopathies. Ageing Res Rev. 2021;68:101336.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"566_CR646","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/jnc.13411","volume":"136","author":"MR Minter","year":"2016","unstructured":"Minter MR, Taylor JM, Crack PJ. The contribution of neuroinflammation to amyloid toxicity in Alzheimer\u2019s disease. J Neurochem. 2016;136(3):457\u201374.","journal-title":"J Neurochem"},{"key":"566_CR647","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood CJ, et al. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011;2:e167.","journal-title":"Cell Death Dis"},{"issue":"3","key":"566_CR648","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA. Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med. 2010;14(3):457\u201387.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"566_CR649","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1582-4934.2001.tb00134.x","volume":"5","author":"KA Jellinger","year":"2001","unstructured":"Jellinger KA. Cell death mechanisms in neurodegeneration. J Cell Mol Med. 2001;5(1):1\u201317.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"566_CR650","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-019-0323-7","volume":"14","author":"ZP Van Acker","year":"2019","unstructured":"Van Acker ZP, Bretou M, Annaert W. Endo-lysosomal dysregulations and late-onset Alzheimer\u2019s disease: impact of genetic risk factors. Mol Neurodegener. 2019;14(1):20.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"566_CR651","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen AT, et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol. 2020;140(4):477\u201393.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"566_CR652","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41583-020-00416-6","volume":"22","author":"MB Fares","year":"2021","unstructured":"Fares MB, Jagannath S, Lashuel HA. Reverse engineering Lewy bodies: how far have we come and how far can we go? Nat Rev Neurosci. 2021;22(2):111\u201331.","journal-title":"Nat Rev Neurosci"},{"key":"566_CR653","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/jnc.13249","volume":"1391","author":"A Villar-Piqu\u00e9","year":"2016","unstructured":"Villar-Piqu\u00e9 A, Lopes da Fonseca T, Outeiro TF. Structure function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies. J Neurochem. 2016;1391:240\u201355.","journal-title":"J Neurochem"},{"issue":"3","key":"566_CR654","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1021\/acschemneuro.8b00579","volume":"10","author":"VC Ruf","year":"2019","unstructured":"Ruf VC, et al. Different Effects of \u03b1-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements. ACS Chem Neurosci. 2019;10(3):1649\u201359.","journal-title":"ACS Chem Neurosci"},{"issue":"10","key":"566_CR655","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/molecules22101769","volume":"22","author":"JT Hsiao","year":"2017","unstructured":"Hsiao JT, Halliday GM, Kim WS. \u03b1-Synuclein Regulates Neuronal Cholesterol Efflux. Molecules. 2017;22(10):1769.","journal-title":"Molecules"},{"issue":"5","key":"566_CR656","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/mds.28396","volume":"36","author":"P Garc\u00eda-Sanz","year":"2021","unstructured":"Garc\u00eda-Sanz P, Aerts JMFG, Moratalla R. The Role of Cholesterol in \u03b1-Synuclein and Lewy Body Pathology in GBA1 Parkinson\u2019s Disease. Mov Disord. 2021;36(5):1070\u201385.","journal-title":"Mov Disord"},{"issue":"1","key":"566_CR657","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12974-019-1532-2","volume":"16","author":"PJ Hallett","year":"2019","unstructured":"Hallett PJ, Engelender S, Isacson O. Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson\u2019s disease. J Neuroinflammation. 2019;16(1):153.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"566_CR658","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1097\/01.JGP.0000225088.29353.08","volume":"14","author":"B Borroni","year":"2006","unstructured":"Borroni B, et al. APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk. Am J Geriatr Psychiatry. 2006;14(12):1022\u201331.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"566_CR659","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1471-4159.2006.04348.x","volume":"101","author":"G Barcel\u00f3-Coblijn","year":"2007","unstructured":"Barcel\u00f3-Coblijn G, et al. Brain neutral lipids mass is increased in alpha-synuclein gene-ablated mice. J Neurochem. 2007;101(1):132\u201341.","journal-title":"J Neurochem"},{"key":"566_CR660","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neulet.2016.02.042","volume":"618","author":"FN Emamzadeh","year":"2016","unstructured":"Emamzadeh FN, et al. Effects of different isoforms of apoE on aggregation of the \u03b1-synuclein protein implicated in Parkinson\u2019s disease. Neurosci Lett. 2016;618:146\u201351.","journal-title":"Neurosci Lett"},{"issue":"1","key":"566_CR661","first-page":"002","volume":"1","author":"TT Rohn","year":"2018","unstructured":"Rohn TT, Mack JM. Apolipoprotein E Fragmentation within Lewy Bodies of the Human Parkinson\u2019s Disease Brain. Int J Neurodegener Dis. 2018;1(1):002.","journal-title":"Int J Neurodegener Dis"},{"issue":"30","key":"566_CR662","doi-asserted-by":"publisher","first-page":"15226","DOI":"10.1073\/pnas.1821409116","volume":"116","author":"W Paslawski","year":"2019","unstructured":"Paslawski W, et al. alpha-synuclein-lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson\u2019s disease patients. Proc Natl Acad Sci U S A. 2019;116(30):15226\u201335.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"566_CR663","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"566_CR664","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1055\/s-0039-1678579","volume":"39","author":"M Sezgin","year":"2019","unstructured":"Sezgin M, et al. Parkinson\u2019s Disease Dementia and Lewy Body Disease. Semin Neurol. 2019;39(2):274\u201382.","journal-title":"Semin Neurol"},{"issue":"1","key":"566_CR665","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, et al. Dementia with Lewy bodies: an update and outlook. Mol Neurodegener. 2019;14(1):5.","journal-title":"Mol Neurodegener"},{"issue":"11","key":"566_CR666","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaneurol.2014.1455","volume":"71","author":"IF Mata","year":"2014","unstructured":"Mata IF, et al. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease. JAMA Neurol. 2014;71(11):1405\u201312.","journal-title":"JAMA Neurol"},{"issue":"2","key":"566_CR667","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","volume":"46","author":"M Federoff","year":"2012","unstructured":"Federoff M, et al. A large study reveals no association between APOE and Parkinson\u2019s disease. Neurobiol Dis. 2012;46(2):389\u201392.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"566_CR668","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0304-3940(02)00819-4","volume":"330","author":"J Eerola","year":"2002","unstructured":"Eerola J, et al. Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson\u2019s disease in Finland. Neurosci Lett. 2002;330(3):296\u20138.","journal-title":"Neurosci Lett"},{"issue":"6","key":"566_CR669","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1212\/WNL.54.6.1272","volume":"54","author":"BS Harhangi","year":"2000","unstructured":"Harhangi BS, et al. APOE and the risk of PD with or without dementia in a population-based study. Neurology. 2000;54(6):1272\u20136.","journal-title":"Neurology"},{"issue":"2","key":"566_CR670","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ajmg.10111","volume":"107","author":"S Zareparsi","year":"2002","unstructured":"Zareparsi S, et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet. 2002;107(2):156\u201361.","journal-title":"Am J Med Genet"},{"issue":"2","key":"566_CR671","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/mds.28342","volume":"36","author":"MMX Tan","year":"2021","unstructured":"Tan MMX, et al. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson\u2019s Disease. Mov Disord. 2021;36(2):424\u201333.","journal-title":"Mov Disord"},{"issue":"1","key":"566_CR672","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3(1):17013.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"566_CR673","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017;47(3):566-581.e9.","journal-title":"Immunity"},{"issue":"1","key":"566_CR674","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41467-020-15119-w","volume":"11","author":"I Choi","year":"2020","unstructured":"Choi I, et al. Microglia clear neuron-released \u03b1-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11(1):1386.","journal-title":"Nat Commun"},{"key":"566_CR675","first-page":"9497147","volume":"2018","author":"S Pang","year":"2018","unstructured":"Pang S, et al. Meta-Analysis of the Relationship between the. Parkinsons Dis. 2018;2018:9497147.","journal-title":"Parkinsons Dis"},{"issue":"12","key":"566_CR676","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, et al. \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. 2018;91(12):e1182\u201395.","journal-title":"Neurology"},{"issue":"529","key":"566_CR677","doi-asserted-by":"publisher","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N, et al. APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. 2020;12(529):eaay1809.","journal-title":"Sci Transl Med"},{"key":"566_CR678","doi-asserted-by":"publisher","unstructured":"Davis AA, Inman CE, Wargel ZM, Dube U, Freeberg BM, Galluppi A, Haines JN, Dhavale DD, Miller R, Choudhury FA, Sullivan PM, Cruchaga C, Perlmutter JS, Ulrich JD, Benitez BA, Kotzbauer PT, Holtzman DM. APOEgenotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med. 2020;12(529):eaay3069. https:\/\/doi.org\/10.1126\/scitranslmed.aay3069.","DOI":"10.1126\/scitranslmed.aay3069"},{"issue":"1","key":"566_CR679","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1038\/s41467-020-18198-x","volume":"11","author":"TE Goldberg","year":"2020","unstructured":"Goldberg TE, Huey ED, Devanand DP. Association of APOE e2 genotype with Alzheimer\u2019s and non-Alzheimer\u2019s neurodegenerative pathologies. Nat Commun. 2020;11(1):4727.","journal-title":"Nat Commun"},{"issue":"11","key":"566_CR680","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","volume":"85","author":"G Berge","year":"2014","unstructured":"Berge G, et al. Apolipoprotein E epsilon2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort. J Neurol Neurosurg Psychiatry. 2014;85(11):1227\u201331.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"566_CR681","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, et al. APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013;70(2):223\u20138.","journal-title":"JAMA Neurol"},{"issue":"4","key":"566_CR682","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/mds.27297","volume":"33","author":"K Ogaki","year":"2018","unstructured":"Ogaki K, et al. Multiple system atrophy and apolipoprotein E. Mov Disord. 2018;33(4):647\u201350.","journal-title":"Mov Disord"},{"issue":"529","key":"566_CR683","doi-asserted-by":"publisher","first-page":"eaay3069","DOI":"10.1126\/scitranslmed.aay3069","volume":"12","author":"AA Davis","year":"2020","unstructured":"Davis AA, et al. APOE genotype regulates pathology and disease progression in synucleinopathy. Sci Transl Med. 2020;12(529):eaay3069.","journal-title":"Sci Transl Med"},{"issue":"529","key":"566_CR684","doi-asserted-by":"publisher","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","volume":"12","author":"N Zhao","year":"2020","unstructured":"Zhao N, et al. APOE4 exacerbates alpha-synuclein pathology and related toxicity independent of amyloid. Sci Transl Med. 2020;12(529):eaay1809.","journal-title":"Sci Transl Med"},{"issue":"1","key":"566_CR685","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s40478-018-0624-z","volume":"6","author":"D Twohig","year":"2018","unstructured":"Twohig D, et al. The relevance of cerebrospinal fluid alpha-synuclein levels to sporadic and familial Alzheimer\u2019s disease. Acta Neuropathol Commun. 2018;6(1):130.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"566_CR686","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. alpha-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(1):23.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"566_CR687","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.pmr.2016.12.001","volume":"28","author":"KJ Dixon","year":"2017","unstructured":"Dixon KJ. Pathophysiology of Traumatic Brain Injury. Phys Med Rehabil Clin N Am. 2017;28(2):215\u201325.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"566_CR688","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/B978-0-444-52892-6.00001-5","volume":"127","author":"M Faul","year":"2015","unstructured":"Faul M, Coronado V. Epidemiology of traumatic brain injury. Handb Clin Neurol. 2015;127:3\u201313.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"566_CR689","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2217\/nmt-2016-0017","volume":"6","author":"K Dams-O'Connor","year":"2016","unstructured":"Dams-O\u2019Connor K, et al. Traumatic brain injury as a risk factor for Alzheimer\u2019s disease: current knowledge and future directions. Neurodegener Dis Manag. 2016;6(5):417\u201329.","journal-title":"Neurodegener Dis Manag"},{"issue":"4","key":"566_CR690","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1037\/neu0000423","volume":"32","author":"J Schaffert","year":"2018","unstructured":"Schaffert J, et al. Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer\u2019s disease. Neuropsychology. 2018;32(4):410\u20136.","journal-title":"Neuropsychology"},{"issue":"6","key":"566_CR691","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/alz.12080","volume":"16","author":"L Grasset","year":"2020","unstructured":"Grasset L, et al. Association of traumatic brain injury with dementia and memory decline in older adults in the United States. Alzheimers Dement. 2020;16(6):853\u201361.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"566_CR692","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/neu.2007.0489","volume":"25","author":"W Zhou","year":"2008","unstructured":"Zhou W, et al. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25(4):279\u201390.","journal-title":"J Neurotrauma"},{"issue":"8","key":"566_CR693","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1089\/neu.2018.6052","volume":"38","author":"CA McFadyen","year":"2021","unstructured":"McFadyen CA, et al. Apolipoprotein E4 Polymorphism and Outcomes from Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis. J Neurotrauma. 2021;38(8):1124\u201336.","journal-title":"J Neurotrauma"},{"issue":"4","key":"566_CR694","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/bph.13125","volume":"173","author":"IP Karve","year":"2016","unstructured":"Karve IP, Taylor JM, Crack PJ. The contribution of astrocytes and microglia to traumatic brain injury. Br J Pharmacol. 2016;173(4):692\u2013702.","journal-title":"Br J Pharmacol"},{"key":"566_CR695","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuroscience.2019.01.049","volume":"404","author":"P Muza","year":"2019","unstructured":"Muza P, et al. APOE Genotype Specific Effects on the Early Neurodegenerative Sequelae Following Chronic Repeated Mild Traumatic Brain Injury. Neuroscience. 2019;404:297\u2013313.","journal-title":"Neuroscience"},{"key":"566_CR696","doi-asserted-by":"publisher","first-page":"e8324","DOI":"10.7717\/peerj.8324","volume":"7","author":"J Zhao","year":"2019","unstructured":"Zhao J, et al. Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats. PeerJ. 2019;7:e8324.","journal-title":"PeerJ"},{"issue":"1","key":"566_CR697","doi-asserted-by":"publisher","first-page":"19919","DOI":"10.1038\/s41598-020-76849-x","volume":"10","author":"AO Giarratana","year":"2020","unstructured":"Giarratana AO, et al. APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes. Sci Rep. 2020;10(1):19919.","journal-title":"Sci Rep"},{"key":"566_CR698","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphys.2020.01030","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, et al. Blood-Brain Barrier Dysfunction in Mild Traumatic Brain Injury: Evidence From Preclinical Murine Models. Front Physiol. 2020;11:1030.","journal-title":"Front Physiol"},{"key":"566_CR699","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, et al. Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders. Front Physiol. 2020;11:914.","journal-title":"Front Physiol"},{"issue":"1","key":"566_CR700","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-018-0249-5","volume":"13","author":"BS Main","year":"2018","unstructured":"Main BS, et al. Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury. Mol Neurodegener. 2018;13(1):17.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"566_CR701","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-021-00073-z","volume":"1","author":"A Montagne","year":"2021","unstructured":"Montagne A, et al. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer\u2019s mice via cyclophilin A independently of amyloid-\u03b2. Nature Aging. 2021;1(6):506\u201320.","journal-title":"Nature Aging"},{"issue":"1","key":"566_CR702","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1038\/s41598-017-06932-3","volume":"7","author":"Z Teng","year":"2017","unstructured":"Teng Z, et al. ApoE Influences the Blood-Brain Barrier Through the NF-kappaB\/MMP-9 Pathway After Traumatic Brain Injury. Sci Rep. 2017;7(1):6649.","journal-title":"Sci Rep"},{"issue":"4","key":"566_CR703","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/bpa.12532","volume":"28","author":"S Abu Hamdeh","year":"2018","unstructured":"Abu Hamdeh S, et al. Rapid amyloid-beta oligomer and protofibril accumulation in traumatic brain injury. Brain Pathol. 2018;28(4):451\u201362.","journal-title":"Brain Pathol"},{"issue":"1","key":"566_CR704","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-015-1435-y","volume":"130","author":"TD Stein","year":"2015","unstructured":"Stein TD, et al. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol. 2015;130(1):21\u201334.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"566_CR705","doi-asserted-by":"publisher","first-page":"11372","DOI":"10.1038\/s41598-017-11654-7","volume":"7","author":"J Cao","year":"2017","unstructured":"Cao J, et al. ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury. Sci Rep. 2017;7(1):11372.","journal-title":"Sci Rep"},{"issue":"9","key":"566_CR706","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1212\/01.WNL.0000063313.57292.00","volume":"60","author":"G Franz","year":"2003","unstructured":"Franz G, et al. Amyloid beta 1\u201342 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology. 2003;60(9):1457\u201361.","journal-title":"Neurology"},{"key":"566_CR707","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2018.01.021","volume":"28","author":"J Ramos-Cejudo","year":"2018","unstructured":"Ramos-Cejudo J, et al. Traumatic Brain Injury and Alzheimer\u2019s Disease: The Cerebrovascular Link. EBioMedicine. 2018;28:21\u201330.","journal-title":"EBioMedicine"},{"issue":"Pt B","key":"566_CR708","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mcn.2015.03.012","volume":"66","author":"H Ling","year":"2015","unstructured":"Ling H, Hardy J, Zetterberg H. Neurological consequences of traumatic brain injuries in sports. Mol Cell Neurosci. 2015;66(Pt B):114\u201322.","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"566_CR709","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/jnnp.53.5.373","volume":"53","author":"GW Roberts","year":"1990","unstructured":"Roberts GW, Allsop D, Bruton C. The occult aftermath of boxing. J Neurol Neurosurg Psychiatry. 1990;53(5):373\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"566_CR710","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1001\/archneur.64.4.541","volume":"64","author":"ST DeKosky","year":"2007","unstructured":"DeKosky ST, et al. Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol. 2007;64(4):541\u20134.","journal-title":"Arch Neurol"},{"key":"566_CR711","doi-asserted-by":"publisher","unstructured":"Goldberg TE, Huey ED, Devanand DP. Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brains. J Neurol Neurosurg Psychiatry. 2020:jnnp-2020-323746. https:\/\/doi.org\/10.1136\/jnnp-2020-323746.","DOI":"10.1136\/jnnp-2020-323746"},{"issue":"5","key":"566_CR712","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1159\/000210432","volume":"27","author":"P Amarenco","year":"2009","unstructured":"Amarenco P, et al. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27(5):493\u2013501.","journal-title":"Cerebrovasc Dis"},{"issue":"5","key":"566_CR713","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","volume":"1862","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862(5):915\u201325.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"566_CR714","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/JAD-190566","volume":"71","author":"E Werden","year":"2019","unstructured":"Werden E, et al. APOE varepsilon4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke. J Alzheimers Dis. 2019;71(1):245\u201359.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"566_CR715","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/STROKEAHA.119.028814","volume":"51","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation DA, Zlokovic BV. APOE4 Accelerates Development of Dementia After Stroke: Is There a Role for Cerebrovascular Dysfunction? Stroke. 2020;51(3):699\u2013700.","journal-title":"Stroke"},{"issue":"3","key":"566_CR716","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1161\/STROKEAHA.119.026927","volume":"51","author":"ST Pendlebury","year":"2020","unstructured":"Pendlebury ST, et al. APOE-epsilon4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study. Stroke. 2020;51(3):751\u20138.","journal-title":"Stroke"},{"issue":"19","key":"566_CR717","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1212\/WNL.0000000000008459","volume":"93","author":"C Lagging","year":"2019","unstructured":"Lagging C, et al. APOE epsilon4 is associated with younger age at ischemic stroke onset but not with stroke outcome. Neurology. 2019;93(19):849\u201353.","journal-title":"Neurology"},{"issue":"3\u20134","key":"566_CR718","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000442678","volume":"41","author":"C Chen","year":"2016","unstructured":"Chen C, Hu Z. ApoE Polymorphisms and the Risk of Different Subtypes of Stroke in the Chinese Population: A Comprehensive Meta-Analysis. Cerebrovasc Dis. 2016;41(3\u20134):119\u201338.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"566_CR719","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.jcbfm.9600385","volume":"27","author":"L Qiu","year":"2007","unstructured":"Qiu L, et al. Less neurogenesis and inflammation in the immature than in the juvenile brain after cerebral hypoxia-ischemia. J Cereb Blood Flow Metab. 2007;27(4):785\u201394.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"566_CR720","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41598-018-36598-4","volume":"9","author":"L Buscemi","year":"2019","unstructured":"Buscemi L, et al. Spatio-temporal overview of neuroinflammation in an experimental mouse stroke model. Sci Rep. 2019;9(1):507.","journal-title":"Sci Rep"},{"issue":"2","key":"566_CR721","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/STROKEAHA.120.032402","volume":"52","author":"Z Cao","year":"2021","unstructured":"Cao Z, et al. Unique Subtype of Microglia in Degenerative Thalamus After Cortical Stroke. Stroke. 2021;52(2):687\u201398.","journal-title":"Stroke"},{"key":"566_CR722","doi-asserted-by":"publisher","first-page":"32893","DOI":"10.1038\/srep32893","volume":"6","author":"X Cheng","year":"2016","unstructured":"Cheng X, et al. Galectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke. Sci Rep. 2016;6:32893.","journal-title":"Sci Rep"},{"issue":"1","key":"566_CR723","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41398-020-00864-9","volume":"10","author":"J Xiang","year":"2020","unstructured":"Xiang J, et al. Melatonin-induced ApoE expression in mouse astrocytes protects endothelial cells from OGD-R induced injuries. Transl Psychiatry. 2020;10(1):181.","journal-title":"Transl Psychiatry"},{"key":"566_CR724","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pneurobio.2016.04.005","volume":"141","author":"Y Wang","year":"2016","unstructured":"Wang Y, et al. White matter injury in ischemic stroke. Prog Neurobiol. 2016;141:45\u201360.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"566_CR725","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3233\/JAD-160527","volume":"54","author":"M Vijayan","year":"2016","unstructured":"Vijayan M, Reddy PH. Stroke, Vascular Dementia, and Alzheimer\u2019s Disease: Molecular Links. J Alzheimers Dis. 2016;54(2):427\u201343.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"566_CR726","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/01.STR.0000259816.31370.44","volume":"38","author":"R Lemmens","year":"2007","unstructured":"Lemmens R, et al. Association of apolipoprotein E epsilon2 with white matter disease but not with microbleeds. Stroke. 2007;38(4):1185\u20138.","journal-title":"Stroke"},{"issue":"11","key":"566_CR727","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1212\/WNL.0000000000001379","volume":"84","author":"R Wang","year":"2015","unstructured":"Wang R, et al. Effects of vascular risk factors and APOE epsilon4 on white matter integrity and cognitive decline. Neurology. 2015;84(11):1128\u201335.","journal-title":"Neurology"},{"issue":"5","key":"566_CR728","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1007\/s12975-020-00786-0","volume":"11","author":"EY Hayden","year":"2020","unstructured":"Hayden EY, et al. Modeling Mixed Vascular and Alzheimer\u2019s Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice. Transl Stroke Res. 2020;11(5):1064\u201376.","journal-title":"Transl Stroke Res"},{"issue":"11","key":"566_CR729","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms20112818","volume":"20","author":"MAJ van den Bos","year":"2019","unstructured":"van den Bos MAJ, et al. Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques. Int J Mol Sci. 2019;20(11):2818.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"566_CR730","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1212\/WNL.0b013e318281cc1b","volume":"80","author":"DA Restivo","year":"2013","unstructured":"Restivo DA, et al. ALS dysphagia pathophysiology: differential botulinum toxin response. Neurology. 2013;80(7):616\u201320.","journal-title":"Neurology"},{"issue":"1","key":"566_CR731","doi-asserted-by":"publisher","first-page":"16582","DOI":"10.1038\/s41598-018-34510-8","volume":"8","author":"SK Vaughan","year":"2018","unstructured":"Vaughan SK, et al. The ALS-inducing factors, TDP43(A315T) and SOD1(G93A), directly affect and sensitize sensory neurons to stress. Sci Rep. 2018;8(1):16582.","journal-title":"Sci Rep"},{"issue":"3","key":"566_CR732","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s12035-018-1218-2","volume":"56","author":"GS Jeon","year":"2019","unstructured":"Jeon GS, et al. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations. Mol Neurobiol. 2019;56(3):2007\u201321.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"566_CR733","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-020-00228-9","volume":"10","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Chen Y, Shang H. Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Transl Neurodegener. 2021;10(1):3.","journal-title":"Transl Neurodegener"},{"issue":"6","key":"566_CR734","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00018-013-1480-4","volume":"71","author":"F Rizzo","year":"2014","unstructured":"Rizzo F, et al. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci. 2014;71(6):999\u20131015.","journal-title":"Cell Mol Life Sci"},{"key":"566_CR735","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front Immunol. 2017;8:1005.","journal-title":"Front Immunol"},{"issue":"26","key":"566_CR736","doi-asserted-by":"publisher","first-page":"5137","DOI":"10.1523\/JNEUROSCI.0536-20.2020","volume":"40","author":"K Dutta","year":"2020","unstructured":"Dutta K, et al. Mitigation of ALS Pathology by Neuron-Specific Inhibition of Nuclear Factor Kappa B Signaling. J Neurosci. 2020;40(26):5137\u201354.","journal-title":"J Neurosci"},{"key":"566_CR737","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fnins.2020.00824","volume":"14","author":"M Izrael","year":"2020","unstructured":"Izrael M, Slutsky SG, Revel M. Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease. Front Neurosci. 2020;14:824.","journal-title":"Front Neurosci"},{"issue":"4","key":"566_CR738","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1468-1331.2010.03225.x","volume":"18","author":"A Jawaid","year":"2011","unstructured":"Jawaid A, et al. Does apolipoprotein E genotype modify the clinical expression of ALS? Eur J Neurol. 2011;18(4):618\u201324.","journal-title":"Eur J Neurol"},{"issue":"4","key":"566_CR739","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10048-004-0193-0","volume":"5","author":"YJ Li","year":"2004","unstructured":"Li YJ, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004;5(4):209\u201313.","journal-title":"Neurogenetics"},{"issue":"2","key":"566_CR740","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/ene.13812","volume":"26","author":"A Canosa","year":"2019","unstructured":"Canosa A, et al. Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis. Eur J Neurol. 2019;26(2):306\u201312.","journal-title":"Eur J Neurol"},{"issue":"7\u20138","key":"566_CR741","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3109\/21678421.2014.918149","volume":"15","author":"F Govone","year":"2014","unstructured":"Govone F, et al. Lack of association between APOE gene polymorphisms and amyotrophic lateral sclerosis: a comprehensive meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7\u20138):551\u20136.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"566_CR742","doi-asserted-by":"publisher","first-page":"823","DOI":"10.18632\/aging.101195","volume":"9","author":"P Andres-Benito","year":"2017","unstructured":"Andres-Benito P, et al. Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration. Aging (Albany NY). 2017;9(3):823\u201351.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"566_CR743","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s12035-017-0453-2","volume":"55","author":"K Mouzat","year":"2018","unstructured":"Mouzat K, et al. Liver X Receptor Genes Variants Modulate ALS Phenotype. Mol Neurobiol. 2018;55(3):1959\u201365.","journal-title":"Mol Neurobiol"},{"issue":"17","key":"566_CR744","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1212\/WNL.0000000000009322","volume":"94","author":"C Ingre","year":"2020","unstructured":"Ingre C, et al. Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis. Neurology. 2020;94(17):e1835\u201344.","journal-title":"Neurology"},{"key":"566_CR745","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fneur.2019.00284","volume":"10","author":"JL Gonzalez De Aguilar","year":"2019","unstructured":"Gonzalez De Aguilar JL. Lipid Biomarkers for Amyotrophic Lateral Sclerosis. Front Neurol. 2019;10:284.","journal-title":"Front Neurol"},{"issue":"47","key":"566_CR746","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","volume":"40","author":"JC Dodge","year":"2020","unstructured":"Dodge JC, et al. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis. J Neurosci. 2020;40(47):9137\u201347.","journal-title":"J Neurosci"},{"issue":"1","key":"566_CR747","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik J, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res. 2017;58(1):267\u201378.","journal-title":"J Lipid Res"},{"issue":"1","key":"566_CR748","doi-asserted-by":"publisher","first-page":"11642","DOI":"10.1038\/s41598-019-48059-7","volume":"9","author":"AB Chaves-Filho","year":"2019","unstructured":"Chaves-Filho AB, et al. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci Rep. 2019;9(1):11642.","journal-title":"Sci Rep"},{"issue":"7772","key":"566_CR749","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41586-019-1404-z","volume":"573","author":"L Schirmer","year":"2019","unstructured":"Schirmer L, et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature. 2019;573(7772):75\u201382.","journal-title":"Nature"},{"issue":"9","key":"566_CR750","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/jmedgenet-2012-101175","volume":"49","author":"CM Lill","year":"2012","unstructured":"Lill CM, et al. Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects. J Med Genet. 2012;49(9):558\u201362.","journal-title":"J Med Genet"},{"issue":"5","key":"566_CR751","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/WNL.57.5.853","volume":"57","author":"F Fazekas","year":"2001","unstructured":"Fazekas F, et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. 2001;57(5):853\u20137.","journal-title":"Neurology"},{"issue":"10","key":"566_CR752","first-page":"1122","volume":"15","author":"Y Tamam","year":"2011","unstructured":"Tamam Y, et al. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis. Eur Rev Med Pharmacol Sci. 2011;15(10):1122\u201330.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"566_CR753","doi-asserted-by":"publisher","first-page":"102954","DOI":"10.1016\/j.ebiom.2020.102954","volume":"59","author":"AL Lumsden","year":"2020","unstructured":"Lumsden AL, et al. Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK Biobank. EBioMedicine. 2020;59:102954.","journal-title":"EBioMedicine"},{"issue":"5","key":"566_CR754","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/jnen\/59.5.361","volume":"59","author":"C Carlin","year":"2000","unstructured":"Carlin C, et al. Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele. J Neuropathol Exp Neurol. 2000;59(5):361\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"566_CR755","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12944-020-01221-x","volume":"19","author":"Z Radikova","year":"2020","unstructured":"Radikova Z, et al. Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation? Lipids Health Dis. 2020;19(1):49.","journal-title":"Lipids Health Dis"},{"key":"566_CR756","doi-asserted-by":"publisher","first-page":"101415","DOI":"10.1016\/j.msard.2019.101415","volume":"36","author":"H Noori","year":"2019","unstructured":"Noori H, et al. The correlation between dyslipidemia and cognitive impairment in multiple sclerosis patients. Mult Scler Relat Disord. 2019;36:101415.","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"566_CR757","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/1352458517696595","volume":"24","author":"J Mailleux","year":"2018","unstructured":"Mailleux J, et al. Active liver X receptor signaling in phagocytes in multiple sclerosis lesions. Mult Scler. 2018;24(3):279\u201389.","journal-title":"Mult Scler"},{"issue":"6","key":"566_CR758","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1002\/jnr.21038","volume":"84","author":"C Hindinger","year":"2006","unstructured":"Hindinger C, et al. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res. 2006;84(6):1225\u201334.","journal-title":"J Neurosci Res"},{"key":"566_CR759","doi-asserted-by":"publisher","first-page":"639757","DOI":"10.3389\/fendo.2021.639757","volume":"12","author":"I Pineda-Torra","year":"2021","unstructured":"Pineda-Torra I, et al. Disrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors? Front Endocrinol (Lausanne). 2021;12:639757.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"566_CR760","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1191\/1352458503ms965oa","volume":"9","author":"A Minagar","year":"2003","unstructured":"Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler. 2003;9(6):540\u20139.","journal-title":"Mult Scler"},{"key":"566_CR761","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2018.00129","volume":"10","author":"J Geng","year":"2018","unstructured":"Geng J, et al. Blood-Brain Barrier Disruption Induced Cognitive Impairment Is Associated With Increase of Inflammatory Cytokine. Front Aging Neurosci. 2018;10:129.","journal-title":"Front Aging Neurosci"},{"key":"566_CR762","doi-asserted-by":"publisher","unstructured":"Engel S, Graetz C, Salmen A, Muthuraman M, Toenges G, Ambrosius B, Bayas A, Berthele A, Heesen C, Klotz L, K\u00fcmpfel T, Linker RA, Meuth SG, Paul F, Stangel M, Tackenberg B, Then Bergh F, Tumani H, Weber F, Wildemann B, Zettl UK, Antony G, Bittner S, Groppa S, Hemmer B, Wiendl H, Gold R, Zipp F, Lill CM, Luessi F; German Competence Network of Multiple Sclerosis. Is APOE \u03b54 associated with cognitive performance in early MS? Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e728. https:\/\/doi.org\/10.1212\/NXI.0000000000000728.","DOI":"10.1212\/NXI.0000000000000728"},{"issue":"1","key":"566_CR763","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1352458506070682","volume":"13","author":"BA Parmenter","year":"2007","unstructured":"Parmenter BA, et al. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms. Mult Scler. 2007;13(1):25\u201332.","journal-title":"Mult Scler"},{"key":"566_CR764","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/nyas.12841","volume":"1351","author":"M Prins","year":"2015","unstructured":"Prins M, et al. Pathological differences between white and grey matter multiple sclerosis lesions. Ann N Y Acad Sci. 2015;1351:99\u2013113.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"566_CR765","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.it.2021.01.005","volume":"42","author":"L Schirmer","year":"2021","unstructured":"Schirmer L, et al. Diversity and Function of Glial Cell Types in Multiple Sclerosis. Trends Immunol. 2021;42(3):228\u201347.","journal-title":"Trends Immunol"},{"issue":"2","key":"566_CR766","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/brain\/aww298","volume":"140","author":"G Ponath","year":"2017","unstructured":"Ponath G, et al. Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology. Brain. 2017;140(2):399\u2013413.","journal-title":"Brain"},{"issue":"3","key":"566_CR767","doi-asserted-by":"publisher","first-page":"eaay6324","DOI":"10.1126\/sciadv.aay6324","volume":"6","author":"JR Plemel","year":"2020","unstructured":"Plemel JR, et al. Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion. Sci Adv. 2020;6(3):eaay6324.","journal-title":"Sci Adv"},{"issue":"4","key":"566_CR768","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00401-020-02193-z","volume":"140","author":"F Cignarella","year":"2020","unstructured":"Cignarella F, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140(4):513\u201334.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"566_CR769","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1001\/jamaneurol.2022.1166","volume":"79","author":"Y Le Guen","year":"2022","unstructured":"Le Guen Y, et al. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease. JAMA Neurol. 2022;79(7):652\u201363.","journal-title":"JAMA Neurol"},{"issue":"2","key":"566_CR770","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ana.24326","volume":"77","author":"KL Rasmussen","year":"2015","unstructured":"Rasmussen KL, et al. Plasma levels of apolipoprotein E and risk of dementia in the general population. Ann Neurol. 2015;77(2):301\u201311.","journal-title":"Ann Neurol"},{"key":"566_CR771","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cortex.2016.12.016","volume":"88","author":"N Zokaei","year":"2017","unstructured":"Zokaei N, et al. Sex and APOE: A memory advantage in male APOE epsilon4 carriers in midlife. Cortex. 2017;88:98\u2013105.","journal-title":"Cortex"},{"issue":"2","key":"566_CR772","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1113\/JP273106","volume":"595","author":"TG Dinan","year":"2017","unstructured":"Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol. 2017;595(2):489\u2013503.","journal-title":"J Physiol"},{"issue":"5","key":"566_CR773","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1167\/iovs.03-1121","volume":"45","author":"PN Baird","year":"2004","unstructured":"Baird PN, et al. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45(5):1311\u20135.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"566_CR774","doi-asserted-by":"publisher","first-page":"843558","DOI":"10.3389\/fimmu.2022.843558","volume":"13","author":"SK Wang","year":"2022","unstructured":"Wang SK, Cepko CL. Targeting Microglia to Treat Degenerative Eye Diseases. Front Immunol. 2022;13:843558.","journal-title":"Front Immunol"},{"issue":"9","key":"566_CR775","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells10092394","volume":"10","author":"N Marchesi","year":"2021","unstructured":"Marchesi N, et al. Ocular Neurodegenerative Diseases: Interconnection between Retina and Cortical Areas. Cells. 2021;10(9):2394.","journal-title":"Cells"},{"issue":"7","key":"566_CR776","first-page":"635","volume":"11","author":"ML Hu","year":"2021","unstructured":"Hu ML, Quinn J, Xue K. Interactions between Apolipoprotein E Metabolism and Retinal Inflammation in Age-Related Macular Degeneration. Life (Basel). 2021;11(7):635.","journal-title":"Life (Basel)"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-022-00566-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-022-00566-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T12:38:17Z","timestamp":1701088697000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-022-00566-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,24]]},"references-count":776,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["566"],"URL":"https:\/\/doi.org\/10.1186\/s13024-022-00566-4","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,24]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}